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Abstract 
Purpose: Despite the proven benefits of cardiac rehabilitation (CR) it remains underutilised 
in the percutaneous coronary intervention (PCI) cohort in many healthcare systems. The 
objective of this thesis is to contribute to the growing area of CR research by systematically 
reviewing CR utilisation determinants in the literature then validate those determinants 
against routinely collected clinical data. 
Methods: A systematic review was conducted to identify CR utilisation determinants in the 
literature. Data from the UK National Audit of Cardiac Rehabilitation (NACR) for patients 
who underwent PCI in 2013 to 2016 was retrieved. Three hierarchical logistic regression 
models were constructed, using multiple imputation as appropriate, to assess the impact of 
the identified determinants on CR engagement, uptake and adherence. To account for mode 
of CR delivery on adherence rates, an online survey was administered to 296 CR 
programmes across the UK. 
Results: During the study period, a total of 149,597 cardiac events were recorded in the 
NACR dataset. Out of this cohort 70,303 (47%) patients underwent a PCI procedure and a 
total of 59,807 PCI patients were eligible to receive CR. From the CR eligible cohort, 38,246 
(63.9%) patients engaged in CR then 28,263 (73.9%) started and finally 22,173 (78.5%) 
patients completed the programme. The constructed logistic regression models revealed 19 
determinants of CR engagement, 23 determinants of CR uptake and 13 determinants of CR 
adherence. A total of 167 programmes (56.4%) responded to the survey and the results 
showed that 104 (62.3%) programmes are delivering CR in group- and home based settings 
while 61 programmes deliver CR in group-based setting only. The Pearson Chi-square test 
revealed no significant association between mode of CR delivery and adherence rate (p = 
0.53, OR: 0.93, 95% CI: 0.87 to 1.01).  
Conclusion: This thesis revealed that current CR programmes are not attractive to those 
who are most deprived, diabetic and smokers. The research has also shown that CR 
utilisation is not a single patient decision but is also related to service level factors, over 
which healthcare systems have more direct control. 
3 
Table of Contents 
Abstract ..................................................................................................................... 2 
List of Tables .............................................................................................................. 8 
List of Figures ........................................................................................................... 10 
Acknowledgments .................................................................................................... 11 
Author’s Declaration ................................................................................................ 12 
1 Introduction ....................................................................................................... 13 
1.1 Background ................................................................................................... 13 
1.2 Coronary artery disease (CAD) ....................................................................... 14 
1.3 Myocardial infarction (MI) ............................................................................. 15 
1.4 Prevalence of CAD ......................................................................................... 16 
1.5 Challenges in modern cardiology ................................................................... 17 
 Cost................................................................................................................. 17 
 Capacity .......................................................................................................... 18 
1.6 Treatment of CAD .......................................................................................... 19 
 Medical treatment ......................................................................................... 19 
 Revascularisation procedures ........................................................................ 20 
 Prevention ...................................................................................................... 22 
1.7 Cardiac rehabilitation (CR) ............................................................................. 23 
 Historical background to CR ........................................................................... 24 
 Modern CR ...................................................................................................... 26 
 CR Benefits ..................................................................................................... 29 
1.8 CR in the UK .................................................................................................. 33 
 History of CR in the UK ................................................................................... 34 
 Structure ......................................................................................................... 35 
 Pathway ......................................................................................................... 36 
 Standards ....................................................................................................... 37 
 Utilisation ....................................................................................................... 38 
1.9 Thesis aim, question and structure ................................................................. 40 
2 Systematic review of CR utilisation ................................................................ 41 
2.1 Background ................................................................................................... 41 
2.2 Methods ....................................................................................................... 42 
 Inclusion criteria ............................................................................................. 42 
 Databases searched ....................................................................................... 43 
4 
 Search strategy .............................................................................................. 44 
 Selection of studies ......................................................................................... 45 
 Data extraction .............................................................................................. 45 
 Quality assessment tools................................................................................ 45 
 Data synthesis and analysis ........................................................................... 47 
2.3 Results .......................................................................................................... 47 
 Literature search results ................................................................................. 47 
 Excluded studies ............................................................................................. 49 
 Included studies analysis ................................................................................ 50 
 Quality assessment ........................................................................................ 51 
2.4 Cardiac rehabilitation utilisation determinants ............................................... 53 
 Engagement determinants ............................................................................ 54 
 Uptake determinants ..................................................................................... 60 
 Adherence determinants ................................................................................ 69 
 Summary of all determinants ......................................................................... 78 
2.5 Discussion ..................................................................................................... 80 
2.6 Limitations .................................................................................................... 82 
2.7 Conclusion .................................................................................................... 82 
3 Methodology ...................................................................................................... 83 
3.1 Background & aim ......................................................................................... 83 
3.2 Research design ............................................................................................ 84 
3.3 Trial vs Observational .................................................................................... 86 
3.4 Data source ................................................................................................... 88 
 The National Audit of Cardiac Rehabilitation ................................................ 89 
3.5 Data analysis ................................................................................................. 96 
 Data preparation ............................................................................................ 97 
 Statistical modelling ..................................................................................... 102 
4 Engagement study ........................................................................................... 109 
4.1 Abstract ...................................................................................................... 109 
 Background and Aims .................................................................................. 109 
 Methods and Results .................................................................................... 109 
 Conclusion .................................................................................................... 109 
4.2 Introduction ................................................................................................ 110 
4.3 Methods ..................................................................................................... 111 
 Data source .................................................................................................. 111 
 Design and inclusion criteria ........................................................................ 112 
5 
 Factors investigated ..................................................................................... 112 
 Data analysis ................................................................................................ 113 
4.4 Results ........................................................................................................ 115 
4.5 Discussion ................................................................................................... 119 
4.6 Study limitations ......................................................................................... 122 
4.7 Conclusion .................................................................................................. 122 
5 Uptake study .................................................................................................... 123 
5.1 Abstract ...................................................................................................... 123 
 Background .................................................................................................. 123 
 Methods ....................................................................................................... 123 
 Results .......................................................................................................... 123 
 Conclusion .................................................................................................... 123 
5.2 Introduction ................................................................................................ 124 
5.3 Methods ..................................................................................................... 125 
 Design and inclusion criteria ........................................................................ 125 
 Data source .................................................................................................. 126 
 Measures ...................................................................................................... 127 
 Data analysis ................................................................................................ 128 
5.4 Results ........................................................................................................ 129 
5.5 Discussion ................................................................................................... 135 
5.6 Study limitations ......................................................................................... 137 
5.7 Conclusion .................................................................................................. 138 
6 Adherence study .............................................................................................. 139 
6.1 Abstract ...................................................................................................... 139 
 Background .................................................................................................. 139 
 Purpose ........................................................................................................ 139 
 Methods ....................................................................................................... 139 
 Results .......................................................................................................... 139 
 Conclusion .................................................................................................... 139 
6.2 Introduction ................................................................................................ 140 
6.3 Methods ..................................................................................................... 141 
 Retrospective approach ............................................................................... 141 
 Prospective approach ................................................................................... 144 
6.4 Results ........................................................................................................ 145 
 Adherence determinants .............................................................................. 146 
 Survey results ............................................................................................... 153 
6 
6.5 Discussion ................................................................................................... 155 
6.6 Study limitations ......................................................................................... 159 
6.7 Conclusion .................................................................................................. 159 
7 Synthesis study ................................................................................................ 160 
7.1 Introduction ................................................................................................ 160 
7.2 Methods ..................................................................................................... 161 
7.3 Results ........................................................................................................ 163 
 Patient flow .................................................................................................. 163 
 Baseline characteristics ................................................................................ 164 
 Determinants synthesis ................................................................................ 165 
 Pooled determinants merged with evidence................................................ 167 
7.4 Discussion ................................................................................................... 170 
 Patient Flow ................................................................................................. 170 
 Baseline characteristics ................................................................................ 171 
 Determinants synthesis ................................................................................ 172 
7.5 Limitations .................................................................................................. 176 
7.6 Conclusion from the synthesis study ............................................................ 176 
8 Conclusion of the thesis .................................................................................. 177 
8.1 Summary..................................................................................................... 177 
8.2 Key findings ................................................................................................. 177 
8.3 Limitations .................................................................................................. 178 
8.4 Implications ................................................................................................ 179 
8.5 Recommendations ...................................................................................... 180 
8.6 Future research ........................................................................................... 181 
Appendices .............................................................................................................. 183 
Appendix A.1 The five main search terms used to identify relevant literature. ......... 183 
Appendix A.2 Search interface: PubMed – Date of search: Aug 16 2017. .................. 185 
Appendix A.3 Extraction sheet for selected studies. ................................................. 188 
Appendix B.1 Predictor variables description for CR engagement. ........................... 196 
Appendix B.2 Explanation of the independent factors of CR uptake ......................... 198 
Appendix B.3 Explanation of the independent factors for CR adherence .................. 202 
Appendix C.1 CR mode of delivery survey. ............................................................... 205 
Appendix C.2 NACR self-reporting questionnaire. .................................................... 208 
Appendix D.1 Engagement study publication. .......................................................... 221 
Appendix D.2 Cardiac rehabilitation history publication. ......................................... 222 
Appendix D.3 Impact of age and gender on CR uptake publication. .......................... 223 
7 
Appendix E.1 SPSS syntax used to create analyses variables .................................... 224 
Abbreviations ......................................................................................................... 253 
References ............................................................................................................... 255 
 
  
8 
List of Tables 
Table 1.1 Patient groups who benefit from CR...................................................................... 28 
Table 2.1 Review inclusion criteria. ...................................................................................... 43 
Table 2.2 Literature search results by database. .................................................................... 47 
Table 2.3 Excluded studies with justification. ....................................................................... 49 
Table 2.4 Cochrane risk of bias table for included RCT’s. .................................................... 52 
Table 2.5 Reported CR utilisation determinants in the included studies. .............................. 54 
Table 2.6 Main features of included engagement studies. ..................................................... 55 
Table 2.7 A summary of all reported determinants in the investigated studies. .................... 79 
Table 3.1 Main types of research designs sorted by strength of evidence. ............................ 85 
Table 4.1 Hypothesised predictors for CR engagement. ...................................................... 113 
Table 4.2 Baseline characteristics of both groups. ............................................................... 115 
Table 4.3 Summary statistics for the four models created by forward stepwise regression. 116 
Table 4.4 Pooled estimates of the model predicting likelihood of CR engagement. ........... 117 
Table 5.1 The factors that impact CR uptake classified into 4 main categories. ................. 127 
Table 5.2 Baseline characteristics of both groups. ............................................................... 129 
Table 5.3 Summary statistics for the five models created by forward stepwise regression. 130 
Table 5.4 Results of all investigated determinants in the model. ......................................... 131 
Table 6.1 Hypothesised factors for CR adherence. .............................................................. 143 
Table 6.2 Baseline characteristics of both groups. ............................................................... 146 
Table 6.3 First model with all independent variables inserted. ............................................ 147 
Table 6.4 Second model with all significant variables in the first model. ........................... 150 
Table 6.5 Significant determinants in the final CR adherence model. ................................. 151 
Table 6.6 Responses to survey questions. ............................................................................ 154 
Table 7.1 Unified tested variables in all studies. ................................................................. 162 
9 
Table 7.2 Baseline characteristics of all groups. .................................................................. 164 
Table 7.3 Pooled investigated determinants as reported in all three studies. ....................... 166 
Table 7.4 Investigated determinants merged with systematic review evidence. ................. 168 
  
10 
List of Figures 
Figure 1.1 Estimated total cost from CVD in 2014 ............................................................... 17 
Figure 1.2 Total PCI vs Isolated CABG procedures as presented by BCIS .......................... 19 
Figure 1.3 Structure of CR in the UK .................................................................................... 36 
Figure 1.4 Department of Health Commissioning Guide Six-Stage Patient Pathway ........... 36 
Figure 1.5 CR utilisation rates in PCI patients as measured by NACR ................................. 39 
Figure 2.1 Study selection process ......................................................................................... 48 
Figure 2.2 Nonrandomised studies quality assessment results. ............................................. 53 
Figure 2.3 Quality assessment results for CR engagement studies ........................................ 56 
Figure 2.4 Determinants of CR engagement as reported in the investigated studies ............. 57 
Figure 2.5 CR uptake studies quality appraisal ...................................................................... 61 
Figure 2.6 Determinants of CR uptake as reported in the investigated studies. .................... 62 
Figure 2.7 CR adherence studies quality appraisal. ............................................................... 71 
Figure 2.8 Determinants of CR adherence as reported in the investigated studies ................ 72 
Figure 3.1 Two different paths of CR collected by NACR. ................................................... 91 
Figure 4.1 Study Flow and sample size ............................................................................... 112 
Figure 4.2 ROC curve of the final CR engagement model .................................................. 117 
Figure 5.1 Study flow and sample size ................................................................................ 126 
Figure 5.2 Age by sex interaction term ................................................................................ 134 
Figure 5.3 ROC curve for the final CR uptake model. ........................................................ 134 
Figure 6.1 Study flow and sample size ................................................................................ 142 
Figure 6.2 ROC for the third model ..................................................................................... 153 
Figure 6.3 Survey respondents flow chart. .......................................................................... 153 
Figure 7.1 Patient flow chart during study period................................................................ 163 
Figure 7.2 Trend changes in baseline characteristics among groups ................................... 165  
11 
Acknowledgments 
I have accumulated a number of obligations in the course of the last three years. My greatest 
debt is to my research supervisor, Professor Patrick Doherty. He has pointed me 
suggestively to unexplored avenues, stimulating my interest in unfamiliar material, and 
fostering a speculative frame of mind. As well as steering me patiently and steadily over the 
three years to completion, he has also been a warm and generous friend. Warm and special 
thanks for useful statistical comments, priceless help and repeated cheer-ups go equally to 
Dr Nils Gutacker, my second supervisor. 
I have also been fortunate to work with the NACR team, Alexander Harrison, Corinna Petre, 
Nerina Onion, Karen Cardy and Jessica Hemingway who have supported my research for all 
NACR related queries. I am also immensely grateful to Dr Mona Kanaan for her inspiring 
teaching of statistics and her ongoing support. I would also like to thank members of staff 
(past and present) within the Department of Health Sciences at the University of York. In 
particular Sally Evans, Di Stockdale and Tracy Lightfoot, without whom this thesis would 
not have been achieved. 
My sincere gratitude to my Sponsorship, King Fahad Medical City, for awarding me a 
scholarship and the opportunity to gain knowledge at the University of York in the 
department of Health Science. First and foremost, I would like to thank Dr Mostafa Yousef 
the former medical director of KFMC who provided the help, guidance and support until I 
secured my scholarship. I am also grateful to Dr Fahad Al Ghofaili, the director of King 
Salman Heart Centre, for his support. 
My debts to friends are too many and too great to number, but I would especially like to 
thank all PhD fellows at Health Sciences, particularly my officemate Jassas Alotaibi, for 
sharing the ups and downs in the research learning process. My acknowledgements would 
not be complete without thanking my beloved wife, Hayat, who supported my decision to 
commence a programme of research, and have encouraged me throughout. Finally I wish to 
express my love and gratitude to my kids, Fawaz, Raneem, Ibrahim and Hessah for their 
moral support, patience and constant prayers that have helped me to apprehend the 
difficulties faced throughout my PhD programme.  
12 
Author’s Declaration 
I declare that this thesis is a presentation of my own original work, of which I am the sole 
author. This work has not previously been presented for an award at this, or any other, 
university. All sources are acknowledged as references. 
 
 Publications arising from this thesis 
1. Al Quait, A. et al., 2017. In the modern era of percutaneous coronary intervention: Is 
cardiac rehabilitation engagement purely a patient or a service level decision? 
European Journal of Preventive Cardiology, p.204748731771706. Available at: 
http://journals.sagepub.com/doi/10.1177/2047487317717064. 
2. Al Quait, A. & Doherty, P., 2017. 5972 Impact of age and gender on cardiac 
rehabilitation uptake in percutaneous coronary intervention patients. European Heart 
Journal, 38(suppl_1). Available at: 
http://academic.oup.com/eurheartj/article/doi/10.1093/eurheartj/ehx493.5972/40863
92/5972Impact-of-age-and-gender-on-cardiac. 
3. Al Quait, A. & Doherty, P., 2017. Overview of cardiac rehabilitation evidence, 
benefits and utilisation. Global Journal of Health Sciences, 9(12), p.38. Available at: 
http://www.ccsenet.org/journal/index.php/gjhs/article/view/72537. 
4. Abdulrahman Al Quait, Jassas Alotaibi, Patrick Doherty. Determinants of cardiac 
rehabilitation engagement, uptake and adherence. PROSPERO 2017 
CRD42017075214 Available from: 
http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017075214 
  
13 
1 Introduction 
1.1 Background 
Percutaneous coronary intervention (PCI) has developed significantly since its introduction 
in 1977 and nowadays represents the first choice of treatment for acute coronary syndrome 
(ACS). Underpinning the success of PCI procedures is an improved rate of survival and 
more attention is being paid towards reducing the risk of recurrent events and improving 
patients’ quality of life. Extensive research has shown that a comprehensive cardiac 
rehabilitation (CR) programmes reduce mortality, hospital readmission and improve quality 
of life (Anderson et al. 2016). Accordingly, enrolment into CR programmes following a 
cardiovascular event is a Class 1 level A recommendation of the European Society of 
Cardiology, the American Heart Association, and the American College of Cardiology 
(Ruano-Ravina et al. 2016). 
Despite the proven benefits of CR it remains underutilised in many healthcare systems, 
however, with major inequities in access for certain patient groups such as the elderly and 
female patients (Sumner et al. 2016). Furthermore, it has previously been observed that 
utilisation rates are lower than expected in patients undergoing percutaneous coronary 
interventions (PCI) in most European countries (< 30%) (Humphrey et al. 2014). In the 
literature, the term ‘CR utilisation’ tends to refer to the measure of the eligible CR patients’ 
use of rehabilitation services available to them. Throughout this thesis, the term ‘CR 
utilisation’ is deployed to refer to the use of core CR services (Figure 1.4) available to 
eligible patients from the first point of contact at baseline assessment (CR engagement) to 
starting (CR uptake) through to completion of this phase by conducting final CR assessment 
(CR adherence). 
The aim of this PhD thesis is to review the existing literature critically and thus to identify 
the factors that determine optimal CR utilisation in the eligible PCI population. The thesis 
will also assess the extent to which these factors identified in the literature are applicable to 
the CR population in England by conducting a retrospective secondary analysis of the 
British Heart Foundation (BHF) National Audit of Cardiac Rehabilitation (NACR) dataset. 
Understanding these factors and validating them against routinely collected clinical data 
14 
should make an important contribution to our understanding of the relatively low CR 
utilisation rates in this cohort despite its known benefits. 
Specifically, the research seeks to investigate the factors that are associated with patients 
attending an initial CR baseline assessment (CR engagement), starting CR by at least 
attending one outpatient session and then successfully completing the outpatient CR 
programme. The primary question of the thesis is therefore: ‘what are the factors that 
determine CR engagement, uptake and adherence in the PCI population?’ where engagement 
is defined here as attending the initial CR baseline assessment session.   
The overall structure of this thesis takes the form of eight chapters. The second chapter of 
the thesis is concerned with an overall systematic literature review of CR utilisation while 
the third chapter will give a clear and detailed explanation of the methodology used in this 
thesis. Next, three themed chapters will evaluate and discuss CR engagement, uptake and 
adherence separately. These three chapters will be followed by a synthesis chapter which 
will try to promote a more unified understanding of the low CR utilisation rates. The final 
chapter will conclude the findings of the research, focusing on the implications of those 
findings and how they might be explored further in future studies. 
The rest of this introductory chapter will provide a framework for the thesis by giving an 
overview of the key topics discussed in the thesis such as coronary artery disease, its 
prevalence and how it is treated. The evidence for and history of CR, how it is conducted in 
the UK, and the guidelines that apply to its use will also be discussed. The aim, therefore, is 
that, by the end of this chapter, the reader will appreciate why the PCI population was 
specifically selected and how improving the utilisation of CR will lead towards better patient 
care, improved cost effectiveness and enhanced patient satisfaction in this growing PCI 
population.  
1.2 Coronary artery disease (CAD) 
Cardiovascular diseases (CVD) are the leading cause of premature death in the world. In 
2012, an estimated 17.5 million people died from cardiovascular diseases, representing 31% 
of all global deaths. Out of these, 7.4 million were due to Coronary Artery Disease (CAD) 
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(WHO 2015). While CVD is an overarching term that includes all diseases of the human 
body arteries, CAD is a condition specifically affecting the coronary arteries that supply the 
heart with blood and oxygen. The primary cause of CAD is a progressive aggregation of 
plaque in the coronary arteries, a process called atherosclerosis (Goff et al. 2014). 
Coronary Heart Disease (CHD) is a common term for the build-up of plaque in the coronary 
arteries, which could eventually lead to a heart attack. Often, CHD and CAD are used 
interchangeably in medicine; however, CHD is actually a result of CAD. Another term 
sometimes confused with CAD is Acute Coronary Syndrome (ACS). Strictly speaking, ACS 
is a sub-category of CAD. CAD can be either symptomatic or asymptomatic, but ACS is 
almost always represented by a symptom, such as chest pain (Sanchis-Gomar et al. 2016). 
1.3 Myocardial infarction (MI) 
Myocardial Infarction (MI) or Acute Myocardial Infarction (AMI), commonly known as a 
heart attack, is one of the most dramatic presentations of CAD (NICE 2013). When a 
progressive aggregation of plaque in the coronary arteries results in a decreased delivery of 
oxygen and nutrients to the myocardium of the heart, accompanied by (or sometimes 
without) increased myocardial metabolic demand, damage to the heart muscle occurs 
(ischemia) (Bolooki & Askari 2010).  
The first working group to define MI was convened by the World Health Organisation 
(WHO) in 1959 in order to study disease prevalence (Thygesen & Searle 2013). The first 
WHO definition was based on electrocardiogram (ECG) findings and patient symptoms. 
Later definitions published by WHO defined MI as a combination of two of three 
characteristics: chest pain, a rise in cardiac enzymes - such as the protein troponin - and a 
typical ECG pattern involving the prominence of Q waves. The diagnosis of MI was 
therefore still mainly ECG based (Ago & Realized 1979). 
Recent developments in medical technology have heightened the need for a more precise 
definition of MI. The Joint Working Group of the European Society of Cardiology (ESC) 
and the American College of Cardiology Foundation (ACCF) published its first consensus 
document for the redefinition of MI in the year 2000. This placed more emphasis on a 
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diagnostic combination of a biochemical approach relying on cardiac biomarkers and a 
prospective approach considering ST changes in the ECG rather than Q waves. With this 
definition the phrase ST Elevation MI (STEMI) was born (Alpert et al. 2000).  
The ESC and ACCF working group was joined by the American Heart Association (AHA) 
and the World Health Federation (WHF) to form a global task force to describe MI 
(Thygesen & Searle 2013). The updated universal definition of MI was presented in the ESC 
conference in Munich 2012 and simultaneously published in five medical journals. The 
major changes in this updated version include the differentiation between myocardial 
ischemia and myocardial injury. Another important change was the revised criteria for the 
diagnosis of acute myocardial ischemia related to PCI and coronary arterial bypass grafting 
(CABG) (Thygesen et al. 2012). 
1.4 Prevalence of CAD 
Although the huge increase in the number of people accessing cardiology services can be 
looked at as a demonstration of success of modern cardiology services, equally it can be also 
looked at as a sign of failing at prevention. In 2014, there were nearly seven times as many 
CVD prescriptions dispensed in England as there were in 1981. In the UK, it is estimated 
that nearly 2.29 million people are currently living with CAD, around 9.25 million with 
hypertension, 493,000 with heart failure and 1.06 million with atrial fibrillation (Bhatnagar 
et al. 2015). Around 146,000 heart attacks occur each year. This translates to someone in the 
UK having a heart attack roughly every three minutes (Townsend et al. 2015).  
In Europe, CVD is the most common cause of death, making up 45% of all deaths, equating 
to more than 4 million deaths per year in total. Of these, the largest proportion of deaths are 
attributed to CAD: 19% of deaths in men and 20% of deaths in women (Nichols et al. 2014). 
In the United States, CAD is also the most common type of heart disease, and is associated 
with the deaths of over 370,000 people annually. Every year about 735,000 Americans have 
a heart attack. Of these, 525,000 suffer a first heart attack and 210,000 occur in people who 
have already had a heart attack (Mozaffarian et al. 2015). The image worldwide is no 
brighter, the World Health Organisation (WHO) estimates that 7.4 million people died from 
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CAD in 2012 with over three quarters of those deaths taking place in low- and middle-
income countries (WHO 2015). 
1.5 Challenges in modern cardiology 
The growth of demand for cardiology services and the rapid advances in modern cardiology 
have resulted in two main challenges: coping with the escalating costs of treatment and the 
associated increased pressure on hospital resources, which leads to limitations in bed 
capacity. 
 Cost 
Cardiovascular diseases are the most costly contributor to national healthcare expenditure. 
The Centre for Economics and Business Research (CEBR) launched research in August 
2014 looking at the costs of CVD in six major European markets (France, Germany, Spain, 
Italy, Sweden and the United Kingdom). These markets account for 74% of the European 
Union’s Gross domestic product (GDP) and 64% of its population. Across these six 
countries, the total financial impact of CVD, including direct and indirect costs, is estimated 
to be €102.1 billion in 2014. By the end of the decade this is set to rise to €122.6 billion 
(Figure 1.1) (CEBR 2014). 
 
Figure 1.1 Estimated total cost from CVD in 20141. 
                                                     
1 Chart courtesy of the Centre for Economics and Business Research (CEBR) 2015. 
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In 2014, the UK faced a total cost of €15.4 billion from CVD (Figure 1.1), equivalent to 
1.4% of GDP. The largest component of this (€11.4 billion) was the direct cost of healthcare 
provision. Indirect costs also contribute substantially to the overall economic burden, 
however: €3.9 billion from productivity lost as a result of premature mortality and €0.1 
billion from productivity lost as a result of morbidity. In 2020 the total cost of CVD is 
expected to increase by another €3.7 billion to reach €19.1 billion (CEBR 2014). The 
situation in the United States is similar: the overall spending on cardiovascular diseases has 
grown at a compound annual growth rate of 5.7% since 1996 (Miller et al. 2011). 
This increase in cost can be associated with major breakthroughs in the way CVD is treated 
with more people than ever surviving heart attacks. Moreover, the life expectancy of other 
patient groups, such as those with heart failure and babies with congenital heart conditions, 
has also increased, and since these patient groups require medical attention throughout their 
lives their treatment has significant cost implications (Piepoli et al. 2015). 
 Capacity 
Matching capacity and demand has always been a challenge in cardiology. The main 
challenge is to have a hospital bed available when a patient needs it. Although this challenge 
is applicable in all healthcare specialities, it is more vital in cardiology as early 
administration of medical interventions improves the patient’s chances of survival. Timing 
plays a vital role in situations where primary PCI is required since this form of 
revascularisation therapy should be done as soon as possible. This is because heart muscle 
starts to infarct once the coronary artery is blocked and the sooner it is revascularised the 
better the outcome for the patient. Primary PCI offers significantly better clinical outcomes 
for patients in that mortality is reduced by one-third, re-infarction by half, and stroke by two-
thirds compared to in-hospital thrombolysis (Hartwell et al. 2005). 
A demonstration of the success of PCI procedures is the huge increase in the number of 
patients accessing the service. In 1991, about 10,000 PCI procedures were performed in the 
UK, whereas by 2014 this had increased to 96,143 procedures, of which 25,276 (26.3%) 
were primary PCIs. On the other hand, the number of CABG procedures remained almost 
stable with 16,700 surgeries performed in 1991 and 17,513 surgeries in 2014 (Figure 1.2) 
(BCIS 2014). As medical technology improves, the duration of a PCI procedure is also 
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becoming shorter which enables an increased number of patients to access the service every 
day. This, however, increases the demand on hospital beds in departments such as cardiac 
wards, intensive care units and the emergency department. 
 
Figure 1.2 Total PCI vs Isolated CABG procedures as presented by BCIS2. 
1.6 Treatment of CAD 
Although CAD cannot be completely cured, treatment can help to manage the symptoms and 
reduce the risk of further complications. CAD can be managed effectively through a 
combination of lifestyle changes, medication and (in some cases) a coronary 
revascularisation procedure. With the right treatment, the symptoms of CAD can be 
significantly reduced and the heart muscle function improved (Windecker et al. 2014). 
 Medical treatment 
Many different medicines are used to treat CAD and these can be classified according to 
what they treat. According to the National Institute for Health and Care Excellence (NICE) 
guidelines, all patients who have had MI should be offered four types of drug: antiplatelet 
                                                     
2 Chart courtesy of British Cardiovascular Intervention Society (BCIS) 2014. 
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agents, statins, beta-blockers and Angiotensin-Converting Enzyme (ACE) inhibitors (NICE 
2015). 
Antiplatelet agents are used to reduce the risk of blood clot formation, since blood clots 
would likely result in a heart attack. Antiplatelet medicines are usually given in the form of 
dual therapy (aspirin plus a second antiplatelet agent), but if the patient has high levels of 
cholesterol a cholesterol-lowering medicine called a statin may also be prescribed (NICE 
2013). 
Beta-blockers are among the most important drugs used by cardiologists nowadays. They 
work mainly by blocking the action of hormones like adrenaline, which in turn reduces the 
heart activity. They are used after a heart attack to treat ongoing conditions including angina, 
heart failure and some heart rhythm disorders (Timmis 2015). 
ACE inhibitors are commonly used to treat high blood pressure and function by blocking the 
activity of a hormone called angiotensin II, which causes the blood vessels to narrow 
(Whitehurst et al. 2006). 
 Revascularisation procedures  
Revascularisation is the restoration of blood flow to an organ. In medicine, revascularisation 
is defined as “the restoration of perfusion to a body part or organ that has suffered ischemia” 
(Oxford Dictionary 2014). The two main methods of revascularisation are Coronary Artery 
Bypass Grafts (CABG) and Percutaneous Coronary Intervention (PCI).  
CABG is a surgical procedure that may take between three and six hours under general 
anaesthesia. The surgeon starts by removing a healthy vein(s) and/or an artery from another 
part of the patient’s body (usually the leg). Traditionally, the surgeon will cut the patient’s 
chest in half through the breastbone (sternum) then retract the rib cage in order to expose the 
heart. When the heart is exposed, the blood is diverted around narrowed or clogged parts of 
the coronary artery by connecting (or grafting) the healthy artery or vein to bypass the 
blocked portion. During surgery, the heart beat is stopped so the surgeon can perform the 
bypass procedure on a “still” heart. A machine called a “cardiopulmonary bypass pump” 
takes over for the heart and lungs during the procedure. Surgeons usually bypass multiple 
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coronary arteries during one surgery. Recently, a novel CABG procedure aiming to decrease 
the invasiveness of traditional CABG while preserving equivalent outcomes has been 
developed (Javaid et al. 2007). Minimally invasive CABG (MICS CABG) is a surgical 
procedure that allows the surgeon to perform revascularisation off-pump, without a 
sternotomy and through small incisions, equivalent to that of a regular CABG (Lapierre et 
al. 2006).  
PCI, or coronary angioplasty, is a non-surgical, less invasive procedure, where a long, 
flexible hollow plastic tube called a catheter is inserted into a blood vessel through a tiny 
incision in the patient’s arm or groin.  A micro balloon attached to the catheter is then 
inflated to widen the artery and a small mesh tube called a stent is often used to help keep 
the artery open. A PCI procedure is usually less than one hour long and it requires much less 
recovery time for the patient compared to CABG. PCI may not be recommended, however, 
if multiple coronary arteries have become blocked or narrowed. 
The first CABG procedure was performed in 1964, and the first PCI thirteen years later by a 
German radiologist, Andreas Gruentzig, in Switzerland (Windecker et al. 2014). Since then, 
the field of cardiology has made great strides in improving both the longevity and the quality 
of life of patients. There has been substantial progress in the understanding of cardiovascular 
pathophysiology, as well as in the application of these advances to clinical cardiology. 
Concurrent improvements in medical technology have led to exciting developments in the 
field of invasive and non-invasive cardiology. 
PCI has developed significantly since its introduction in 1977, and has now overtaken 
CABG as the dominant revascularization treatment for CAD (Astin et al. 2008). PCI is the 
first choice for coronary reperfusion during acute MI, with thrombus aspiration and stenting 
of the culprit lesion, and is also widely regarded as the treatment of choice for coronary 
revascularisation in cases of acute coronary syndrome and stable angina, or silent ischemia 
(Varenne & Hemery 2008). 
The growth in popularity of PCI is due to the speed of the procedure, patient preference over 
CABG and increasing patient populations, including patients with multi-vessel coronary 
artery disease, acute MI or cardiogenic shock, and elderly patients. Success rates and 
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complications for PCI have remained stable or even improved, despite the expanding 
indications and the persistent problem of restenosis (i.e. renewed narrowing of an already 
treated artery (Windecker et al. 2014). 
 Prevention 
There is a general consensus in the medical literature that many incidents of cardiovascular 
disease can be avoided or at least delayed. Prevention and control in cardiovascular care can 
be classified into two main types depending on the targeted population: 
1. Primary prevention (general public). 
2. Secondary prevention (CVD patients). 
Primary prevention aims to delay or prevent the onset of CVD. The potential advantages of 
primary prevention strategies in cardiovascular care have been tested in large prospective 
cohort studies. For example, Stampfer and colleagues assessed the combination of lifestyle 
practices on the risk of CHD by following 84,129 women (age 30 – 55 years) for 14 years. 
The primary objective of their study was to estimate the proportion of coronary events that 
could potentially be prevented by adherence to a set of dietary and behavioural guidelines. 
All women were free of diagnosed CVD, cancer and diabetes at baseline. The population 
was then defined into low risk and high risk subjects. The low risk subjects were those 
women who maintained a healthy weight and diet, exercised routinely and did not smoke 
tobacco for the follow-up period. The low risk population experienced an 83% decrease in 
the incidents of coronary events compared to the high risk group indicating that primary 
prevention is very effective (Stampfer et al. 2000). 
The evidence that most cardiovascular disease is preventable continues to grow, driving 
major cardiac bodies and associations, such as the American Heart Association (AHA) and 
the European Society of Cardiology (ESC), to publish periodical guidelines for primary 
prevention. WHO estimates that the risk of CAD increases two- to threefold for an 
individual who smokes tobacco. In contrast, the number of cardiac events reduce by 50% in 
people who stop smoking, and the risk of CAD, including MI, also decreases significantly 
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over the first two years after quitting smoking (WHO 2011). Collectively, many 
cardiovascular diseases can be reduced by making simple lifestyle changes. 
With respect to secondary prevention, many evidence-based studies and randomised control 
trials have shown that the majority of known risk factors contributing towards 
cardiovascular disease progression are modifiable by preventive measures including 
therapeutic lifestyle changes and adjunctive drug therapies of proven benefit (Windecker et 
al. 2014). In the AHA guidelines it was stated that: 
“Indeed, the growing body of evidence confirms that in patients with atherosclerotic 
vascular disease, comprehensive risk factor management reduces risk as assessed by a 
variety of outcomes, including improved survival, reduced recurrent events, the need for 
revascularization procedures and improved quality of life” (Goff et al. 2014).  
Other lifestyle changes that will reduce the risk of CAD progression include healthy eating, 
being more physically active, lowering blood pressure and cholesterol levels, controlling 
diabetes, reducing alcohol consumption and maintaining a healthy weight. The sum of all 
these activities is commonly known in cardiovascular care as “cardiac rehabilitation”. 
1.7 Cardiac rehabilitation (CR) 
In medicine, while saving a patient’s life is clearly vital, it is also important to attempt to 
help patients recover a good quality of life. Experiencing a heart attack or a hospital 
admission following a cardiac event can be very stressful and patients who suffer such a 
dramatic event will definitely need support to live with their developing heart condition. In 
particular, they will benefit from lifestyle change interventions to stay as healthy as possible 
and therefore reduce the risk of suffering another event. Knowing that CAD is a long term 
and progressive condition, the concept of rehabilitation in cardiac care is that the recipients 
gain the knowledge, skills and support necessary to live as normal a life as possible 
alongside their cardiac condition. 
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CR has been defined by various organisations and national entities and can be encompassed 
by: 
“The coordinated sum of activities required to influence favourably the underlying cause of 
cardiovascular disease, as well as to provide the best possible physical, mental and social 
conditions, so that the patients may, by their own efforts, preserve or resume optimal 
functioning in their community and through improved health behaviour, slow or reverse 
progression of disease” (BACPR 2017). 
Traditionally, exercise training is known as the core component of CR. Current practices 
guidelines, however, push towards “comprehensive rehabilitation” and thus CR’s regulating 
bodies drive programmes to add other components to optimise the reduction of risk factors 
and improve adherence to healthy behaviours among recipients. Those additional 
components include health education, advice on the reduction of cardiac risk factors and 
stress management. 
 Historical background to CR 
For centuries, bed rest was considered essential in the treatment of a disease, and mobility 
restrictions were imposed on most patients, and particularly patients with heart disease. This 
practice was not challenged until 1802 when Heberden reported the observation of an angina 
patient who improved after sawing wood for half an hour a day (Didier et al. 2010). Despite 
some evidence of the benefits of physical activity for heart patients, the misguided focus on 
bed rest persisted until chair therapy was introduced in the 1940s. A few years later, daily 
short walks of 3 to 5 minutes were allowed four weeks after the coronary event (Mampuya 
2012). Since then advances in clinical research have led to better ways of understanding 
heart disease management. 
The early  evidence of the benefits of physical activity started in 1953 when a study 
conducted by Morris and Heady showed that CHD was at least one third higher in light 
occupation workers (bus drivers) compared to heavy occupation workers, in this case bus 
conductors (Morris & Heady 1953). Albeit being a very important study, the decrease in 
CHD incidents was erroneously attributed to the extra physical activity performed by heavy 
occupation workers. Subsequent analysis of anthropometric data, from the London Bus 
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Company tailors, revealed that many of the bus conductors where lighter in body weight 
compared to bus drivers on commencing their jobs with the company. In 1966, Saltin and 
co-workers conducted a study on five men, each 20 years of age, to compare the effects of 
three weeks of bed rest and eight weeks of intense physical exercise on the subjects’ 
physical condition. Regardless of its small sample size, this study, which was known as the 
‘Dallas Bed Rest and Training Study’, enriched the early discussions and analyses of the 
positive impact of exercise and the detrimental effects of bed rest on subjects’ physical 
condition (McGavock et al. 2009). 
In the late 1970s, the concept of prescribing exercise therapy for post-MI patients began to 
gain momentum as it became increasingly clear that immobilisation and reduced activity 
results in poor long-term prognosis and survival (Lear & Ignaszewski 2001). The 
establishment of the benefits of exercise therapy on patients’ prognosis led to a surge of 
interest in the effects of exercise therapy on morbidity and mortality rates which then 
revealed undeniable improvements. Since that time a large and growing body of literature 
has emerged to establish the physiologic basis of the benefits of exercise and this has led to 
the development of CR programmes. 
Nowadays, CR is a complex intervention that has eventually evolved from the emphasis on 
exercise therapy to become a comprehensive secondary prevention programme that provides 
patients with supervised exercise and education sessions to help them to recover and get 
back to as full a life as possible (Dalal et al. 2015). CR has been proven to be as much a part 
of CAD treatment as medicines are. Unfortunately, the proven benefits of CR are not 
matched by a strong endorsement of CR in the cardiology community. A possible reason 
behind this reticence can be the development of powerful drugs and new therapeutic 
technologies that have made it difficult for CR to compete in its own right. Particularly if a 
cardiologist is attracted to the immediate and short-term results of the conventional direct 
medical interventions (Mampuya 2012). Recent years, however, have seen increasingly 
rapid advances in the field of cardiology. These recent developments have led to a better 
understanding of heart disease management which is in turn reflected in a renewed interest 
in CR.  
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 Modern CR  
Historically, the main objective of CR as an exercise-based programme was to improve 
patients’ regular physical activity after a cardiac event (Mampuya 2012). Since CR has 
evolved into a comprehensive secondary prevention programme, the objectives of CR, and 
indications and contraindications for its use have also developed in sophistication. Current 
CR programmes are designed to stabilise or even reverse the progression of heart disease by 
controlling all modifiable risk factors (Dalal et al. 2015). They are also concerned with 
improving patients’ quality of life by restoring their wellbeing. All this should be achieved 
with the maximum safety levels to patients. 
1.7.2.1 Objectives of CR 
The main objective of CR continues to be helping recipients to regain their autonomy by 
improving regular physical activity after a cardiac event. Controlling the modifiable risk 
factors and therefore reducing the negative effects of CAD is another objective of CR. The 
term risk factor is defined by WHO as: 
“any attribute, characteristic or exposure of an individual that increases the likelihood of 
developing a disease or injury” (WHO 2014). 
Obviously, the more risk factors a patient has for a specific disease, the greater the chance 
they have of acquiring that disease. In cardiology, there are modifiable risk factors (those 
that can be controlled) and unmodifiable risk factors (which cannot be changed). 
Unmodifiable risk factors for CAD include age, gender, ethnicity and family history. 
Although unmodifiable risk factors cannot be changed, making changes to patients’ 
lifestyles can significantly reduce the risk of acquiring CAD prematurely. Other 
characteristics that may lead to an increased chance of acquiring CAD include social, 
economic and cultural change (e.g. urbanisation). Stress and poverty are also other 
determinants of an increased chance of getting CAD (WHO 2014). These characteristics and 
determinants are not direct causes of CAD but can be looked at as “the causes of the 
causes”. Modifiable risk factors that may have an adverse impact on the prognosis of CAD 
include: hypertension, hypercholesterolemia, diabetes, sedentary lifestyle, obesity and 
smoking (Montalescot et al. 2013). Curing or at least controlling these factors can 
significantly reduce the progression of CAD disease. 
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A comprehensive CR programme should also educate recipients about their conditions so as 
to allow them to become responsible for their medical treatment and lifestyle changes and 
therefore achieve optimal outcomes (Dalal et al. 2015). These education sessions should be 
delivered in a structured workshop-based teaching programme and by a skilled and 
experienced multidisciplinary team such as dietitians, psychologists, exercise specialists, etc. 
(BACPR 2017). Anxiety and depression, for example, have been reported to be associated 
with lower exercise capacity, fatigue and sense of wellbeing. The use of a skilled and 
experienced psychiatrist to educate recipients about stress management and self-control tools 
can help recipients to have a better control of other risk factors (Sign 150 2017). 
Lastly, CR programmes should aim to limit the physiological and psychological effects of 
heart disease by controlling disease symptoms and the side effects of medications. This 
should have a favourable impact on patients’ quality of life, making the benefits of CR more 
tangible to recipients and therefore encouraging them to complete the programme, foster 
healthy behaviours and thus achieve optimal outcomes (Dalal et al. 2015). 
1.7.2.2 Indications of CR 
The literature on CR has highlighted several patient groups that should benefit from joining 
a CR programme. Generally accepted indications for CR include: MI, CABG, PCI, valve 
repair or replacement and angina. The recent trends in CR which encourage programme 
commissioners to tailor special programmes for special patient groups have widened the 
scope of CR to include patients with heart failure and heart transplants. Different countries 
allocate different resources into CR, however, and therefore the indications for CR may vary 
between countries. In the UK, the National Institute for Health and Care Excellence (NICE), 
Department of Health, British Association for Cardiovascular Prevention and Rehabilitation 
(BACPR), and wider European guidelines agree that the patient groups listed in (Table 1.1) 
will benefit from a CR programme (Dalal et al. 2015). 
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Table 1.1 Patient groups who benefit from CR.3 
Indication Description 
ACS  Including STEMI, NSTEMI, and unstable angina; also all patients 
undergoing reperfusion (such as CABG, primary PCI and elective PCI). 
Heart Failure (HF) Patients with newly diagnosed chronic HF and chronic HF with a step 
change in clinical presentation. 
Heart surgery Heart transplant, ventricular assist device, intra-cardiac defibrillator, 
valve replacement or repair and cardiac resynchronisation therapy. 
Angina Patients with a confirmed diagnosis of exertional angina. 
 
1.7.2.3 Contraindications & safety 
Contraindications for the use of CR are only concerned with the exercise aspect of the 
programme while all other parts of CR are considered relatively safe. Since the exercise in a 
CR programme is medically prescribed and supervised, the risks of CR are considered to be 
low, and most patients referred to CR are eligible to participate in the programme. 
Furthermore, the capacity of CR providers to tailor their programme to suite the medical 
needs of individual patients has reduced the contraindicated patient groups even further. 
Nonetheless, medically unstable or life threatening conditions are examples of patients who 
are not eligible to enrol in a CR programme (Thomas et al. 2010). 
The literature on CR has highlighted a number of studies that have documented the safety of 
exercise in a CR programme. In 2007, the AHA issued a statement to discuss the potential 
complications of exercise in a CR programme. This statement has estimated the incidence of 
exercise-related cardiovascular complications in CHD patients as one cardiac arrest per 
116,906 patient-hours of supervised exercise, one MI per 219,970 patient-hours of 
                                                     
3 Modified from (Dalal et al. 2015). 
29 
supervised exercise, one death per 752,365 patient-hours of supervised exercise and one 
major complication per 81,670 patient-hours of supervised exercise (Thompson et al. 2007).   
Another observational study from a French registry with a population of 25,000 patients has 
reported one cardiac incident per 50,000 hours of supervised exercise. This is equivalent to 
1.3 cardiac arrests per million patient-hours (Pavy et al. 2006). A qualitative Japanese study 
surveyed 136 hospitals operating core phase CR amounting to 383,096 patient-hours of 
supervised exercise. The incident rate of all adverse events was 12 per 383,096 patient-hours 
while life-threatening events (death, cardiac arrest, AMI and cardiac rupture) occurred at the 
rate of one per 383,096 patient-hours of supervised exercise. This is equivalent to 3.13 and 
0.26 events per 100,000 patient-hours of supervised exercise respectively (Saito et al. 2014). 
Taken together, these results suggest that supervised exercise in a CR programme is 
generally safe. These findings can only be extended to CR programmes that are equipped to 
handle major emergency events such as cardiac arrest. In addition, it should be noted that 
subjects in the above studies are medically evaluated before enrolling in the programme 
which could decrease the number of incident rates. In general, all these considerations 
support safety in supervised exercise programmes but they should not be extrapolated to 
home based programmes.     
 CR Benefits 
The benefits of CR for the indicated patient groups have been reviewed comprehensively in 
several systematic reviews and meta-analyses including seven Cochrane reviews. These 
benefits are the result of all components of a comprehensive multi-disciplinary CR 
programme. In this section, the benefits of a comprehensive CR programme will be assessed 
with brief supporting evidence from the literature. 
1.7.3.1 Mortality 
A 2016 Cochrane review and meta-analysis of 63 randomised control trials (RCT) with 
14,486 participants with a median follow-up of 12 months showed that CR has a varied 
effect on mortality. In this review 47 trials with a total sample size of 12,455 subjects 
reported all-cause mortality. Reduction in all-cause mortality between control and 
intervention groups was not statistically significant in these studies (relative risk (RR): 0.96; 
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95% confidence interval (CI): 0.88 to 1.04). On the other hand, 27 trials (n = 7,469) reported 
cardiovascular mortality and showed a statistically significant reduction of cardiovascular 
mortality (RR: 0.74; 95% CI: 0.64 to 0.86). Twenty studies in this review reported both 
types of mortality and results in this sub-group were consistent with the overall meta-
analysis results (all-cause mortality RR: 0.91, 95% CI: 0.82 to 1.01; cardiovascular mortality 
RR: 0.78, 95% CI: 0.67 to 0.90) (Anderson et al. 2016). 
Another systematic review and meta-analysis of 34 RCT’s with a total pooled population of 
6,111 subjects has revealed a reduction in all-cause mortality for CR patients compared to 
control groups by 26% (odds ratio (OR): 0.74, 95% CI: 0.58 to 0.95). It also showed a 
reduction in cardiovascular mortality by 36% (OR: 0.64, 95% CI: 0.46-0.88) (Lawler et al. 
2011). Conversely, a UK based trial titled ‘Rehabilitation after myocardial infarction trial 
(RAMIT)’ reported no significant difference in mortality between patients referred to 
rehabilitation and controls at two years follow up period (RR: 0.98, 95% CI: 0.74 to 1.30) or 
after 7–9 years (RR: 0.99, 95% CI: 0.85 to 1.15) (West et al. 2012). The negative findings of 
this trial can be attributed to the biased study design and failure to recruit a large enough 
sample size for the trial (< 1000 patient in each arm of trial). In fact, RAMIT was designed 
to measure the effectiveness of CR as provided in ‘real life’ rather than if CR ‘works’ 
(Doherty & Lewin 2012). 
This section has attempted to provide a brief summary of the literature relating to the impact 
of CR on all-cause mortality and cardiovascular mortality. In general, it seems that enrolling 
in a CR programme can impact rates of mortality favourably. The inconsistency in the 
literature may be due to several reasons related to the included studies such as study periods, 
duration of CR, and intensity of CR or whether CR was delivered effectively. 
1.7.3.2 Hospital admissions 
To date, the latest Cochrane systematic review has shown that the risk of hospital admission 
was reduced by 18% when comparing exercised-based CR with usual care (RR: 0.82; 95% 
CI: 0.70 to 0.96) (Anderson et al. 2016). This data is based on 15 RCTs with a population 
size of 3,030 patients. Another systematic review aiming to update a previously published 
Cochrane systematic review of exercise-based CR for heart failure patients, measured 
hospital admission as a CR outcome. This study systematically reviewed 33 trials with six or 
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more months of follow-up and included only patients with reduced ejection fraction (<40%) 
and New York Heart Association class II and III (n= 4,740). The findings revealed a reduced 
risk of overall hospital admission (RR: 0.75; 95% CI: 0.62 to 0.92) and heart failure-specific 
admission (RR: 0.61; 95% CI: 0.46 to 0.80) in patients who received comprehensive CR 
compared with no exercise controls (Sagar et al. 2015). A drawback of this study, however, 
was the inclusion of trials with relatively small sample sizes and short-term follow-up. This 
reflected on the number of hospital admissions reported by the majority of the included 
trials. 
It has been previously discussed in this chapter (section 1.5) that the main two challenges in 
modern cardiology are cost and capacity. It can therefore be assumed that CR, by reducing 
the number of hospital admissions, is a significant tool in facing the challenges in modern 
cardiology. It can thus also be said that the outcomes of CR go beyond the benefits to 
individuals and encompass improvements to the whole cardiac care system. 
1.7.3.3 Quality of life and psychological wellbeing 
Two of the main objectives of a comprehensive CR programme are to improve the quality of 
life and the psychological state of the patient. Improvements in quality of life can be 
achieved through improvement in exercise performance (fitness) and through alleviation of 
symptoms, i.e. reducing chest pain, dyspnoea and fatigue (Mampuya 2012). A Cochrane 
review of exercise-based CR for CHD patients reported 20 trials, with a total population of 
5,060 subjects, assessing Health Related Quality of Life (HRQL) using a variety of validated 
generic or disease-specific outcome measures. Fourteen of the 20 trials (65%) documented 
an increase in HRQL in one or more domains in patients subsequent to a CR programme 
compared to controls. Within these 14 trials, five reported a higher level of HRQL in at least 
one-half of the subscales (Anderson et al. 2016). The authors of the Cochrane review, 
however, expressed the HRQL scores as mean differences and were unable to quantify the 
effect of the 14 trials together due to the heterogeneity among the included studies. 
This view is supported by another Cochrane systematic review that was conducted on heart 
failure patients. Sagar et al. (2015) reviewed a total of 18 trials which reported a validated 
HRQL measure. Thirteen of those 18 trials (72%) reported higher HRQL scores in patients 
following exercised-based CR programmes compared with control subjects (Sagar et al. 
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2015). This finding provides a valuable insight into the subject as all 13 trials used the same 
validated HRQL scoring measure, the disease-specific Minnesota Living with Heart Failure 
Questionnaire (MLHFQ). 
Another benefit of CR is to improve the psychological state of the patient by stress reduction 
and the enhancement of the overall sense of psychosocial wellbeing. A meta-analysis of 23 
RCTs with a total population size of 3,180 CAD patients was conducted to evaluate the 
impact of including a psychosocial component within a standard exercise-based CR 
programme. Patients who received psychosocial intervention showed greater reductions in 
psychological distress (with effect size differences of 0.34) (Linden et al. 1996). An 
American observational study tried to assess improvements in depression in patients who 
developed heart failure due to CHD after receiving a comprehensive CR programme. 
Depressive symptoms were assessed at baseline and after CR by standard questionnaire 
(Kellner Symptom Questionnaire). In patients who completed CR (n= 151) depressive 
symptoms decreased by 40% post CR, from 22% to 13% (p <0.0001). In addition, 
Depressed patients who completed CR had a 59% lower mortality (44% vs 18%, p <0.05) 
compared to depressed dropout subjects (n= 38) (Milani et al. 2011). This study, however, 
suffers from the limited sample size, especially in the dropout subjects and also from using a 
questionnaire that is not well established for measuring depressive symptoms in clinical 
trials of depression. 
Furthermore, two observational studies, one British (n= 465,825) and one American (n= 
635), reported improvements in anxiety and depression after CR (Al Quait & Doherty 2016; 
Lavie & Milani 2006). Although the main objective of both studies was to compare levels of 
improvement in a range of outcomes between young and old patients, varied improvements 
in anxiety and depression were evident post CR in both groups with younger patients 
achieving better outcomes. 
1.7.3.4 Cardiovascular risk profile 
Modern CR programmes are designed to provide a reduction in the modifiable 
cardiovascular risk factors (see section 1.7.2.1). A systematic review and meta-analysis of 
34 RCT’s (n= 6,111) examined the effect of CR on modifiable risk factors. Overall, trials 
found a more favourable effect on the prevalence of risk factors among subjects who were 
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randomised to CR compared with controls. The risk factors in which improvements were 
observed in the intervention groups in these trials were smoking cessation, blood pressure 
and total cholesterol, whereas changes in body weight were minimal in both groups (Lawler 
et al. 2011). 
Another systematic review and meta-analysis of 23 trials and a total population size of 3,180 
(2,024 intervention subjects and 1,156 controls) CAD patients reported the impact of CR on 
selected modifiable risk factors. The findings revealed that patients who received CR 
showed a greater reduction in systolic blood pressure, heart rate and cholesterol level (with 
effect size differences of -0.24, -0.38, and -1.54, respectively) (Linden et al. 1996). These 
results must be interpreted with caution, however, since the effect of medical drugs such as 
statins and beta-blockers could not be excluded. 
In a large cohort retrospective observational study (n= 465,825) Al Quait & Doherty 
conducted an evaluation of nine patient outcomes pre and post CR. The outcomes reported 
in this analysis were Body Mass Index (BMI), waist size, total cholesterol, blood pressure, 
smoking, walking fitness, physical activity, anxiety and depression. Although the primary 
objective of the study was to determine if CR outcomes were influenced by age in CHD 
patients, undeniable improvements were documented in modifiable risk factors in both 
groups. This analysis revealed that elderly patients achieved better outcomes in body shape 
risk factors while younger patients achieved much better outcomes across a wider range of 
risk factors, in particular with regards to smoking cessation (Al Quait & Doherty 2016). 
1.8 CR in the UK 
The availability of CR and how it is organised varies across countries. This is mainly to do 
with differences in health policies and politics since different countries allocate different 
resources into the healthcare system. Resource allocation is largely dependent on the income 
of each country, with high income countries generally investing more in healthcare services, 
and therefore CR, than low income countries (Grace et al. 2016). Worldwide, the availability 
of CR is low compared to the benefits it offers, as only 38% of countries globally have CR 
programmes. More specifically, 68% of those programmes are allocated in high income 
countries, 28.2% in middle income countries and only 8.3% in low income countries (Turk-
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Adawi et al. 2013a). The provision, pathway and guidelines of CR can therefore be different 
across countries. 
 History of CR in the UK 
The earliest attempt to promote CR in the UK goes back to the year 1970 when Groden and 
co-authors circulated a questionnaire to all active adult cardiologists of the British Cardiac 
Society to assess their attitude towards CR. With a 75% response rate, the survey revealed 
that 74.3% of cardiologists were in favour of developing special services for the 
rehabilitation of cardiac patients whereas 25.7% felt that such special services were not 
indicated (Groden et al. 1971). The same study, however, found just nine cardiologists were 
in a position to offer CR to their patients in a special CR centre. In 1989 the number of CR 
centres had risen to 99 and by the year 1992 the BHF could identify 151 centres (Bethell et 
al. 2000). This figure continues to rise and in the first NACR report in 2007, 360 UK 
programmes have been identified (NACR 2007). 
Until the introduction of the first guidelines and audit standards in 1996, there had been no 
protocol for the provision of CR in the UK and there was no information on what most 
programmes did, nor who their subjects were (Bethell et al. 2000). Two years prior to the 
introduction of the first national guidelines, specifically in January 1994, Thompson and 
colleagues posted a survey to the senior nurse of 244 centres in England and Wales to 
determine the level of CR provision. With a 100% response rate the results showed that most 
programmes were based in hospitals (92%) and had been in operation for between three 
months and 17 years. Content-wise, 100% of the programmes were delivering education and 
supervised exercise sessions, 96% were delivering stress management sessions and 40% 
counselling (Thompson et al. 1996). In 1997, the BACPR, which was then known as BACR 
and had been established in 1993, embarked on a three stage questionnaire survey designed 
to evaluate the quality of CR provision in the UK, promote record keeping and to measure 
CR outcomes (Bethell et al. 2000). Since then, research into CR in the UK has evolved and 
significant funding has been attracted from sources including the BHF, the Department of 
Health and the Medical Research Council (Thompson 1998). This has resulted in placing the 
UK into the top countries in Europe in CR utilisation (NACR 2016). 
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In 2000, a target was set for England that, by 2002, 85% of MI, PCI and CABG patients 
should be invited to attend CR (NACR 2007). To ensure that this target is met and that all 
established guidelines are adhered to, the National Audit of Cardiac Rehabilitation (NACR) 
was formally established in 2005, led by Prof Bob Lewin, and the first national audit report 
was published in 2007. In 2013 the NACR, under Prof Doherty’s leadership and supported 
by the BHF, took a significant step in transforming the audit into a service improvement and 
quality assurance system where the ultimate beneficiaries are CVD patients. Nowadays, the 
overall mean uptake to CR in the UK has achieved a significant milestone by reaching 50%. 
This improvement brings the UK into the top 2% of countries in Europe (NACR 2016). 
 Structure 
Traditionally, CR in the UK has been delivered by clinicians in supervised groups of patients 
in outpatient hospital clinics or community centres (Dalal et al. 2015). NICE clinical 
guidelines advise the National Health Service (NHS) on caring for people with specific 
conditions, such as heart disease, and the treatment they should receive, while the BACPR is 
an association that represents CR professionals in the UK and is responsible for setting the 
standards by which clinicians work. The NACR, funded by BHF and hosted by the 
University of York, collects comprehensive audit data to support the improvement and 
monitoring of CR services in terms of their uptake, quality and clinical outcomes. The 
BACPR works in conjunction with the NACR to develop a certification system which 
ensures that CR programmes in the UK are meeting minimum standards. The structure of 
NACR in the UK is illustrated in Figure 1.3. 
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Figure 1.3 Structure of NACR in the UK.4 
 Pathway 
Recent guidance from the UK Department of Health commissioning guide for CR refers to a 
six stage pathway of care that begins with patient presentation (diagnosis of a cardiac event) 
and is followed by identification for eligibility, referral and recruitment, baseline assessment 
and the development of a care plan, delivery of a comprehensive CR programme, the 
completion of a final CR assessment and then discharge and transition to long term 
management (Figure 1.4). 
 
Figure 1.4 Department of Health Commissioning Guide Six-Stage CR Patient Pathway 
of Care.5 
                                                     
4 Adapted version from the NACR website. 
5 Courtesy of BACPR 2017. 
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Each stage in this pathway is vital for CR uptake, adherence and outcomes and, overall, it 
should have an effect on long-term behavioural change leading to the desired health 
outcomes (BACPR 2017).  
 Standards 
Formal CR programmes vary between countries in terms of their delivery, intensity and 
duration. All programmes, however, are seeking the presentation of evidence-based best 
practice to provide effective prevention and rehabilitation services to their recipients. As the 
association in charge of setting the standards by which CR clinicians work, BACPR 
continuously revises and updates CR standards in the UK.  
In the updated third edition of the BACPR Standards and Core Components (2017), these 
standards and core components have been reduced from seven to six with the aim of this 
reduction being to increase the emphasis on measurable clinical outcomes, audit and 
certification (BACPR 2017). The six standards for cardiovascular prevention and 
rehabilitation as issued by BACPR are: 
Standard One The delivery of six core components by a qualified and competent 
multidisciplinary team, led by a clinical coordinator. 
Standard Two Prompt identification, referral and recruitment of eligible patient 
populations. 
Standard Three Early initial assessment of individual patient needs which informs the 
agreed personalised goals that are reviewed regularly. 
Standard Four Early provision of a structured cardiovascular prevention and rehabilitation 
programme (CPRP), with a defined pathway of care, which meets the individual’s goals and 
is aligned with patient preference and choice. 
Standard Five Upon programme completion, a final assessment of individual patient needs 
and demonstration of sustainable health outcomes. 
Standard Six Registration and submission of data to the National Audit for Cardiac 
Rehabilitation (NACR) and participation in the National Certification Programme 
(NCP_CR). (BACPR 2017). 
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These revised standards and core components place health behaviour change and education 
at the very centre of CR programmes whilst placing equal emphasis on risk factor 
management and psychosocial health. Standard six, for instance, has been designed in order 
to ensure that CR programmes in the UK are meeting, or at least working towards, the 
minimum standards. 
 Utilisation 
Existing research recognises the critical role played by CR in heart disease prevention. 
Despite the robust evidence of the clinical benefits and cost effectiveness of CR, utilisation 
rates vary widely worldwide, ranging from 20% to 50% (Dalal et al. 2015). Different 
healthcare policies and CR delivery systems among countries may explain, at least partially, 
this variability (Grace et al. 2016). 
In the year 2000 England set a target that, by 2002, 85% of MI, PCI and CABG patients 
should be invited to attend CR. The first NACR report in 2007, however, revealed that this 
target was far from being met on the ground: of the 152,417 new eligible cardiac patients in 
the year April 2005 to March 2006, only 65,012 received CR, around 40% (NACR 2007). A 
few years later, the NHS England CVD strategy for 2015/16 set a target to increase CR 
uptake to 65% for patients admitted with CAD (NHS England Guideline 2014). The 2016 
NACR report showed that the overall uptake of eligible patients in CR programs is only 
50%, a 3% increase from 2015 and 5% increase from 2014 (NACR 2016). Although current 
CR utilisation rates in the UK fall below national recommendations, however, they still far 
exceed those seen in other European countries, with an overall mean of 30% (Humphrey et 
al. 2014). In fact, with a 51% average CR uptake in 2016, CR programmes in the UK are 
among the highest uptake figures globally (NACR 2017). 
To date, however, little research has been conducted in regards to CR utilisation in the 
growing PCI population (see Figure 1.2) and it is not clear what factors influence this. 
Figure 1.5 illustrates CR utilisation rates in PCI patients for the past six years in the UK. 
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Figure 1.5 CR utilisation rates in PCI patients as measured by NACR. 
The graph shows that there has been a gradual increase in the number of patients starting CR 
over the years although the number of referred patients dropped starting from the year 2013. 
Figure 1.5 also reveals that the number of PCI procedures has increased from around 28,000 
in 2011 to more than 41,000 patients in 2016 (46%). It also shows that the gap between 
those starting and those completing the CR programme is getting wider, however, this might 
be attributed in part to the fact that the quality of data entry in the NACR portal has 
improved in recent years. 
When CR utilisation rates are analysed in respect to the type of treatment received, more 
gaps can be seen. The NACR 2016 report has shown low uptake rates in patients following 
MI (39%) and elective PCI (45%) compared to the world-leading uptake rate in the CABG 
population (60%). This is of major concern when we realise that there were 92,445 PCI 
procedures carried out in the UK in 2012 compared to 16,791 CABG procedures (Townsend 
et al. 2015). In other words, around 50,000 eligible CR patients were not offered CR to 
prevent further MI and the progression of CAD (NACR 2014). Although NHS England’s 
CVD strategy for 2015/16 has an ambition to increase the uptake of CR to 65% for patients 
admitted with CAD, only a 2% increase in uptake has been recorded from the previous year 
(NACR 2015; England & Guideline 2014; NACR 2016). Looking deep into the differences 
and into those factors that may contribute to low uptake rates might help inform future 
strategies to increase CR uptake (Karmali et al. 2014). 
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1.9 Thesis aim, question and structure  
There are two primary aims of this PhD thesis: first, to review the existing literature 
critically and thus to identify the determinants of optimal CR utilisation in the eligible PCI 
population. Second, this thesis will assess the extent to which those determinants identified 
in the literature are applicable to the CR population in England by conducting a retrospective 
secondary analysis of the NACR dataset. In general, this thesis aims to contribute to the 
growing area of CR research by exploring those determinants in the PCI population and 
validating them against routinely collected clinical data. It is hoped that the findings of this 
research will make an important contribution to our understanding of the relatively low CR 
utilisation rates in this cohort despite the known benefits of CR. 
The first study in this thesis seeks to investigate the factors that are associated with patients 
attending an initial CR baseline assessment (CR engagement). The second study will 
examine the factors associated with starting CR by at least attending one outpatient session. 
In the third study, the determinants that lead patients to complete the outpatient CR 
programme will be evaluated. The fourth and final study in this thesis will be a synthesis of 
the three previous studies in an attempt to find the common factors that affect the patient 
journey in CR from engagement to completion. The primary question of this thesis is 
therefore: ‘what are the factors that determine CR engagement, uptake and adherence in the 
PCI population?’  
The overall structure of this thesis takes the form of eight chapters, including three themed 
chapters that will discuss CR engagement, uptake and adherence separately. These three 
chapters will be followed by a synthesis chapter which will try to promote a more unified 
understanding of the low CR utilisation rates. The second chapter of the thesis is a 
systematic review of CR utilisation determinants while the third chapter will give a clear and 
detailed explanation of the methodology used in this thesis. The final chapter will conclude 
the findings of the research, focusing on the implications of its findings and how they might 
be explored further in future studies. 
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2 Systematic review of CR utilisation 
2.1 Background 
This PhD thesis is constructed to identify and evaluate the determinants of Cardiac 
Rehabilitation (CR) engagement, uptake and adherence in percutaneous coronary 
intervention (PCI) patients since CR utilisation rates worldwide are still below desirable. 
Furthermore, it has previously been observed that utilisation rates are lower than expected in 
patients undergoing PCI in most European countries (Humphrey et al. 2014). This is of a 
concern particularly with PCI being nowadays the first method of choice for coronary 
revascularisation in cases of acute coronary syndrome (ACS) and stable angina, or silent 
ischemia (Varenne & Hemery 2008). 
A considerable amount of literature has been published on CR. These studies are different in 
design, targeted population and era. As this might be a significant source of heterogeneity 
when conducting the analysis and synthesis of literature, this chapter has evaluated trials and 
cohort studies separately taking into account population type and the date of each study. 
However, search strategy, search terms, sources searched and inclusion/exclusion criteria are 
identical despite the study design. 
Although this study is specifically targeting patients undergoing interventional cardiology 
often referred to as a PCI patient cohort, there is a tendency in the CR literature to include 
mixed population in the analysis. This is of a concern especially if we believe that there may 
be some intrinsic patient related clinical factors in the PCI cohort like age, number of 
comorbidities and hospital length of stay that is different from other CR indication groups 
such as heart failure patients. 
This study attempts to systematically review the existing literature around the determinants 
of CR utilisation. This goal will be achieved through the adaption of a validated systematic 
search strategy, analysis and synthesis of the available literature. However and due to the 
anticipated clinical heterogeneity in the included studies, the results will be synthesised 
under each identified determinant in the included studies. A key strength of the present 
review is that the searched articles were screened by two reviewers. This approach decreases 
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the risk of missing relevant evidence as reviews conducted without the aid of a second 
reviewer are more vulnerable to study selection bias. Furthermore, using search strategy and 
inclusion criteria established in advance reduces the risk of study selection based on 
individual’s preferences, practice or products (Centre for Reviews and Dissemination 2009). 
This approach also maintains transparency and reproducibility of systematic review method. 
2.2 Methods 
Adopting the systematic review techniques in reviewing the literature should allow for a 
transparent and concise way of identifying and evaluating studies that investigated the 
determinants of CR utilisation (Tashakkori 2010). This systematic review applied a robust 
approach to searching and evaluating literature and used validated search strategies, data 
analysis and quality assessment tools. Three previously published systematic reviews 
investigating CR were consulted to develop the methods of this review (Sumner et al. 2017; 
Rauch et al. 2016; Dressler et al. 2012). Although these reviews were concerned with CR 
outcomes not determinants, relevant methods like sections of search strategy were adopted 
(see section 2.2.3). The detailed methods of this review has been registered and published in 
the PROSPERO database (CRD42017075214). 
 Inclusion criteria 
The first step was to set up criteria of the literature that best serve the review’s focus, goals 
and coverage. This was achieved by explicitly specifying a comprehensive inclusion and 
exclusion criteria for eligible studies to be included in the review Table (2.1). These criteria 
were chosen first as they are fundamental to identify other parts of the review such as search 
strategy and quality assessment tools (Randolph 2009). 
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Table 2.1 Review inclusion criteria. 
 Inclusion criteria 
Study design Randomised and non-randomised study designs. 
Quantitative or mixed methods studies. 
Population  
 Age > 18 years. 
 Diagnosis CAD 
 Treatment Revascularisation (PCI or CABG) 
Objective Investigating CR engagement, uptake or adherence 
determinants. 
Comparative groups 
 Exposed 
Patients participating in an outpatient 
multidisciplinary CR in supervised settings within 
12 months from referral. 
 Comparators Patients offered CR but didn’t engage or start or 
complete the programme within 12 months from 
referral. 
Primary outcome Engaging, starting or completing a 
multidisciplinary CR programme. 
Publication Fully published articles. 
Language Published in English. 
     
 Databases searched 
All relevant key databases for health sciences that are provided by the University of York 
library at the time of literature search have been addressed. The review has searched the 
following seven databases: Cochrane Central Register of Controlled Trials (CENTRAL) 
(Issue 8, 2017), EBSCOhost Research Databases CINAHL Plus (August week 3 2017), 
MEDLINE (Ovid, 1946 to August week 3 2017), EMBASE (Ovid, 1980 to August week 03 
2017), AMED (Allied and Complementary Medicine) (1985 to July 2017), PsycINFO (1806 
to July Week 5 2017) and Scopus (Elsevier B.V August week 03 2017). 
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 Search strategy 
The Cardiac Rehabilitation Outcome Study (CROS) review developed a sensitive search 
strategy that was developed by a graduate information scientist for seven databases in order 
to identify two types of study designs: trials and observational studies (Rauch et al. 
2016).This section of their search strategy that captures all study designs around CR will be 
utilised. 
Sumner et al review (2017) which was investigating non-randomised studies developed a 
search strategy in conjunction with a trained information specialist (Sumner et al. 2017). Part 
of this strategy was a combinations of medical subject headings and keywords around 
cardiac population descriptors. This part will be used in this review. Permission was gained 
from one of the main authors of each of the above studies to use the relevant aspects of their 
approach. 
Dressler et al (2012) conducted a review to assess interventions to increase CR uptake. The 
search strategy for this review was developed by experts in the field of CR in the UK and 
included not only terms related to cardiac disease and CR but also an extensive selection of 
terms of potentially underrepresented population groups in CR programmes (Dressler et al. 
2012). These terms were suggested by the literature and included older women, ethnic 
minorities and patients with lower socioeconomic status. This part of their search will be 
used to identify studies that was concerned with investigating barriers against CR utilisation.  
A combination of the selected sections from each review will be constructed to form five 
main search terms that best fits the objectives of this thesis review. The five main search 
terms used to identify relevant literature are illustrated in (Appendix 1.1). These terms are: 
CR indications, rehabilitation terms, utilisation terms, CR determinants terms and study 
design terms. 
Utilising a search strategy based on these terms is believed to be more accurate in capturing 
relevant literature since it was developed by specialists and experts in the field. However, 
this review has been conducted without date restrictions and only published studies in 
English have been retrieved. An example of a search strategy used for MEDLINE database 
is shown in (Appendix 1.2). 
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 Selection of studies 
Results were retrieved, assessed and irrelevant titles were excluded from the review by the 
author (AQ). The remaining abstracts were evaluated independently against the previously 
determined inclusion and exclusion criteria by two researchers (AQ & JA). In case of 
disagreement, joint discussions were held to resolve the issue. If any disagreement persists, 
the third author (PD) was consulted. Excluded studies were listed along with the reason for 
exclusion in (section 2.3.2). 
 Data extraction 
A data extraction sheet has been developed to capture information on each study design, 
country of origin, date, aim, measures outcomes, sample size, population mean age and 
gender distribution. Where ambiguity incomplete data were found in any study regarding the 
above data extraction fields, N/A mark was placed in that field as it was difficult to contact 
the authors for further information (Appendix 9-3). 
 Quality assessment tools 
As systematic reviews aim to identify all available literature relating to a particular subject, 
it also aim to assess the quality of identified studies to achieve unbiased results (Schulz et al. 
1995). The objective of study quality assessment is to quantify in a scientific way how much 
‘truth’ its findings has and whether these findings are relevant to the settings or targeted 
population (Centre for Reviews and Dissemination 2009). It is therefore fundamental for 
systematic reviews to assess individual studies against key parameters such as risk of bias 
and lack of applicability (Whiting et al. 2003). With the aim to standardise research quality, 
considerable efforts were deployed to develop appropriate research quality assessment tools. 
Most available quality assessment tools are proposed to assess the methodological quality of 
studies. This is normally achieved by evaluating the study internal validity, external validity 
and statistical analysis (Verhagen et al. 2001). In principal, three types of assessment tools 
are available: scales, simple checklists and checklists with summary scales (Stang 2010). 
The outcome of these tools can be used in different ways such as weighting studies or 
addressing gaps in the methodology of included studies (Deeks et al. 2003). 
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As illustrated in Table 3.1, different study designs can be arranged in a hierarchy based on 
their susceptibility to bias. However, this categorisation does not take into account quality 
variations among studies in the same design (Centre for Reviews and Dissemination 2009). 
As a result, quality assessment tools tends to be specific to particular study designs, and if 
reviews cover different study designs, separate assessment tools will be used. For this 
review, trials have been assessed using the Cochrane risk of bias table (Higgins et al. 2011) 
while nonrandomised studies have been assessed using the checklist developed by Wells and 
colleagues (Wells et al. 2013). 
The Cochrane risk of bias table was developed by 16 statisticians, epidemiologists, and 
review authors to cover six domains of bias: selection bias, performance bias, detection bias, 
attrition bias, reporting bias, and other bias. Within each domain, one or more items are 
assessed. For each item, bias risk assessment is in two parts; the judgment (high, low or 
unclear risk of bias) and a free text description to summarise how this judgment was reached 
(Higgins & Green 2011). Although this tool is valuable in assessing the internal validity of 
trials, it lacks the ability to assess the external validity or the applicability of the outcomes. 
These issues can be assessed by evaluating different parameters such as how narrow is the 
inclusion criteria and clinical relevance of the primary assessed outcome. 
The checklists of methodological issues on nonrandomised studies developed by Wells 
group covers five methodological domains: study design, confounding, selective of analysis 
reporting, selective of outcome reporting and directness of evidence. Each domain is framed 
by several questions that the reviewer can response to using the quality assessment of studies 
of diagnostic accuracy included in systematic reviews (QUADAS-2) tool (i.e. ‘yes’, 
‘probably yes’, ‘probably no ’, and ‘no’) (Wells et al. 2013). Sumner et al (2107) used an 
adapted version of Wells checklist for the purpose of assessing the quality of observational 
studies included in their CR outcomes systematic review. The same adapted version will be 
utilised in this review (Sumner et al. 2017). 
Nonrandomised studies are more susceptible to bias than trials as treatment selection in this 
type of design is often influenced by subject characteristics (Austin 2011). Therefore, the 
absence of confounding cannot be assumed between exposed and unexposed subjects. As a 
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result, exploration of planned adjustment for confounding factors should be conducted and 
the use of a validated quality assessment tool is favourable. 
 Data synthesis and analysis 
Selected abstracts were imported into Mendeley desktop reference manager (version 1.17.9) 
and all duplicates were removed. If more than one publication was found to the same study, 
the most relevant paper to the review objectives was included. As the main objective of this 
review is to systematically review existing literature around CR utilisation determinants and 
due to the anticipated clinical heterogeneity in the included studies, the results were 
synthesised under each identified determinant. 
2.3 Results 
This section focuses on literature search results and the final study selection process. It will 
also cover an overview of the studies included in the final review with their bias assessment 
results. 
 Literature search results 
The electronic databases search revealed a total of 604 studies. The results per database 
searched are shown in Table 2.4 below. This search was conducted on the third week of 
August 2017. 
Table 2.2 Literature search results by database. 
Database Initial search results After title screening 
MEDLINE (Ovid) 91 70 
CINHAL Plus (EBSCO) 112 72 
Cochrane library (CENTRAL) 8 7 
AMED (Ovid) 13 8 
EMBASE (Ovid) 304 123 
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PsycINFO (Ovid) 1 1 
Scopus 75 50 
Total 604 331 
Duplicates - 46 
Total (-) duplicates  - 285 
Of the 604 titles found, 273 were excluded due to obvious irrelevance after title screening. 
Results were then uploaded to the referencing manager and a further 46 titles were removed 
due to duplication. The remaining 285 studies qualified to abstract screening phase. After 
abstract screening 228 titles were excluded and 79 studies progressed to full text analysis. 
Upon further appraisal, 32 studies failed to meet the inclusion criteria and a final of 46 
articles have been included in the review. Figure 2.1 illustrates the selection process and the 
reasons for exclusion. 
 
Figure 2.1 Study selection process. 
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 Excluded studies 
Table 2.3 lists excluded studies from the review with the reason for elimination. Studies 
have been excluded if they don’t meet one or more of the inclusion criteria. 
Table 2.3 Excluded studies with justification. 
# Study Exclusion justification 
1 Johnson & Heller (1998) Unrelated measured outcome 
2 Wyer et al (2001) Study design – literature review 
3 King et al (2001) Publication – double publication 
4 Daly et al (2002) Study design – literature review 
5 Beswick et al (2004) Study design – systematic review 
6 Jolly et al (2004) Study design – qualitative study 
7 Jolly et al (2005) Unrelated study aim 
8 Jones et al (2007) Study design – qualitative study 
9 Cooper et al (2007) Study design – qualitative study 
10 Beckie et al (2008) Unrelated measured outcome 
11 Sharp & Freeman (2009) Study design – qualitative study 
12 Martin et al (2011) Publication – conference abstract only 
13 Taylor et al (2011) Study design – systematic review 
14 Valencia et al (2011) Study design – literature review 
15 Gravely (2011) Population diagnosis – heart failure patients 
16 De Vos et al (2012) Study design – qualitative study 
17 Barboza et al (2012) Publication – conference abstract only 
18 Ghisi et al (2012) Unrelated measured outcome 
19 Mellville et al  (2012) Unrelated measured outcome 
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20 Reges et al (2012) Publication – double publication 
21 Martin & Woods (2012) Unrelated measured outcome 
22 Prior et al (2013) Publication – conference abstract only 
23 Shanmugasegaram et al (2013) Unrelated measured outcome 
24 Nielsen et al (2013) Unrelated study aim 
25 Samayoa et al (2014) Publication – conference abstract only 
26 Mikkelsen et al (2014) Study design – No comparator group 
27 Colella et al (2015) Study design – systematic review 
28 Doll et al (2015) Study design – Descriptive analysis only 
29 Grace et al (2015) Study design – No comparator group 
30 Pack et al (2015) Unrelated study aim 
31 Pola et al (2016) Publication – conference abstract only 
32 Kuijpers et al (2017) Publication – conference abstract only 
33 Pedersen et al (2017) Publication – conference abstract only 
 Included studies analysis 
All forty-six studies included in the review were conducted in the modern era of cardiology 
between the years 1995 and 2016 and only four studies conducted before 2001 (< 10%) 
(Rauch et al. 2016; Sumner et al. 2017).  Collectively, these studies should reflect the current 
CR practice knowing that in the year 2000 the National Service Framework for CHD was 
published in the UK establishing modern standards of care including CR services. Moreover, 
in the year 1994 the American Heart Association published position statement on CR 
programmes and CR core components which was again updated in 2000. In 2003, the 
European Society of Cardiology released recommendations on the design and development 
of CR programmes (Sumner et al. 2017). The reviewed studies were conducted in 8 different 
countries: 9 in Canada, 8 in US, 5 in UK, 2 in Australia, 1 in Israel, 1 in Denmark, 1 in 
Switzerland and 1 in Iran. 
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The studies included a total of 398,667 participants (ranging from 131 to 267,427) with eight 
studies having relatively small sample size (< 200) and five studies having relatively large 
sample size (> 10,000). The mean age of participants across all studies is 63.4 years (ranging 
from 55 to 73.5 years) with female representation of 30.32% of the total sample (ranging 
from 15.5% to 78.5%) whereas 8 studies were investigating CR utilisation determinants in 
female gender only (Missik 1999; Gallagher et al. 2003; Allen et al. 2004; Mochari et al. 
2006; Sanderson et al. 2010; Beckie & Beckstead 2010; Beckie et al. 2015; S. L. Grace et al. 
2016). 
In this review, 3 studies investigated CR engagement as the only outcome (N = 4,564), 29 
studies investigated the determinant of CR uptake as the only outcome (N = 341,989), 10 
investigated CR adherence as the only outcome (N = 28,633), 3 investigated both CR uptake 
and adherence determinants (N = 19,945) and 1 study investigated both CR engagement and 
uptake determinants (N = 3536). 
The population diagnosis reported in all studies was Myocardial Infarction (MI) in 18 
studies, ACS in 7 studies, CAD in 6 studies, CHD in 3 studies, and mixed diagnosis in 12 
studies. The revascularisation method across studies was PCI, CABG or medical treatment 
in 23 studies, PCI or/and CBAG in 11 studies, CABG only in 5 studies, PCI only in 1 study 
and 6 studies failed to report on this item. 
With regards to study design, the review consists of 2 RCT’s (Beckie & Beckstead 2010; S. 
L. Grace et al. 2016) and 44 observational studies. Among the observational studies 25 
utilised the prospective approach while 19 used retrospective approach. Out of the 44 
observational studies included in this review 18 conducted secondary analyses of other 
datasets to investigate the study outcome. The extraction sheet containing all the data will be 
in (Appendix 9-3). 
 Quality assessment 
The way individual studies’ are executed and designed can threaten the validity of their 
findings. Therefore strong systematic reviews utilise explicit and systematic quality 
assessment methods in order to minimise bias in the collated evidence. In this review and as 
discussed in section (2.2.6), trials were assessed using the Cochrane risk of bias table 
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(Higgins et al. 2011) while nonrandomised studies have been assessed using the checklist 
developed by Wells and colleagues (G. Wells et al. 2013; Rauch et al. 2016). Results of the 
quality assessment of randomised trials are presented in (Table 2.4). Both trials were 
conducted with the aim to measure the effect of CR programme type (women-only, mixed 
sex or home based) on female participants’ adherence to CR. Since this is the case, it was 
impossible to blind study participants from knowledge of which CR programme they were 
randomised into. 
Table 2.4 Cochrane risk of bias table for included RCT’s. 
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Domain Sub-domain 
Selection bias 
Random sequence generation   
Allocation concealment 
  
Reporting bias Selective reporting   
Other bias Other sources of bias   
Performance bias Blinding (participants & personnel)   
Detection bias Blinding (outcome assessment)   
Attrition bias Incomplete outcome data   
 
Results of nonrandomised studies are presented in (Figure 2.2). In randomised trials 
confounding may arise from flaws in the randomisation process whereas confounding in 
nonrandomised studies may arise from different potential confounding variables. The 
researcher in nonrandomised studies has to carefully decide what variables to include in the 
analysis and what statistical methods to utilise to control confounding (G. A. Wells et al. 
2013). In the majority of studies it was difficult to judge if there was no effect of 
confounding as these studies failed to justify the selection of the included variables. Another 
keynote about the investigated studies was the insufficient reporting about how missing 
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values were treated. However, all studies created appropriate comparison groups and no 
unusual categorical cut-offs or unusual subgroups were evident. 
 
Figure 2.2 Nonrandomised studies quality assessment results. 
 
2.4 Cardiac rehabilitation utilisation determinants 
A total of 604 studies were found using the pre-specified selection criteria, and 46 were 
included in the final review. This is 17 studies more than a recent systematic review 
conducted to analyse factors affecting CR utilisation (Ruano-Ravina et al. 2016). Below is a 
data synthesis of all reported determinant in the included studies. For clarity, those 
determinants were grouped under four main categories; patient’s socio-demographics, 
cardiac risk factors, lifestyle & health status and service level factors (Table 2.5). This 
synthesis will start by outlining the determinants of CR engagement, CR uptake and finally 
CR adherence. 
 
0% 50% 100%
1) Relevant comparison group(s)
2) Group formation: patient decision
3) Confounding compared between groups at…
4) Justification for confounding domains
5) Confounding considered in methods
6) Evidence of confounding control
7) Evidence of no effect from confounders
8) Robust confounding control
9) Representative cohort
10) Multiple analysis & selective reporting
11) Unusual subgroups
12) Multiple missing data methods & selective…
13) Unusual categorical cut-offs
Observational studies quality appraisal
Yes No Unclear
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Table 2.5 Reported CR utilisation determinants in the included studies. 
 
Patient’s socio-
demographics 
Cardiac risk factors 
Lifestyle & health 
status 
Service level factors 
1 Age Hypertension Wellbeing Referral profession 
2 Gender Diabetes Angina Referral Source 
3 Ethnicity Hyperlipidaemia Previous event Hospital length of stay 
4 Marital status Family history Smoking CR type 
5 Education Being overweight Alcohol intake Confirmed joining date 
6 Employment Physical inactivity Transportation Treatment type 
7 Social deprivation Anxiety Settlement location Previous CR 
8 Social support Depression Religion Language 
 
 Engagement determinants 
The adopted search strategy has identified 3 studies (N = 4,564) that investigated CR 
engagement (Grace et al. 2008; Grace et al. 2010; Grace et al. 2011) while 1 study (N = 
3,536) investigated both CR engagement and uptake (Smith et al. 2006). A note of caution is 
due here since the main purpose of two out of the four included studies was to investigate 
the impact of referral strategy on CR engagement (Grace et al. 2010; Grace et al. 2011). 
However, Grace et al (2010) reported other determinants beside the main measured 
determinant (referral strategy) while the other study Grace et al (2011) only reported the 
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impact of referral strategy on CR engagement. The main features of the included four studies 
are outlined in Table (2.6). 
Table 2.6 Main features of included engagement studies. 
 
Smith et al 
(2006) 
Grace et al 
(2008) 
Grace et al 
(2010) 
Grace et al 
(2011) 
Average 
Sample size 3,535 1,268 661 2,637 2,025 
Mean age 64 66 61.2 65 64.1 
Female % 20.9 28.0 23.8 26.8 24.9 
Country Canada Canada Canada Canada - 
Study 
design 
Retrospective 
secondary 
Prospective 
primary 
Prospective 
primary 
Prospective 
primary 
- 
Diagnosis CAD CAD ACS ACS - 
Treatment CABG Mixed Mixed PCI/CABG - 
The results of quality assessment for the four included studies in CR engagement is 
presented in Figure (2.3). These studies were assessed for quality according to the adapted 
checklist explained in (section 2.2.6). According to the displayed results in Figure (2.3) the 
included studies are ranked as high quality observational studies. 
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Figure 2.3 Quality assessment results for CR engagement studies. 
A summary of the CR engagement determinants as reported in the investigated studies is 
displayed in (Figure 2.4). The figure bars are colour coded according to the role of the 
determinant in CR engagement while the labels in the centre of each bar reflect the total 
number of studies that investigated that determinant. 
  
0% 50% 100%
1) Relevant comparison group(s)
2) Group formation: patient decision
3) Confounding compared between groups at
baseline
4) Justification for confounding domains
5) Confounding considered in methods
6) Evidence of confounding control
7) Evidence of no effect from confounders
8) Robust confounding control
9) Representative cohort
10) Multiple analysis & selective reporting
11) Unusual subgroups
12) Multiple missing data methods & selective
reporting
13) Unusual categorical cut-offs
CR Engagement studies quality appraisal
Yes No Unclear
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Figure 2.4 Determinants of CR engagement as reported in the investigated studies. 
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2.4.1.1 Patient’s socio-demographics 
Only one study has found that younger age is a significant determinant of engaging in CR in 
a multivariate analysis (OR: 1.3, 95% CI: 1.1 to 1.5, p = 0.001) (Smith et al. 2006). Grace et 
al (2008) has found that the mean age of engaged patients (65.7 years) at the baseline level is 
significantly less than the mean age of the non-engaged group (68.2 years) (p < 0.001). 
However, this association was not significant in the final logistic regression model (p = 0.61) 
(Grace et al. 2008). The same non-significant association between age and CR engagement 
was reported by Grace et al (2010) (OR: 1.02, 95% CI: 0.99 to 1.04, p =0.16). Gender was 
also significant determinant of CR engagement in only one study Smith et al (2006) as male 
patients were 1.6 times more likely to engage in CR compared to their female counterparts 
(OR: 1.59, 95% CI: 1.34 to 1.89, p < 0.001). 
The effect of patient’s ethnic group was reported only in one study Grace et al (2010) and 
found not to be statistically significant (OR: 0.58, 95% CI: 0.30 to 1.10, p = 0.10). Patient’s 
marital status was found to be significant in two studies (Smith et al. 2006; Grace et al. 
2008) and non-significant in one study (Grace et al. 2010). Patients living with a spouse 
were found to be 1.4 more likely to engage in CR (OR: 1.39, 95% CI: 1.16 to 1.68, p < 
0.001) (Smith et al. 2006). Grace et al (2008) found in an adjusted analysis that marital 
status has significant correlation with CR engagement (p = 0.01). The same study also 
proved that employment status, family income and education level have no significant 
correlation with CR engagement (p = 0.42, p = 0.93 and p = 0.88 respectively) (Grace et al. 
2008). This in contrast to the finding of Grace et al (2010) which found that family income 
is a strong predictor of CR engagement (OR: 1.66, 95% CI: 1.03 to 2.67, p = 0.04) (Grace et 
al. 2010). 
2.4.1.2 Cardiac risk factors 
Smith et al (2006) reported in three modifiable cardiac risk factors; diabetes, obesity and 
hyperlipidaemia. The study concluded that diabetic patients are 22% more likely to engage 
in CR (OR: 1.22, 95% CI: 1.04 to 1.44, p = 0.017). Patients with a body mass index (BMI) > 
30 were 24% more likely to engage in CR (OR: 1.24, 95% CI: 1.04 to 1.47, p = 0.015). 
Hyperlipidaemia patients were also more likely to engage in CR by 45% compared with 
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patients not diagnosed with hyperlipidaemia (OR: 1.45, 95% CI: 1.24 to 1.69, p < 0.001) 
(Smith et al. 2006). 
The bivariate analysis conducted by Grace et al (2008) revealed that diabetes, depressive 
symptoms, family history, exercise behaviour and BMI are not significantly associated with 
CR engagement (p > 0.05) (Grace et al. 2008). The logistic regression model run by Grace et 
al (2010) has also concluded that activity status and BMI are not associated with CR 
engagement (OR: 1.01, 95% CI: 1.00 to 1.02, p = 0.15) (OR: 0.97, 95% CI: 0.92 to 1.02, p = 
0.19) respectively (Grace et al. 2010). All included studies failed to report on hypertension 
and anxiety levels. 
2.4.1.3 Lifestyle & health status 
The strongest independent predictor of engaging in CR that was found by Smith et al (2006) 
is the geographical proximity to the CR centre (OR: 3.09, 95% CI: 2.52 to 3.78, p < 0.001). 
This single predictor was accounted for approximately 80% of the overall explained 
variance for engaging in CR (Smith et al. 2006). This finding is supported by the findings of 
the mixed logistic regression analysis conducted by Grace et al (2008) which concluded that 
shorter distance to CR centre is statistically significant predictor of CR engagement (p = 
0.001) (Sherry L. Grace et al. 2008).  
Smith et al (2006) also found that patients with a previous CABG are 89% more likely to 
engage in CR than their counterparts (OR: 1.89, 95% CI: 1.36 to 2.63, p < 0.001) (Smith et 
al. 2006). Smoking status of patient at the time of the cardiac event was investigated in three 
of the included studies. Surprisingly all three studies agreed that the smoking status is not 
associated with the CR engagement.  Other medical conditions that might prevent exercise 
as reported by patients were found not statistically significant with CR engagement (Sherry 
L. Grace et al. 2008). All other listed determinants under this category have not been 
addressed in the included studies. 
2.4.1.4 Service level factors 
This set of determinants mainly revolve around how the service has been 
introduced/delivered to the patient and what type of treatment the patient received. To 
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investigate the type of referral on CR engagement Grace et al (2010) compared automatic 
versus usual referral to CR services. Patients automatically referred to CR were 2.1 times 
more likely to engage in CR (OR: 2.10, 95% CI: 1.35 to 3.28, p < 0.01) (Grace et al. 2010). 
One year later Grace et al (2011) have dedicated their study to investigate the impact of 
referral strategy on CR engagement. Basically they compared the engagement rate of four 
different referral strategies. They concluded that automatic referral combined with a patient 
discussion can achieve the highest engagement rates (OR: 8.41, 95% CI: 3.57 to 19.85) 
(Grace et al. 2011). Also, the ability to speak the first language of the country is a major 
determinant of CR engagement as found in one study (OR: 2.73, 95% CI: 1.67 to 4.47, p < 
0.001) (Smith et al. 2006). 
The strength of physician endorsement was found to be statistically significant with CR 
engagement (p =0.01) (Sherry L. Grace et al. 2008). However, other factors that are related 
to referral source to CR such as physician referral intentions and positive physician 
perception of CR was found not significant by the same study (Sherry L. Grace et al. 2008) . 
Patients who were referred to CR prior to CABG were 2.3 as likely to engage in CR (OR: 
2.27, 95% CI: 1.77 to 2.92, p < 0.001) (Smith et al. 2006). Patients with a cardiac event or 
procedure other than PCI were more likely to engage in CR than those hospitalised for PCI 
procedure (OR: 1.79, 95% CI: 1.14 to 2.82, p = 0.01) (Grace et al. 2010). 
 Uptake determinants 
As mentioned previously, 29 studies (N = 341,989) investigated the determinants of CR 
uptake as the only outcome while 3 studies investigated both CR uptake and adherence in 
the same study (N = 22,041). Collectively, the 32 studies included a total of 361,934 
participants (ranging from 131 to 267,427). The mean age of participants across all studies 
was 62.8 years (ranging from 58 to 69 years) with female representation of 29.2% of the 
total sample (ranging from 15.5% to 48%) whereas 5 studies were investigating CR uptake 
determinants in female gender only (Sanderson et al. 2010; Mochari et al. 2006; Allen et al. 
2004; Missik 1999; Gallagher et al. 2003). 
The population diagnosis reported in all studies was MI in 15 studies, ACS in 3 studies, 
CAD in 3 studies, CHD in 3 studies, and mixed diagnosis in 6 studies. The revascularisation 
method across studies was PCI, CABG or medical treatment in 12 studies, PCI or/and 
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CABG in 10 studies, CABG only in 3 studies, PCI only in 1 study and 6 studies failed to 
report on this item. 
With regards to study design, all included studies were observational studies. Among those, 
19 studies utilised the prospective approach while 13 studies were conducted retrospectively. 
Out of the 32 observational investigating CR uptake, 18 studies conducted secondary 
analysis of other datasets to investigate the study outcome. The results of quality assessment 
for the 33 included studies in CR uptake is presented in Figure (2.5). 
 
Figure 2.5 CR uptake studies quality appraisal. 
A summary of the CR uptake determinants as reported in the investigated studies is 
displayed in (Figure 2.6). The figure bars are colour coded and labelled as previously 
described in (Figure 2.4).  
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Figure 2.6 Determinants of CR uptake as reported in the investigated studies. 
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2.4.2.1 Patient’s socio-demographics 
Out of the 32 studies that investigated CR uptake, 21 studies found age to be a significant 
determinant, 8 not significant determinant and 3 studies; Harrison & Wardle (2005), Molloy 
et al (2008) and Lemstra (2013) did not report on age as the aim was to measure a specific 
determinant. All 21 studies found that younger participants are more likely to start CR 
compared to older patients. However and in a less robust method, 6 studies computed this 
finding from a univariate analysis. In the remaining 16 studies, the odds of young patients 
starting CR ranged from 40% to 72% in studies that measured age as a categorical variable 
and from 0.95 to 0.99 in studies that measured age as a continuous variable. 
The impact of gender was investigated in 21 studies while 4 studies Gallagher et al (2003), 
Allen et al (2004), Mochari et al (2006) and Sanderson et al (2010) had 100% female 
participants and 1 study Suaya et al (2007) stratified the sample by gender prior to analysis. 
The remaining 6 studies didn’t report in gender. Out of the 21 studies, 14 studies found that 
gender is a significant determinant of CR uptake where males are more likely to start CR 
compared with their female counterparts. The odds of male patients starting CR ranged from 
1.11 to 2.86 in 10 studies while 5 studies reported gender as a significant predictor (p < 0.05) 
of CR uptake as only univariate analysis was conducted. 
Patient ethnicity as a determinant of CR uptake was investigated in 8 studies. Six studies 
found that patients from ethnic minorities are less likely to uptake CR (ranging from 58% to 
200% less likely). However, 2 studies found ethnicity as a non-significant determinant of CR 
(Harlan et al. 1995; Sanderson et al. 2010). Subjects’ marital status was investigated in 13 
studies with 7 studies reporting it as a significant determinant of CR uptake. Overall, 
partnered subjects were found to be more likely to commence a CR programme compared 
with single or previously partnered. The odds of partnered patients to start CR ranged from 
1.44 to 3.53 more likely. 
The role of patient’s level of education on CR uptake was investigated in twelve studies. Six 
studies concluded that patient’s level of education is not associated with CR uptake (Lane et 
al. 2001; Reges et al. 2013b; McKee et al. 2014; Soo Hoo et al. 2016; Allen et al. 2004; 
Mochari et al. 2006). Three studies found it significant in a univariate analysis (p < 0.05) 
(Evenson et al. 1998; Harlan et al. 1995; Missik 1999). In a multivariate analysis, three 
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studies found that patients with at least high school education were more likely to start CR 
(OR: 1.50, 1.81 and 3.32) (Parashar et al. 2012; Dunlay et al. 2009; Sanderson et al. 2010) 
respectively.   
The employment status was investigated in 15 studies. Five studies found that the 
employment status of a participant is not significant. Four studies found that employment 
status is a significant determinant of CR uptake by conducting a univariate analysis. The 
remaining six studies conducted a multivariate analysis and found that patients in full 
employment are more likely to join CR. The odds of fully employed participants to start CR 
ranged from 1.52 to 3.07 compared with unemployed or retired participants. 
Patient’s income was reported as a significant predictor in 8 studies and not significant in 1 
study (Sanderson et al. 2010). Two out of the eight studies investigated this determinant in a 
univariate analysis Harlan et al (1995) and Reges et al (2013) while six studies conducted a 
multivariate analysis and found out that patients with low income are less likely to start CR 
ranging from 44% to 77%. Social deprivation was also investigated in five studies and all 
found it a significant determinant of CR uptake. The least deprived patients were more likely 
to join (ranging from 17% to 35%) compared with the most deprived patients in three studies 
while two studies reported this determinant in a univariate analysis (p < 0.05). 
The role of social support in CR uptake was controversial among the studies reporting this 
determinant. While five studies found that social support is not a significant predictor, 
another five studies reported that it is strongly correlated with increase in CR uptake. In 
those studies reporting social support as a predictor of CR uptake, four studies indicated that 
subjects reporting enough social support were more likely to attend CR (OR: 1.46, 3.42, 4.26 
and 4.5) (Cupples et al. 2010; Chamosa et al. 2015; Molloy et al. 2008; Lane et al. 2001) 
respectively. The remaining study reported social support as a significant predictor in a 
univariate analysis (p = 0.019) (Beauchamp et al. 2013). 
2.4.2.2 Cardiac risk factors 
As outlined in Table 2.5), this group contains eight determinants; hypertension, diabetes, 
high blood cholesterol, family history, being overweight, physical inactivity, anxiety and 
depression. Hypertension was investigated in eight studies where it was found significant in 
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four studies (King et al. 2001; Dunlay et al. 2014; Parashar et al. 2012; Evenson et al. 1998) 
and not significant in four studies (McKee et al. 2014; Lane et al. 2001; Sanderson et al. 
2010; Beauchamp et al. 2013). Hypertensive patients were found to be less likely to start CR 
in two multivariate analysis studies (OR: 0.85 and 0.58) (Parashar et al. 2012; King et al. 
2001) while it was significant determinant in two univariate studies (Evenson et al. 1998; 
Dunlay et al. 2014). 
Diabetes as a determinant of CR uptake was investigated in thirteen studies. Seven studies 
concluded that it was not a significant predictor of CR uptake while six studies proved the 
opposite. Among those six studies, three studies reported that diabetic patients were less 
likely to start CR (OR: 0.40, 0.58 and 0.70) (Turk-Adawi et al. 2014; van Engen-Verheul et 
al. 2013; Dunlay et al. 2009) respectively, and three studies found diabetes is a significant 
determinant of CR uptake in a univariate analysis (p < 0.05) (Evenson et al. 1998; 
Beauchamp et al. 2013; Dunlay et al. 2014). 
Hyperlipidaemia or high blood cholesterol was investigated in nine studies. Two studies 
found it significant determinant of CR uptake by conducting a univariate analysis (Evenson 
et al. 1998; Dunlay et al. 2014) and one study reached the same finding by conducting a 
bivariate analysis controlling for age (OR: 1.90, 95% CI: 1.2 to 3.1) (Nielsen et al. 2008). 
The remaining six studies found hyperlipidaemia not significant determinant of CR uptake. 
Family history of cardiac disease was investigated in five studies and was found significant 
in only one univariate study (Evenson et al. 1998). 
 Individuals who had BMI > 30 were found to be less likely to start CR in two studies (OR: 
0.89) (King et al. 2001) and (p = 0.002) (Dunlay et al. 2014). Five studies found no 
association between BMI and CR uptake (Parashar et al. 2012; McKee et al. 2014; Chamosa 
et al. 2015; Sanderson et al. 2010; Beauchamp et al. 2013). Individuals performing regular 
exercise were found more likely to start CR in two studies. Harlan et al (1995) found that 
performing regular exercise is a significant determinant of CR uptake (P = 0.03) (Harlan et 
al. 1995). While Lane et al (2001) found those who took less frequent exercise prior to MI 
are less likely to join (OR: 0.85, 95% CI: 0.80 to 0.91) (Lane et al. 2001). However, two 
studies found this association is not significant (Sanderson et al. 2010; Beauchamp et al. 
2013). 
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Participants levels of anxiety was investigated in four studies and found not significant in 
three of them (French et al. 2005; Harlan et al. 1995; McKee et al. 2014). In the study 
conducted by Lane et al (2001) it was found that those who started CR had lower trait 
anxiety scores (OR: 1.04, 95% CI: 1.01 to 1.06) (Lane et al. 2001). Two studies have found 
that the presence of depressive symptoms had a large impact on CR uptake. Hoffmann et al 
(2013) reported that individuals with depressive symptoms are less likely to start CR (OR: 
0.26, 95% CI: 0.08 to 0.88) (Hoffmann et al. 2013). This finding was in agreement with 
another American multivariate study (OR: 0.56, 95% CI: 0.36 to 0.88) (Turk-Adawi et al. 
2014). However, three studies found no association between depression and CR uptake 
(French et al. 2005; McKee et al. 2014; Sanderson et al. 2010). 
2.4.2.3 Lifestyle & health status 
How patients perceived their health before the cardiac event has been investigated in two 
studies. Dunlay et al (2009) concluded that patients whom perceived their health as excellent 
before MI were 7.33 times more likely to uptake CR than those who perceived it as poor 
(OR: 7.33, 95% CI: 1.38 to 38.88) (Dunlay et al. 2009). Also Harlan et al (1995) found that 
in a univariate analysis that CR participants were significantly less impaired than non-
participants before CABG (p = 0.001) (Harlan et al. 1995). Another important indicator of 
patient’s wellbeing is the total number of comorbidities. Sundararajan et al (2004) found that 
patients with two or more comorbidities are less likely to start CR (OR: 0.82, 95% CI: 0.72 
to 0.93) (Sundararajan et al. 2004). This finding differs from Allen et al (2004) who assessed 
comorbidity by Charlson index score and found that increased number of comorbidities is 
not associated with CR uptake (OR: 1.16, 95% CI: 0.93 1.45) (Allen et al. 2004). This result 
is consistent with two later studies (Parashar et al. 2012; Soo Hoo et al. 2016). 
The feeling of cardiac symptoms like angina has been investigated as a driver of CR 
participation. Lane et al (2001) found in a multivariate analysis that patients starting CR 
were less likely to suffer from angina pectoris (OR: 2.02, 95% CI: 1.16 to 3.50) (Lane et al. 
2001). This finding is contrary to that of Nielsen et al (2008) who found that chest pain is a 
positive predictor of CR uptake (OR: 8.6, 95% CI: 3.0 to 24.8) (Nielsen et al. 2008). 
However, three studies reported that the presence of angina or chest pain is not associated 
with CR uptake (Parashar et al. 2012; McKee et al. 2014; Allen et al. 2004). 
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The association of CR uptake and history of a previous cardiac event was investigated in 
thirteen studies. Three studies found that a previous MI is a strong barrier against CR uptake 
(OR: 0.24, 95% CI: 0.09 to 0.65) (Melville et al. 1999), (OR: 0.24, 95% CI: 0.12 to 0.51) 
(Dunlay et al. 2009) and (OR: 0.62, 95% CI: 0.39 to 0.97) (McKee et al. 2014). Another two 
studies confirmed this findings by reporting that non-starters are more likely to have a 
history of MI (OR: 3.04, 95% CI: 1.52 to 6.10) (Lane et al. 2001) and (OR: 1.29, 95% CI: 
0.71 to 2.33) (Chamosa et al. 2015). In univariate analysis, three studies also confirmed that 
previous MI is significantly associated (p < 0.05) with CR uptake (Evenson et al. 1998; 
Missik 1999; Hoffmann et al. 2013). However, this association was not found to be 
significant in another five studies (French et al. 2005; Parashar et al. 2012; Soo Hoo et al. 
2016; King et al. 2001; Reges et al. 2013b). 
Smokers were found to be starting CR less likely than non-smokers in two multivariate 
studies (OR: 0.59; 95% CI, 0.44 to 0.80) (Parashar et al. 2012) and (OR: 0.59; 95% CI, 0.44 
to 0.78) (Turk-Adawi et al. 2014). It was also found significant in one univariate analysis (p 
= 0.001) (Dunlay et al. 2014). History of smoking was found to be significant determinant of 
CR uptake in one univariate study (p < 0.05) (Evenson et al. 1998), and not significant in 
one multivariate study (OR: 1.05, 95% CI: 0.91 to 1.21) (Turk-Adawi et al. 2014). The 
association of smoking with CR uptake was found not significant in another six studies 
(Harlan et al. 1995; McKee et al. 2014; Melville et al. 1999; King et al. 2001; Lane et al. 
2001; Sanderson et al. 2010). 
Transportation distance to CR location has been investigated as potential determinants of CR 
uptake in six studies. Suaya et al (2207) found that those at the greatest distance from a CR 
centre (15 – 231 miles) have the least likelihood of CR uptake (OR: 0.29, 95% CI: 0.27 to 
0.31) (Suaya et al. 2007). This is in line with Chamosa et al (2015) findings which confirms 
that patients driving more than 50 km are less likely to start CR compared with those driving 
less than 10 km (OR: 2.87, 95% CI: 1.29 to 6.41) (Chamosa et al. 2015). Brual et al (2010)  
also attempted to empirically test the drive time threshold for CR utilization and concluded 
that only those who have to drive over 80 minutes are less likely to start CR compared to 
those who drive less than 10 minutes (OR: 0.22, 95% CI: 0.11 to 0.42) (Brual et al. 2010). 
This association was not evident in univariate analysis conducted in four other studies 
(French et al. 2005; Cupples et al. 2010; Melville et al. 1999; Sanderson et al. 2010). 
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In the same context, the ability to drive was associated with increased CR uptake in three 
studies. Non-drivers were three-folds less likely to start CR than drivers in a secondary 
retrospective Australian study conducted by Worcester et al (2004) (OR: 3.09, 95% CI: 1.62 
to 5.57) (Worcester et al. 2004). This is supported by another primary prospective American 
study (OR: 0.16, 95% CI: 0.06 to 0.42) (Dunlay et al. 2009). These findings were further 
confirmed by another study which found out that those who possess driving license are more 
likely to start CR (OR: 2.42, 95% CI: 1.02 to 5.73) (Reges et al. 2013b). Also the 
participants’ geographic place of residence was investigated in two studies. King et al (2001) 
found that the odds of those who live in tertiary care centre city were 4.48 times higher than 
their counterparts (King et al. 2001), while Sundararajan et al (2004) reported that those who 
live in an accessible geographic place of residence (according to the Australian index of 
remoteness) were 28% more likely to start CR (OR: 1.28, 95% CI: 1.13 to 1.45) 
(Sundararajan et al. 2004). The impact of the patient’s spiritual beliefs on CR uptake was 
investigated in one multivariate middle-eastern study and found not to be significant (Reges 
et al. 2013b). 
2.4.2.4  Service level factors 
The most influential determinant in this group is treatment type. Whether a patient received 
CABG, PCI or medical treatment for the index cardiac event seems to have a large impact 
on his decision to uptake CR. A total of seventeen studies investigated this determinant with 
only three studies finding it not significant (Parashar et al. 2012; McKee et al. 2014; 
Sanderson et al. 2010).  The remaining fourteen studies, including five univariate analysis 
studies, concluded that patients who underwent revascularisation procedure are more likely 
to start CR than those treated medically. Within the revascularisation procedures, patients 
receiving CABG treatment are even more likely to start CR than those receiving PCI (OR 
ranging from 2.76 to 58) (Suaya et al. 2007; Sundararajan et al. 2004; van Engen-Verheul et 
al. 2013; Hoffmann et al. 2013). Also patients having elective PCI are less likely to start CR 
than those receiving primary PCI (OR: 0.48, 0.41 to 0.56) (van Engen-Verheul et al. 2013). 
Patient’s length of stay in hospital was investigated in four studies. Dunlay et al (2014) have 
found that non-starters had longer hospital length of stay (p < 0.001) (Dunlay et al. 2014). A 
more recent study by Soo Hoo and colleagues (2016) conducted a multivariate analysis to 
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measure CR uptake after 4 weeks and 6 months from the index cardiac event and found out 
that hospital length of stay is not significant in both time points in patients admitted with ST-
elevation MI (p = 0.179 and 0.792) respectively (Soo Hoo et al. 2016). Another study 
conducted a univariate analysis to investigated this determinant in MI population and found 
out starting CR was not associated with the number of days stayed at hospital (p = 0.50) 
(French et al. 2005). 
Patients treated in small hospitals (1 - 160 beds) were more likely to start CR (OR: 1.27, 
95% CI: 1.11 to 1.46) and patients transferred from long term care or a skilled nursing 
facilities were less likely to start CR compared with those admitted from home (OR: 0.72, 
95% CI: 0.65 to 0.79). Also patients admitted to hospitals affiliated to medical schools were 
33% more likely to start CR than hospitals with the opposite characteristics (OR: 1.33, 95% 
CI: 1.21 to 1.46) (Suaya et al. 2007). This last finding is in line with the findings of a 
previous study which concluded that patients admitted to private hospitals are 32% more 
likely to start CR than those admitted to teaching hospitals (OR: 1.32, 95% CI: 1.17 to 1.48) 
(Sundararajan et al. 2004). 
Patients not receiving a confirmed joining CR appointment were found to be less likely to 
start CR than those who were given an appointment (OR: 0.31, 95% CI: 0.18 to 0.54) 
(Melville et al. 1999). Also those patients who received a recommendation letter from their 
physician to start CR were more likely to join than those who didn’t (OR: 2.79, 95% CI: 
1.51 to 5.14) (Reges et al. 2013b). Those who attended CR previously were found to be less 
likely to uptake CR again (OR: 0.26, 95% CI: 0.12 to 0.56) (Dunlay et al. 2009). The last 
determinant in this group was proficiency of the native language which was investigated in 
only two studies and reported as a significant predictor of CR uptake in a bivariate analysis 
(p = 0.001) by (Reges et al. 2013b) and as not significant determinant (p = 0.42) by 
(Beauchamp et al. 2013). 
 Adherence determinants 
A total of 13 studies investigating CR adherence have been identified in this systematic 
review (N = 48,578). Among which there are ten studies that were looking at CR adherence 
as the only outcome (N= 28,633) including two RCT’s (N = 335). The remaining 
observational studies were conducted either prospectively (five studies) or retrospectively 
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(six studies). Secondary analysis of other datasets to investigate the study outcome was 
utilised in five studies. 
Since the definition of ‘CR adherence/completion’ varies among researchers, it is important 
to clarify how the term has been used in the included studies. Five studies defined drop out 
by computing a cut-point based on the number of sessions attended (Worcester et al. 2004; 
Beckie & Beckstead 2010; Turk-Adawi et al. 2013a; Doll et al. 2015; Beckie et al. 2015). 
Three studies defined completion of CR by attending 100% of the prescribed sessions 
(Sarrafzadegan et al. 2007; Lemstra et al. 2013; Armstrong et al. 2014). Two studies marked 
a participant as a completer relying on feedback from the participant himself or from the CR 
programme manager (Harrison & Wardle 2005a; Casey et al. 2008). Two studies defined 
completion by conducting a second CR assessment (Yohannes AM, Yalfani A, Doherty P 
2007; S. L. Grace et al. 2016) while the definition of completers in one study was ambiguous 
(Ananya Tina Banerjee et al. 2007). 
The mean age of participants across all studies is 63.3 years (ranging from 55 to 73.5 years) 
with female representation of 35.7% of the total sample (ranging from 24.0% to 78.5%) 
whereas 3 studies were investigating CR adherence determinants in female gender only 
(Beckie & Beckstead 2010; Beckie et al. 2015; S. L. Grace et al. 2016). The population 
diagnosis reported in all studies was MI in 4 studies, CAD in 1 study, CHD in 1 study, and 
mixed diagnosis in 7 studies. The revascularisation method across studies was PCI, CABG 
or medical treatment in 8 studies, PCI or/and CBAG in 4 studies and CABG only in 1 study. 
The Cochrane risk of bias table for the included RCT’s is presented in (Table 2.4) while the 
nonrandomised studies quality assessment for the included adherence studies is displayed in 
(Figure 2.7). 
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Figure 2.7 CR adherence studies quality appraisal. 
A summary of the CR adherence determinants as reported in the investigated studies is 
displayed in (Figure 2.8). The figure bars are colour coded and labelled as previously 
described in (Figure 2.4). 
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Figure 2.8 Determinants of CR adherence as reported in the investigated studies. 
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2.4.3.1 Patient’s socio-demographics 
Seven studies investigated the impact of age on CR adherence and all concluded that 
younger age is associated with higher dropout rates. Among which, three studies measured 
age as a continuous variable (in years) while the other three dichotomised age into two 
groups (≤ 65 and > 65 years). In the latter case, the odds of subjects older than 65 years to 
complete CR was (1.56, 1.9 and 2.39) (Casey et al. 2008; Turk-Adawi et al. 2013a; Harrison 
& Wardle 2005a) respectively. Within subjects aged 65 years or older, Doll et al (2015) 
found no association between age and CR adherence in those aged (65 - 74 years) and those 
aged (> 75 years) ( p = 0.53) (Doll et al. 2015). In studies measuring age in years, Yohannes 
et al (2007) found out that younger participants are less likely to complete (OR: 0.89, 95% 
CI: 0.82 to 0.95) (Yohannes AM, Yalfani A, Doherty P 2007). Sarrafzadegan et al (2007) 
confirmed this finding by reporting that young patients are more likely to drop out (OR: 
1.02, 95% CI: 1.00 to 1.03) (Sarrafzadegan et al. 2007). The last study conducted a t-test to 
compare the mean age of completers (63.5 years) to the mean age of non-completers (55.4 
years) which was statistically significant (p < 0.001) (Beckie et al. 2015). 
The impact of participants’ gender on CR adherence was investigated in five studies. 
Yohannes et al (2007) and Sarrafzadegan et al (2007) found out that the odds of female 
participants to drop out early was (5.59 and 1.82) respectively(Yohannes AM, Yalfani A, 
Doherty P 2007; Sarrafzadegan et al. 2007). Among older participants (> 65), Doll et al 
(2015) found out that those attending (≥ 26 CR sessions) were more likely to be males (p < 
0.001) (Doll et al. 2015). Also a univariate analysis study reported that participant’s sex is 
statistically significant in the overall completion of CR (p = 0.02) (Harrison & Wardle 
2005a). However, in a logistic regression analysis controlling for age, BMI, employment 
status and depression concluded that gender was not found a predictor of CR completion 
(OR: 1.34, 95% CI: 0.86 to 2.06) (Casey et al. 2008). 
Participant’s ethnicity was investigated in three studies. An American study concluded that 
Non-whites were less likely to adhere to CR than Whites (OR: 0.60, 95% CI: 0.41 to 0.88) 
(Turk-Adawi et al. 2013a). A UK study also revealed that South Asians are less likely than 
Whites to fully adhere to a 6-month CR program despite equal access and no cost barrier (p 
=0.04) (Banerjee et al. 2007). Among older American cohort (> 65 years), a study found out 
that White race is not associated with increased CR adherence (p = 0.79) (Doll et al. 2015). 
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Marital status was investigated in only one study and found to not to be significant 
(Sarrafzadegan et al. 2007). 
The influence of employment status on CR adherence was investigated in three studies. 
Worcester et al (2004) revealed that retired and unemployed participants are more likely to 
drop out early than employed participants (OR: 1.83 and 4.69) respectively (Worcester et al. 
2004). This is in contrast of the findings of Iranian study which reported that the number of 
CR sessions in which the subjects attended did not differ according to job category 
(Sarrafzadegan et al. 2007). Also a retrospective secondary analysis investigating CR 
adherence determinants in a mixed population found no association between employment 
and CR completion (OR: 1.37, 95% CI: 0.78 to 2.40) (Casey et al. 2008). However, CR 
completion rates are significantly higher in high-income neighbourhoods compared with 
low-income neighbourhoods as reported by a Canadian secondary retrospective study (OR: 
5.40, 95% CI: 1.45 to 20.10) (Lemstra et al. 2013). The last reported determinant in this 
group is participant’s education level which was investigated in only one study. This 
primary prospective multivariate analysis study, revealed that participants with educational 
level ranging from diploma to bachelor degree are attending more CR sessions than those 
with ( ≤ high school) and those with ( ≥ master degree) (20.9 ± 1.6 versus 17.2 ± 0.4, p = 
0.004) (Sarrafzadegan et al. 2007). 
2.4.3.2 Cardiac risk factors 
The most reported determinant among this group is diabetes mellitus. It has been found 
statistically significant determinants of CR adherence in five out of six studies investigating 
this factor. The only two multivariate studies reporting this outcome were controversial. 
While Turk-Adawi et al (2013) observed higher adherence in patients with diabetes than 
without diabetes (OR: 1.3, 95% CI: 1.13 to 1.49), a previous study by Worcester et al (2004) 
reported that having a history of diabetes was associated with drop-out amongst attending 
men (OR: 3.38, 95% CI: 1.43 to 7.97) (Turk-Adawi et al. 2013a) (Worcester et al. 2004). 
In the same vein but with a less robust method, Armstrong et al (2014) revealed that among 
7,036 nondiabetic and 1,546 diabetic patients who completed CR, 84.9% of nondiabetic 
versus 79.6% of diabetic patients completed the 12-wk CR program (p < 0.001) (Armstrong 
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et al. 2014). Also an American secondary retrospective study reported that in patients older 
than 65 years, those with diabetes attend less number of sessions (≥26 sessions) (p = 0.04) 
(Doll et al. 2015). Similarly another American primary prospective study in a mixed 
population reported that completers are more likely to be nondiabetic (p = 0.009) (Beckie et 
al. 2015). The only study that couldn’t prove this association was a middle-eastern study 
conducted by (Sarrafzadegan et al. 2007). 
The impact of obesity, either reported as a BMI or waist size measurement, on CR adherence 
has been reported in four studies. A middle-eastern study prospectively investigating CR 
adherence determinants in MI patients reported that lower BMI (<30) and higher waist-to-
hip ratio are significant predictors of CR completion (OR: 0.95, 95% CI: 0.92 to 0.98) and 
(OR: 12.87, 95% CI: 1.87 to 88.49) respectively (Sarrafzadegan et al. 2007). Conversely, an 
American prospective study investigating CR adherence determinants in mixed population 
found that women not completing CR had a larger waist circumference (107.5 ± 15.5 cm 
versus 99.6 ± 15.5 cm; p = 0.014) and reported no significant association between BMI or 
body weight and CR completion (p = 0.06 and 0.07) respectively (Beckie et al. 2015). The 
same conclusion was reached by another American retrospective secondary analysis studies 
which found no association between BMI and CR adherence (OR: 0.99, 95% CI: 0.95 to 
1.02) and (p = 0.70) respectively (Casey et al. 2008; Doll et al. 2015). 
Those who have higher psychological distress (anxiety and depression) as measured by 
Hospital Anxiety Depression (HAD) score were found to have higher drop out ratios (OR: 
1.48, 95% CI: 1.21 to 1.82) (Yohannes AM, Yalfani A, Doherty P 2007). This finding is 
supported by another study which reported that participants who had higher levels of 
depressive symptoms were less likely to complete CR (OR: 0.96, 95% CI: 0.93 to 0.99) 
(Casey et al. 2008). Also this study revealed significant differences in anxiety and 
depression levels among young women and those who dropped out of CR compared with 
older women (p < 0.001) (Casey et al. 2008). 
The impact of physical inactivity as a cardiac risk factor on CR adherence has been 
investigated in one study conducted by (Worcester et al. 2004). This study reported that 
women who exercise < 6 hours/week are 2.29 more likely to drop out than women 
exercising ≥ 6 hours/week (OR: 2.29, 95% CI: 0.58 to 9.03) and women who never exercise 
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are 7.32 more likely to drop out (OR: 7.32, 95% CI: 1.32 to 41.21). Hypertension, 
hyperlipidaemia and family history of cardiac disease were reported as not significant 
determinants of CR adherence (Beckie et al. 2015; Doll et al. 2015; Sarrafzadegan et al. 
2007). 
2.4.3.3 Lifestyle & health status 
The most debated determinant in this group is smoking status. It has been found significant 
determinant of CR adherence in three out of six studies. An Australian primary prospective 
study reported that former smokers and current smokers are more likely to drop out from CR 
than those who never smoked (OR: 2.98, 95% CI: 1.07 to 8.27) and (OR: 3.33, 95% CI: 1.50 
to 7.39) respectively (Worcester et al. 2004). This is supported by the findings of Iranian 
study which reported that non-smokers are 78% more likely to complete CR than smokers 
(OR: 1.78, 95% CI: 1.25 to 2.53) (Sarrafzadegan et al. 2007). Among older people (aged > 
65 years), (Doll et al. 2015) reported that current and recent smokers are attending less 
number of CR sessions than non-smokers (p < 0.001). In (Yohannes AM, Yalfani A, 
Doherty P 2007) study, drop-out patients were more likely to be active smokers than were 
completers (26.2% versus 16.3%), however, this difference was not statistically significant. 
Furthermore, two more recent studies revealed no significant association between CR 
adherence and smoking status (Beckie et al. 2015; Turk-Adawi et al. 2013a). 
The patient’s risk category for cardiac events during exercise as defined by the American 
Association of Cardiovascular Pulmonary Rehabilitation (AACVPR) has been investigated 
in one study (Turk-Adawi et al. 2013a). This study revealed that those in the high risk 
category attended more CR sessions than the low risk group (OR: 1.42, 95% CI: 1.15 to 
1.76) while there was no significant difference between the low and the moderate group 
(OR: 0.91, 95% CI: 0.68 to 1.22). The same study investigated the impact of different 
comorbid conditions on CR adherence such as arthritis, pulmonary disease, stroke, back 
pain… etc. and found no statistical significant association with CR adherence (Turk-Adawi 
et al. 2013a). 
Older patients (> 65 years) who have a history of previous MI, PCI or CABG were found to 
be less likely to attend more CR sessions (≥ 26) than their counterparts (p = 0.01) (Doll et al. 
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2015). The influence of the participant’s geographical location (urban or rural) on CR 
adherence has been investigated in two studies and found not significant (Harrison & Wardle 
2005a; Turk-Adawi et al. 2013a). 
2.4.3.4 Service level factors 
The study conducted by Turk-Adawi et al (2013) measured CR adherence (≥ 21 sessions) by 
characteristics of CR facility. Programmes providing diet classes and diet counselling have 
higher rates of adherence (OR: 1.75, 95% CI: 1.34 to 2.27) and (OR: 1.55, 95% CI: 1.13 to 
2.11) respectively. Also programmes offering psychological counselling, medications 
counselling, relaxation training, lifestyle modification lessons and medical director 
involvement have higher rates of adherence (OR: 1.49, 95% CI: 1.08 to 2.07), (OR: 1.41, 
95% CI: 1.02 to 1.95), (OR: 1.25, 95% CI: 1.01 to 1.56), (OR: 1.32, 95% CI: 1.01 to 1.74) 
and (OR: 1.76, 95% CI: 1.02 to 3.04) respectively. In addition, those programmes with 
adequate space, adequate equipment and continuously assessing patients satisfaction have 
the highest adherence rates (OR: 2.57, 95% CI: 1.65 to 4.00), (OR: 2.03, 95% CI: 1.08 to 
3.81) and (OR: 3.32, 95% CI: 1.30 to 8.51) respectively (Turk-Adawi et al. 2013a). 
With regards to disease recognition, Yohannes et al (2007) in a primary prospective study 
reported that participants who consider their illness has less severe consequences are more 
likely to drop out (OR: 0.61, 95% CI: 0.50 to 0.76) (Yohannes AM, Yalfani A, Doherty P 
2007). In the same line, a secondary retrospective revealed that those who underwent CABG 
are 54% more likely to attend more CR sessions (≥ 21) (OR: 1.54, 95% CI: 1.24 to 1.82) 
(Turk-Adawi et al. 2013a). Also another secondary retrospective study investigated the 
impact of the revascularisation strategy (PCI, CABG or medical therapy alone) on CR 
adherence (≥ 26 sessions) among older patients (> 65 years) and found it significant in a 
univariate analysis (p < 0.001) (Doll et al. 2015). 
In a randomised trial, Beckie & Beckstead (2010) tried to compare the impact of two gender 
tailored programme on CR adherence among women (women’s only versus mixed-sex). 
Overall, the mean number of sessions attended by women in the gender tailored CR was 
higher than traditional CR (p < 0.001) (Beckie & Beckstead 2010). Conversely, Grace et al 
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(2016) clinical trial concluded that women adhered moderately to all included CR models 
(supervised mixed-sex, supervised women-only, or home-based CR) (Grace et al. 2016). 
 Summary of all determinants 
This study set out to systematically review the existing literature around the determinants of 
CR utilisation. As detailed in the previous sections, a total of 46 different determinants have 
been identified in the investigated studies. Table 2.7 displays an overview of all reported 
determinants for CR engagement, uptake and adherence. In this table, there are four columns 
where the first one displays the name of the determinant and the remaining three columns 
represent each stage of CR utilisation. Each cell of this table has two types of data; (1) a 
figure to show the total number of studies investigated that determinant (2) a small coloured 
doughnut chart. The chart reflects the proportion of studies that reported the determinant as a 
barrier (red colour), facilitator (green colour) or not statistically significant (yellow colour). 
The benefit of this approach is to give the reader a general overview of the number of studies 
that investigated each determinant and to show any controversy in the literature about this 
determinant. However, this table doesn’t show the strength nor the quality of the evidence 
displayed. 
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Table 2.7 A summary of all reported determinants in the investigated studies. 
Variable Engagement Uptake Adherence 
Older age 3 29 7 
Female gender 1  14  5  
Ethnic minority 1  8  3  
Least deprived patient - 5  1  
Partnered 3  13  1  
Social support (yes) - 10  - 
Employed 1  11  3  
Educated 1  12  1  
BMI > 30 3  7  3  
Physical inactivity (yes) 2  4  1  
Smoking (yes) 3  9 6 
High income (yes) 2  9  - 
Angina (yes) - 4  - 
Diabetes (yes) 2  13  6  
Hypertension (yes) - 8  3  
Anxiety (yes) - 4  2  
Depression (yes) 1  2  2  
Family history of cardiac disease (yes) 1  - 3  
Hyperlipidaemia (yes) 1  9  3  
Increased number of comorbidities 1  3  1  
Previous cardiac Event (yes) - 13  1  
Elective PCI (yes) - 1  - 
CABG procedure (yes) 2  4  2  
Medically treated (yes) - 17  1  
Travel distance (furthest) 2  9  - 
First language proficiency (yes) 1  2  - 
Ability to drive (yes) - 3  - 
Health perceived as excellent (yes) - 2  - 
Multidisciplinary team centre (yes) - - 1  
Received confirmed joining date (yes) - 2   - 
Patient received early CR (yes) - 1 - 
Day case PCI (yes)  - 3  - 
BMI/Private Hospital - 1  - 
Small or affiliated Hospital (<160 bed) - 2  - 
Automatic referral to CR 2  - - 
Positive physician perception of CR 1  - - 
Physician referral intention 1  - - 
Strength of physician endorsement 1  - - 
Referral prior to CABG 1  - - 
Disease recognition (less severe) - - 1  
High risk patient (yes) - - 1  
Rural residency (yes) - - 2  
Gender tailored programme (yes) - - 2  
Key: Systematic review (SR) findings        = proportion of studies in each category 
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2.5 Discussion  
This study set out with the aim of assessing the determinants of CR engagement, uptake and 
adherence since CR utilisation rates worldwide are below desirable. A total of 46 studies 
(N= 398,667) were included in the final review. This is 17 studies more than a recent 
systematic review conducted to analyse factors affecting CR utilisation (Ruano-Ravina et al. 
2016). Included studies were performed in eight different countries, with different study 
designs, covered mixed diagnoses and different treatment methods. Although these factors 
may increase heterogeneity among reported results, however, it ensures that the reported 
determinants are reflecting the real practiced CR worldwide. Despite the sparse controversial 
disagreements among studies’ results, our findings clearly indicate that there is a sort of 
global homogeneity in CR utilisation determinants. 
Although extensive research has been carried out on CR uptake and adherence, researchers 
have not treated CR engagement in much detail. Our search strategy has identified only four 
studies that investigated CR engagement where three of them were conducted by the same 
first author. Patients experiencing automatic referral combined with head-to-head discussion 
are eight times more likely to engage in CR than patients following usual referral strategy 
(Grace et al. 2011). The second strongest reported determinants of CR engagement is 
geographical proximity to CR centre. Those individuals living near a CR centre were found 
to be three times more likely to engage in CR than those living further away (Smith et al. 
2006). Other determinants with relatively high impact on CR engagement were age, gender, 
language proficiency and treatment type. However, with such a small study number, these 
data must be interpreted with caution as the findings might not be extrapolated to the whole 
population. 
CR uptake determinants captured the largest share of the included studies in this review, 32 
studies with a population of 361,934 participants. Being investigated in 29 studies, patient’s 
age has been the most investigated determinant of CR uptake. Despite discrepancies in the 
statistical techniques used, 21 studies found younger age to be significantly associated with 
CR uptake reporting odd ratios between 40-70% in multivariate analysis studies. Similarly, 
gender has been reported in 14 studies indicating that males are more likely to start CR 11-
280%. This phenomena has led to the introduction of studies dedicated to investigate CR 
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uptake in female population exclusively. Despite the documented critical role played by age 
and gender in health related behaviours (Thompson et al. 2016; Deeks et al. 2009), only one 
study has investigated age-gender interaction (Dunlay et al. 2009).  
Among the included studies and within the socio-demographic group, 7 out of 13 studies 
reported marital status as significant determinant, 5 out of 10 for social support and 6 out of 
12 for education level. With such controversy in findings, these determinants remain the 
most debated in regards to CR uptake. It is difficult to explain these contradictory findings, 
but it might be attributed to the susceptibility of observational study designs to confounding. 
Particularly, some of these studies utilised amenable statistical techniques, univariate 
analysis. Moreover, most of these studies were conducted in relatively small studies which 
may not contain all of the characteristics and variables reported previously in the literature. 
Geographic barriers like transportation time, urban/rural differences and the ability to drive 
are reported as a major determinant of CR uptake. As anticipated, those who live farther 
away from the CR centre were found to have the least likelihood of starting CR (up to 80% 
less). Also the ability to drive has increased the likelihood of subjects to start CR by two to 
three-fold. The overcoming of this type of barriers is usually beyond the scope of clinical 
practice, however, other types of CR like home-based CR might be a possible alternative. 
The type of treatment received for the index cardiac event also plays a major role on the 
patient’s decision to start CR. Those who underwent revascularisation procedure, 
particularly CABG, are more likely to start compared with those treated with medications 
only.  A possible explanation for this might be that those patients treated by medications do 
not perceive that their condition warrants CR compared to those hospitalised for 
revascularisation (Grace et al. 2010). 
With regard to adherence and unlike uptake, younger age has been found to be a determinant 
of early dropout in all 7 studies that investigated age. While female gender remained a 
predictor of poor CR utilisation. Diabetes mellitus was also found to be a factor increasing 
dropout rates in 4 studies but vice versa in 1study. Also smokers or former smokers are less 
likely to adhere to CR as reported in three studies. These findings raise a flag to CR directors 
that current CR programmes are less attractive to those who are in increased risk of having 
another event. 
82 
Service level factors play a major influence on the patient’s decision to stay in the 
programme. The study conducted by Turk-Adawi et al (2013) concluded that some 
modifiable organisational factors such as assessment of patient satisfaction and having 
adequate space and equipment can largely improve patients’ adherence (Turk-Adawi et al. 
2013a). Despite the negative finding by Grace et al (2016) trial, with regards to the 
introduction of a gender tailored programme which might be attributed to sessions timing. 
Introducing alternative programme models might increase adherence in the less 
representative groups as proven by Beckie & Beckstead (2010) trial (Grace et al. 2016; 
Beckie & Beckstead 2010). However, the data with regards to CR adherence must be 
interpreted with caution due to the different definitions of CR adherence and completion 
across studies. 
2.6 Limitations 
The most important limitation lies in the fact that it was not possible to pool the results 
through meta-analysis due to the significant heterogeneity of studies included. This 
heterogeneity resulted from different sample size, different population, study design, 
statistical analysis and how CR engagement, uptake and adherence are defined across 
included studies. Another source of weakness is the limited number of studies investigating 
CR engagement that were included in this review. 
2.7 Conclusion 
This systematic review analysed data from 46 studies conducted in 8 countries (N = 
398,667). This study has identified determinates of CR utilisation from baseline assessment 
to completing the programme. Taken together, some of the determinants like age and gender 
are not modifiable and the only way to counter their influence is to understand how CR is 
offered and seek solutions around how to optimise throughput so that services tackle such 
inequalities. While other determinants are service related and more work can be done in this 
area to improve utilisation. As there is a good rationale for increasing CR utilisation, further 
high quality research is needed to better understand barriers against CR utilisation 
particularly in the CR engagement stage. 
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3 Methodology 
3.1 Background & aim 
Published research in the medical field is being generated at high rates with an aim to 
increase clinical knowledge and thus better understanding of health related issues. This 
‘explosion of knowledge’ as referred to by many authors, must be accompanied by training 
on how to critique and conduct robust evidence based clinical research. Therefore, there is a 
need to quality assure papers so that decisions made about clinical practice are based on 
valid evidence. This type of evidence is obtained by conducting high-quality research in a 
systematic and principled way. These methods are distinguished by following a sequential 
process while obeying explicit rules. These processes and rules form what is known in 
research as ‘methods’ which should not be confused with the other term ‘methodology’. In 
fact and strictly speaking, the terms ‘methodology’ and ‘methods’ refer to different 
meanings. Polgar & Thomas in their book ‘introduction to research in the health sciences’ 
define methods as the rules used for acquiring and analysing data which lead to establishing 
evidence in research whereas methodology refers to the critical discussion, comparison and 
application of different methods (Polgar & Thomas 2013). 
As discussed above, there is a need to quality assure papers so that decisions made about 
clinical practice are based on high-quality research. Hence, the purpose of the first section in 
this chapter is to conduct a critical discussion on the possible valid methods that can be used 
to answer the primary research question. This is better achieved by comparing all applicable 
scientific methods then justifying why a specific method was favoured over the others. The 
second section of this chapter will attempt to explain how the primary data used throughout 
this research is collected and managed by the NACR team. The third and last section of this 
chapter will focus on data analysis and what steps should be followed to obtain robust 
research findings. This latter section will include a sub-section on how data is prepared prior 
to being analysed focusing on how to handle missing data and outlier values. Another sub-
section about model building, model diagnostics and model validation will close this 
chapter. However, each study in this thesis will have its own methods section that contains 
more specific details related to that study.    
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3.2 Research design 
Quality of research can vary considerably due to methodological rigour. Defects in design or 
the way research is conducted may result in bias and therefore measured effects can be 
obscured. Research design is defined as the clear statements of how the research data is 
collected in the study and this design should guide data collection suitable for answering the 
research question (Polgar & Thomas 2013). This design should also help to give an unbiased 
estimate of whether one treatment is more effective or safer than another for a particular 
population (Anglemyer et al. 2014). Bias in the literature has been defined as; 
“The systematic deviations from the true underlying effect brought about by 
poor study design or conduct in the collection, analysis, interpretation, 
publication or review of data” (Centre for Reviews and Dissemination 2009). 
In the field of clinical research, there are different types of research designs that are in use 
and each type can address different research questions more appropriately. One way to 
classify different types of research designs is by the strength of evidence they provide. This 
classification is known as ‘evidence hierarchy’ (Ligthelm et al. 2007) (Table 3.1).  
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Table 3.1 Main types of research designs sorted by strength of evidence6. 
S
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R
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w
 Systematic review 
&meta-analysis 
Collects all previous studies on the topic and 
statistically combine their results. 
Bias 
E
x
p
er
im
en
ta
l 
Randomised 
control trial (RCT) 
Randomly assign a group of individuals to receive 
treatment or placebo. 
Quasi-experiment Same as above but without random assignment. 
O
b
se
rv
a
ti
o
n
a
l 
Cohort study A defined group of participants is followed over 
time and comparison is made between those who did 
and did not receive an intervention. 
Case-control study Compares histories of a group of people with a 
condition to a group of people without. 
Cross-sectional 
study 
Assessing the prevalence of an outcome at one point 
in time at a broad population. 
As shown in (Table 3.1), research designs can be classified in a hierarchical shape based on 
their susceptibility to bias and therefore the strength of evidence they provide (Centre for 
Reviews and Dissemination 2009). Although experimental designs are considered less 
susceptible to bias than observational, researchers may instead use observational designs in 
cases that it is unworkable or unethical to use experimental designs. When is it more suitable 
to use one design over the other and what are the pros and cons of each will be discussed in 
the following section focusing mainly on RCTs versus cohort observational as these are the 
main two types used in clinical research (Noordzij et al. 2009). Particularly that these types 
of design have led to debate in the area of cardiology and CR (e.g. RAMIT and Cochrane 
RCT only reviews versus CROS observational reviews). 
 
                                                     
6 Adapted from Oxford centre for evidence-base medicine. 
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3.3 Trial vs Observational 
Before comparing the two research designs, it is fundamental to understand what each term 
exactly refers to. RCTs mainly refer to the study design where individuals are randomly 
assigned into control group or intervention group (or to multiple intervention groups) by the 
play of chance (randomisation). Another important feature of RCT is concealment which 
means that the intervention or treatment allocated to groups cannot be known in advance. 
Although there are different types of RCTs such as parallel RCT, cross-over RCTs and 
cluster RCTs, they all share these two main features which are conducted to limit the risk of 
bias (Centre for Reviews and Dissemination 2009). Researchers normally use evidence from 
RCTs to evaluate the efficacy of an intervention or treatment under ideal settings. 
In the other hand, observational designs do not require randomisation and the assignment of 
individuals is determined by usual practice or ‘real world’ choices. That means the 
allocation of individuals into control or intervention groups is outside the control of the 
researcher (Rosenbaum 2002). In this design, the researcher merely observe in natural 
settings the differences between those who did and did not receive the intervention. 
Observational designs can be used to measure the efficacy of an intervention or treatment in 
non-experimental ‘real world’ environment at the general population level (Anglemyer et al. 
2014). Researchers normally use observational designs for hypothesis generation and 
highlighting areas for further research (Centre for Reviews and Dissemination 2009). Taken 
together, observational studies are vital in building clinical evidence, exploring how an 
intervention is practiced on the ground and understanding disparities in access to and 
delivery of healthcare services (Carlson & Morrison 2009). 
Regardless of the chosen research design, the ultimate goal is to achieve unbiased, reliable 
and generalisable results. RCTs, when properly conducted, limit the risk of bias more than 
observational designs. This is because in RCTs the groups being compared are similar in all 
aspects other than the intervention. Also the groups, in properly implemented RCT, are 
balanced for both known and unknown factors that might affect the measured outcome. This 
type of setting limits the influence of any confounding factor that might mediate the results.  
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Although RCTs are considered the most rigorous method in research designs and level A 
evidence in the evidence hierarchy by AHA, ACC and ESC (Hannan 2008; Silverman 
2009), this method has a number of weaknesses. The tightly controlled environment required 
for RCTs does not include all the issues faced by clinicians in real world practice. Also the 
selective process in choosing participants may make the study population less representative 
of the whole population. These strict selection criteria of environment and participants in 
RCTs question the generalisability of its findings (Noordzij et al. 2009). Because RCTs are 
time consuming and expensive in addition to the difficulty in recruiting suitable participants, 
they may have inadequate statistical power which can make them underpowered to detect 
important differences in outcomes (Hannan 2008). A major limitation of RCT designs is in 
cases where it is unethical to randomise patients such as situations where the intervention is 
believed (but not yet proven) to have a negative effect on participants (Collet 2000). Other 
situations where RCTs are possible but not appropriate, include the follow up of adverse 
events that are rare or may take several years to develop (Noordzij et al. 2009). In summary, 
where a solid evidence of efficacy exists, there is no further need to conduct RCT’s. This is 
why some RCT’s, like RAMIT, failed to recruit even a quarter of the planned sample size 
(Silverman 2009; Doherty & Lewin 2012).    
The weaknesses and limitations mentioned above have led to a call for other relevant 
research design to supplement the important findings achieved by RCTs. This design should 
complement findings from RCTs by assessing treatment efficacy in a natural real world 
environment and in larger more diverse population with longer follow up periods. This 
design should also be capable of identifying clinically important differences among proven 
treatments which should complement the clinicians’ knowledge of available treatments. 
Moreover, this design should provide data on treatments long-term safety and tolerability. 
All these features are inherent features of well performed observational designs. It could be 
argued that observational designs are an important addition to the clinical researcher 
resources by complementing RCTs findings with information on efficiency, safety and 
patient clinical behaviour in a real world population. Furthermore, observational studies 
allow researchers to better understand which factors determine the likelihood of taking up 
trial based interventions in the real world setting (Silverman 2009).  
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However, it should be noted that the most serious shortcoming of observational designs is 
the selection bias which is happening due to the absence of randomisation (Hannan 2008). 
Selection bias can lead to large unobserved differences between treatment and control 
groups which may result in false estimates of treatment effects and therefore manipulate the 
outcomes being measured. These unobserved differences are known as confounders and can 
be controlled for by robust statistical techniques (Field A. 2013). This effect can also be 
reduced by conducting the analysis in large high quality database that contains all of the 
characteristics and variables reported in the literature previously and known to have an effect 
on the measured outcome (Hannan 2008). 
In this thesis, the primary research question is: ‘what are the factors that determine CR 
engagement, uptake and adherence in the PCI population?’ This question focuses 
predominately on determinants and not outcomes which means RCT designs are not 
appropriate. There is also evidence from the NACR, wider literature and health care policy 
targets that patients are not utilising evidence based programmes which further legitimates 
the use of observational studies to help understand how CR utilisation can be improved and 
how CR can be made more attractive to patients (NACR reports).  In addition, cohort 
observational design will provide a large enough sample of patients to be investigated and 
followed for longer periods which is a major limitation of the previous studies. Also the 
NACR dataset with close to a million patient and more than 1,000 variables collected can be 
analysed using rigours statistical techniques to achieve valid and reliable results. 
3.4 Data source 
This thesis intends to generate new knowledge and insights on the determinants of CR 
engagement, uptake and adherence in the PCI population. This will be achieved by 
conducting a secondary analysis on the NACR dataset aimed at addressing key research 
questions. The specific objective of this section is to explain what NACR is and how it 
collects the data. 
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 The National Audit of Cardiac Rehabilitation 
Established in 2005 and funded by the BHF, NACR was designed to support cardiovascular 
prevention and rehabilitation services to achieve the best possible outcomes for patients. The 
aims of NACR are to increase the availability and uptake of prevention and rehabilitation 
programmes, and promote best practice and quality improvement in cardiovascular 
prevention and rehabilitation services by: 
 Monitoring and supporting cardiovascular rehabilitation (CR) teams, 
commissioners and coordinators in delivering high-quality and effective 
services, to evidence-based standards, for the benefit of all eligible patients; 
 Highlighting inequalities and insufficiencies in the delivery of cardiovascular 
rehabilitation services against key service indicators at strategic clinical 
network, clinical commissioning group, health board and cardiac network levels 
for over 308 CR programmes in the UK; 
 Designing and implementing research to determine the effectiveness of routinely 
delivered CR services on patient agreed outcomes, cardiovascular disease risk 
profiles and health and social care utilisation; 
 Using audit and research data generated through the NACR to inform: 
• NICE clinical guidance and service specification development 
• Clinical practice standards from national associations 
• NHS healthcare commissioning processes and decision making 
• The public and cardiac patient groups about how their local services are 
performing. 
NACR is managed by a team based in the Department of Health Sciences at the University 
of York. Informatics and data management services are provided by the NHS Digital based 
in Leeds.  
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3.4.1.1 Data collection 
NACR has approval to collect anonymised patient data for a range of clinical variables. The 
audit collects data for patients who undergo CR in the UK including the following criteria.  
 Demographic - gender, date of birth, postcode, ethnic status (national census 
method). Clinical - blood pressure, weight, height, cholesterol, medication, initiating 
event (reason for rehabilitation), previous cardiac events, and comorbidities. 
 Behavioural - smoking status, activity level, economic activity measures from 
National Census, physical fitness. 
 Health-related quality of life as scored via the Dartmouth Coop questionnaire. 
 Mental health - anxiety and depression as scored via the Hospital Anxiety and 
Depression Scale (HADS). 
 Wait time - date of initiating event, date referred to cardiac rehabilitation, date 
invited to join, date started rehabilitation programme, date finished. 
 Uptake - agreed to take part (yes, no) and reason for refusal or being unable to 
attend. 
 Drop-out rates - reason for not completing cardiac rehabilitation, if known. 
Some of the data fields are collected via a set of self-reporting questionnaires in which 
respondents read the question and select a response by themselves without medical staff 
interference (copy of questionnaires in appendix 9-8). In addition to electronic data 
collection, staffing details (per centre) were collected from the annual NACR paper survey, 
which collects data on types of staff, hours worked and numbers of staff per program 
(NACR 2016). 
Information is entered manually into the NACR through a secure online portal, provided by 
NHS digital. Alternatively, data files of records for multiple patients are uploaded. Data is 
gathered by clinicians and by purpose-designed questionnaires. Patients complete a 
questionnaire before, immediately after, and 12 months after attending rehabilitation. The 
staff of the individual CR programmes distributes the questionnaires themselves, receive the 
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replies, and submit the data to the NACR database. Postal surveys collect information on 
organisational elements such as staffing and activity.  
The NACR team at York send questionnaires out to the co-ordinators of every 
cardiovascular prevention and rehabilitation service on the register they maintain, receive the 
responses, collate the results and include them in the project's annual reports. Electronic-
survey is also collected to enable the audit to be sensitive to changes in clinical practice. The 
York team use the data to produce annual reports and ad hoc reports on request by individual 
programmes. Programmes can also view and download their data for local analyses. 
For all collected data the NACR team record who created them, which centre and the date of 
creation. Also they the team creates additional variables that can be utilised such as CR 
duration and variety of waiting times variables. Figure 3.1 below illustrates two different 
paths of CR collected by the NACR team. 
 
Figure 3.1 Two different paths of CR collected by NACR. 
In (Figure 3.1) the red numbers 1, 2, and 3 refer to the following; 
Identified on the Ward post cardiac event treatment. 
1. Discharge from hospital. 
2. Core CR, or outpatient CR, what the NACR report mainly focuses on and lasts 
for 8-12 weeks, on either side is the Assessments 1 and 2 (pre and post, used in 
most NACR research). 
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3. 12 months post CR, this was the community based CR also known as Phase 4, at 
12 months on patients are invited to complete questionnaires and come in for the 
last assessment. 
3.4.1.2 Data entry 
Data entry is the process of digitising data by keying it into a computer system; manual data 
entry describes the physical process of typing information into computer software. NACR 
data collection involves human operators keying in data found on patients’ record. The 
manual process of data entry has a main disadvantage in speed and accuracy.  Manual data 
entry occasionally introduces the possibility of human error. Moreover, workers working 
under stress or suffering from a lack of concentration or fatigue may make more errors. 
These entry errors impact the quality of data and may affect the outcome result. 
One of the greatest challenges facing any large database managers is how to improve and 
maintain the quality of their data. NACR has tightened up on data quality procedures to 
align with NICE guidance and the emerging NHS commissioning and accountability 
frameworks (NACR 2014). In order to improve the quality of data, two main techniques are 
usually adopted. The first approach is an automated data auditing and cleaning by adding 
validations to the entry fields in the portal system to prevent users from keying in extreme 
values. The second, is by exploratory data analysis and cleaning conducted manually by the 
person analysing the data (Hellerstein 2008). 
3.4.1.3 Ethical & research approval 
Gaining patient consent to use their data for national audit purposes is extremely difficult 
challenge and would create extra burden on staff and services during the management of a 
heart attack or following a cardiac surgery. This is an issue for many NHS services which 
has led the UK Government and the NHS to adopt a national process whereby, in certain 
circumstances and with sufficient safeguards applied, the requirement for patient consent is 
relaxed. For this reason NHS give exemption from individual consent in such cases. In fact, 
NACR is authorised from the Health Research Authority’s Confidentiality Group (CAG) to 
collect patient identifiable data without explicit consent from individual patients (under 
section 251 of the NHS act 2006). However, patients are informed about the purpose of the 
audit and how their data will be used in face to face communication and through any 
93 
questionnaire they fill. They are also told that they can opt out without any effect on their 
treatment (NACR 2016). 
With respect to researchers, NACR data is used for a large number of purposes, including 
post graduate and PhD theses (NACR Information Sheet 2017). However, before analysing 
NACR data, the researcher should be aware that NACR has a strict Data Sharing Agreement 
with NHS Digital and they should adhere to number of regulations all the time. First a 
researcher must complete and pass the Information Security Training Course arranged by the 
University of York before being permitted to access the data. The researcher should also be 
aware of what is permitted and not permitted for the processing and dissemination of the 
audit data. The following is a list of what is permitted and not permitted as stated in the 
information sheet about the usage of NACR data (July 2017 update). 
First, what is permitted; 
 The researcher is permitted, based on pre-arranged meetings with data 
controller/supervisor, to report aggregated versions of the data in thesis’, 
publications and conferences abstracts. Note all versions of the data/iterations prior 
to submission must be signed off by the NACR Lead/ NACR team/supervisor/. 
 Outputs from the original data may be stored on a private network for processing 
and writing of dissemination material, this does not include any data. 
 Data can be archived on the Department of Health Sciences network for 
retrospective review and analysis. Access may be given for review post the 
timescale or research project has terminated depending on approval from the NACR 
Lead. 
Second, what is not permitted; 
 The data must not be copied or removed from the Department of Health Sciences 
secure network (“I Drive”) in original or altered forms even when using a password 
protected external storage device. 
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o This includes, C and P drives on the computer, data can only be and should 
only be stored in the permitted folder within the I Drive, if you are unsure 
about which folder this is please contact the NACR Team. 
 The data must not be transferred onto online storage platforms such as Google Drive 
or Dropbox and should never be shared through email with internal (NACR) or 
external staff and researchers. 
 The data must only be processed in approved manners, with research plans set out in 
meetings with the NACR Lead, supervisors or the NACR Team. Additionally, the 
data must not be merged with any secondary data unless agreed to do so by the 
NACR Lead, supervisors or the NACR Team. 
 No dissemination of original or processed material is permitted without the approval 
from the NACR Lead/ NACR team/ supervisor/. 
o This includes primary or secondary research articles, update papers, 
conference abstracts and presentations, talks, interviews, personal use and 
any other non-agreed uses. 
 Once the research or enrolment period ends access to the Department of Health 
Sciences shared network will be removed, at which point all data must be provided 
to the NACR team for archiving. 
 The data must never be presented as non-aggregated data, and although every effort 
will be made to anonymise the names and locations of Cardiac Rehabilitation 
organisations within the data, no organisation should ever be presented as 
identifiable without approval from the NACR Lead/ NACR team /supervisor. 
3.4.1.4 Quantitative secondary data analysis 
The word quantitative has a direct meaning which refers to data that express a certain 
quantity, amount or range (numerical data) while the term secondary analysis is more 
complicated. In the field of clinical research, the difference between the terms primary and 
secondary data depends on the relationship between the person who collected a dataset and 
the person who is analysing it. This is an important concept as the same set of data could be 
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primary in one analysis and secondary in the other (Boslaugh 2007). The term secondary 
data is used in social science when the data were collected by someone other than the 
researcher. Several definitions for secondary data analysis appear in the literature with 
minimal differences. One of the earliest definitions was suggested by Glaser in 1963: “the 
study of specific problems through analysis of existing data which were originally collected 
for another purpose” (Long-Sutehall et al. 2011).  
Another recent definition was proposed by Hewson in 2006: “the further analysis of an 
existing dataset with the aim of addressing a research question distinct from that for which 
the dataset was originally collected and generating novel interpretations and conclusions” 
(Smith et al. 2008). Secondary data can come from many sources such as large, government-
funded datasets, university or college records etc. 
Re-using existing data has some major advantages. First, data contains large sample sizes of 
higher quality data than most researchers could realistically produce themselves, saving time 
and resources. Second, data represent real populations where low prevalence groups are 
oversampled which results in increased statistical power and precision. Other advantages 
include the fact that datasets often contain considerable breadth (hundreds of variables). 
Researchers can assess change across time using data collected for several years - this would 
be difficult for one researcher to collect (Cheng & Phillips 2014; Vartanian 2011).  
The use of secondary data means study design and data collection has already completed and 
researchers must be careful to interrogate and explore new questions with caution as the data 
may not facilitate particular research questions. In addition, users of secondary data should 
spend some time exploring associated documentation to understand how the data were 
collected, from whom it was collected and what was done with it after data collection 
(Vartanian 2011). 
Secondary data analysis imposes retrospective analysis of the data. Retrospective analysis is 
the opposite of prospective analysis where researchers design the study before subjects 
develop the measured outcome. One advantage of retrospective analysis, using large 
registries or audits, is that it makes use of existing data, which, compared to prospective 
studies requiring patient recruitment, means the data collection phase of the study is much 
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quicker. Subject to having strong statistical support and data modelling expertise 
retrospective observational studies are also good for studying multiple outcomes and 
addressing less common exposures which normally requires large cohort in prospective 
analysis. For instance, this was evidenced in prospective CR studies, such as RAMIT, which 
struggled to recruit sufficient patients to allow robust analysis (see chapter 2) (Doherty & 
Lewin 2012). Although there are inherent weaknesses with retrospective studies mainly the 
disadvantage that the data was originally constructed to measure another outcomes, this can 
be accounted for as part of the new study design. 
The use of large datasets requires in-depth knowledge of statistics and experience in at least 
one statistical software package, which is not generally provided by basic graduate statistics 
courses. This is fundamental as the user will need to do some data manipulation in order to 
structure their chosen dataset into a form appropriate for analysis for each study. The 
required statistical knowledge includes how to deal with missing data and outliers in an 
appropriate way as the researcher has no means to access the original dataset. A key aspect 
of secondary data analysis is the need to behave ethically when using the data. It is important 
to ensure that the data is used to its full potential, whilst ensuring promises of confidentiality 
made to the data subjects are kept. 
3.5 Data analysis 
A well designed study, poorly analysed, cannot lead to reliable results. Data analysis, in 
general, is defined as ‘the process of systematically applying statistical and/or logical 
techniques to describe and illustrate, condense and recap, and evaluate data’ (Rcr & Project 
2008). Data analysis is the stage when researchers manipulate the raw data in a scientific 
method to convert it into information that inform the answers for research questions, test 
hypothesis or challenge previous knowledge. The famous statistician John Tukey defined 
data analysis in 1961 as ‘Procedures for analysing data, techniques for interpreting the 
results of such procedures, ways of planning the gathering of data to make its analysis 
easier, more precise or more accurate, and all the machinery and results of (mathematical) 
statistics which apply to analysing data’ (Tukey 1962). 
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There are several phases in data analysis that can be distinguished. These phases are 
interrelated and iterative in a way that feedback from later phases may generate extra work 
in earlier phases (Schutt & O´neil 2014). After data collection the data should be processed 
or organised for analysis (data structuring). Once the data have been structured, evaluating 
the data for missingness, duplication and errors will be more plausible. This phase is known 
as the data preparation phase. After that, data is ready to be explored. Normally the first 
stage in this phase is to run descriptive statistics to begin to understand the key messages 
contained in the data (Few 2004). Descriptive statistics, however, may result in additional 
data cleaning or even additional data collection. Descriptive statistics is an important phase 
in data analysis as it helps the researcher to visualise the data by expressing it in graphical 
format or in mathematical format such as averages and medians. 
The following phase in data analysis is to identify relationships among the analysed 
variables, such as correlation, by applying mathematical formulas or models called 
algorithms (Judd & McClelland 1989). This phase is usually conducted with the aid of 
sophisticated software statistical packages such as SPSS or STATA. These packages will 
help the researcher to conduct statistical modelling such as regression in which an outcome 
variable is predicted by a combination of one or more predictor variables (Field A. 2013). 
The final stage of data analysis is validating the obtained results to decide whether these 
results are acceptable as discerptions of the data analysed. 
In order to meet the required statistical skills to answer the research question, the author of 
this thesis has successfully completed basic and advanced statistics modules provided by the 
department of Health Sciences at the University of York. In addition, the NACR research 
team provides senior statistical support to its researchers. Furthermore, Dr Nils Gutacker 
(second supervisor) has provided valuable advice and assistance on data preparation, 
analysis and modelling. 
 Data preparation 
Data preparation plays a critical role in secondary data analysis. Research findings and 
hypothesis testing can go profoundly wrong if data preparation has been overlooked. In 
order to conduct a robust secondary data analysis, the researcher should prepare the data 
appropriately to decrease error rates and increase both the power and replicability of results. 
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This includes learning the necessary skills on how to deal with missing values and outliers in 
a methodological way as the researcher has no means to access the original dataset. Missing 
values and outliers arise in almost all secondary statistical analysis. They have been always a 
threat to the validity of clinical research (Langkamp et al. 2010; Kwak & Kim 2017; Cheng 
& Phillips 2014). 
3.5.1.1 Missing values 
When no data value is stored for a covariate in an observation we say there is a missing data 
or missing values in the dataset. In the field of statistics, various definitions of missing 
values are found. One definition of missing values in the literature is ‘the values that are not 
available and that would be meaningful for analysis if they were observed’ (Dupont 2011). 
Missingness in the data can occur for several reasons such as non-respondents in a survey or 
dropout subjects in longitudinal studies. Missing values are unavoidable in clinical research 
but their potential to impact the analysis has often been overlooked in the medical literature 
(Wood et al. 2004). 
Large data sets are full of legitimately missing data, and researchers need to be thoughtful 
about handling this issue in an appropriate methods (Osborne 2012). Due to the nature of 
how NACR collects its data, there is a considerable number of missing data. Although 
timely NACR data entry has improved and is prompt for some programmes, it can be behind 
by months due to working processes, waiting times or lack of data entry clerks. In addition, 
the electronic update of the NACR database is performed every three months while the 
survey data is only updated once per year. However, NACR team has made enormous 
efforts to improve the quality of the data collected which can be easily noted when 
comparing recent data quality to those five years ago. 
Researchers in health sciences usually address missing data by excluding incomplete cases 
in the analysis (Sterne et al. 2016). This practice has been adopted for two possible reasons. 
First, it has commonly been assumed that if data are missing at random, the analyses will 
tend to be unbiased, although based on a smaller sample size than the original data set 
(Higgins & Green 2011). Second, statistical techniques that can handle missingness in the 
data have, until recently, not been readily accessible to medical researchers (Sterne et al. 
2016). However, research findings using only complete data should be based not only on 
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observed data values but should also take account of why data are missing (Seaman et al. 
2013). Understanding the causes of data missingness is vital to appropriately tackle the 
incomplete data. If values are missing completely at random, the collected data sample may 
still represent the population. But if the values are missing in a systematic pattern, the 
analysis may generate biased findings (Adèr & Mellenbergh 2008). 
When we say values in a dataset are missing completely at random (MCAR) that means 
missingness is independent on the response or any of the other observed data, i.e. 
missingness occur entirely at random (unsystematic). The analysis conducted on MCAR 
data is unlikely to be biased, however, data are rarely MCAR (Hosmer, Lemeshow 2013; 
Polit & Beck 2012). A less stringent assumption is that data missingness is not random 
(systematic) but it can be entirely explained by other observed variables. For example, 
respondents in service occupations were less likely to report their income. Data that meets 
this assumption is known as data missing at random (MAR) (Bhaskaran & Smeeth 2014). 
Complete cases analysis in MAR data is more vulnerable to bias compared with MCAR, 
however, exclusion of subjects with incomplete data may increase the loss of precision and 
power in the analysis (Sterne et al. 2016). The third type of missingness is known as missing 
not at random (MNAR). This is when data missingness is systematic even after the observed 
data are taken into account. To extend the previous example, respondents with high income 
were less likely to report their income. In this situation, complete data analysis will 
definitely generate biased results (Little, R.J.A., Rubin 1987). 
If we assume data are MAR, then unbiased and statistically more powerful analyses can 
generally be done by including subjects with incomplete data. A range of simple techniques 
are commonly used to deal with missing values. One of which is replacing the missing 
values with imputed values from the observed data e.g. the mean of the observed values. 
Another techniques is replacing missing values with the last measured value (last value 
carried forward). Unfortunately, none of these simple techniques is statistically valid 
nowadays because they can lead to biased results. This is due to the fact that single 
imputation of missing data techniques usually cause standard errors to be very small, since it 
doesn’t account for our uncertainty about the missing values (Sterne et al. 2016). Other more 
sophisticated techniques are available to handle missing data such as weighting the analysis 
to allow for the missing data and maximum likelihood estimation technique. However, in the 
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modern era of statistical computing, more robust method of dealing with missing data is 
available ‘multiple imputation’ (Hosmer & Lemeshow 2013; Osborne 2015; Sterne et al. 
2016; Molenberghs, G 2007). 
Since its introduction in 1978, multiple imputation has become an influential technique in 
handling missing data in statistical analysis. The literature around this technique continues to 
grow including experimental studies and systematic reviews (Molenberghs, G 2007). The 
key idea of multiple imputation is to replace each missing value with a set of multiple 
plausible values (determined by the analyst). Each replacing value is drawn from a 
conditional distribution of the missing value given the observed value. Normally, multiple 
imputation involves three steps. Starting with an analysis of the complete dataset to define 
and quantify the missingness patterns. Secondly, the imputation step which creates a 
predefined number of complete datasets. Finally pooling the results of the multiple data sets 
(Hosmer & Lemeshow 2013). 
Multiple imputation technique has potential to strengthen the validity of medical research 
outcomes (Sterne et al. 2016). One great strength of multiple imputation technique is that the 
researcher can compare the results of the original and imputed datasets (Molenberghs, G 
2007). However, the validity of the generated results from multiple imputation depends on 
careful and appropriate implementation of the technique and it shouldn’t be applied at the 
push of a button. In 2007, a prospective cohort study reported the development of CVD risk 
prediction tool based on a large clinical database (Hippisley-Cox et al. 2007). The authors 
reported difficulties with missing values in the analysed database so they utilised multiple 
imputation technique. In their published final model they couldn’t prove significant 
correlation between cholesterol and CVD risk which was surprising. However, when the 
authors subsequently restricted their analysis to complete cases (excluded cases with missing 
value) there was a significant association between cholesterol and CVD risk. Furthermore, 
when a revised improved imputation technique was conducted, a similar result was obtained 
(Sterne et al. 2016). 
Another drawback of multiple imputation is the inability of current statistical packages to 
run hybrid sophisticated statistical techniques for the same dataset. For example conducting 
multiple imputation and bootstrapping in one statistical test or multiple imputation with 
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multilevel modelling. As result, the researcher should make a balanced choice on what 
technique to use based on the analysed dataset and the tested hypothesis. Throughout this 
thesis, all analyses will be conducted using the multiple imputation technique as the NACR 
dataset suffers from a considerable number of MAR data.     
3.5.1.2 Outliers 
In statistics, an outlier is a data point that deviates considerably from the remaining data as 
to flag suspicions that it was generated by a different mechanism (Aggarwal 2013). Outliers 
may be due to extreme measurements or may indicate data entry error. Data entry is the 
process of digitising data by keying it into a computer system; manual data entry describes 
the physical process of typing information into computer software. NACR data collection 
involves human operators keying in data found on patients’ record. The manual process of 
data entry has a main disadvantage in speed and accuracy.  Manual data entry occasionally 
introduces the possibility of human error. Moreover, workers working under stress or 
suffering from a lack of concentration or fatigue may make more errors. These entry errors 
impact the quality of data and may affect the outcome result. 
One of the greatest challenges facing any large database managers is how to improve and 
maintain the quality of their data. NACR has tightened up on data quality procedures to 
align with NICE guidance and the emerging NHS commissioning and accountability 
frameworks (NACR 2014). In order to improve the quality of data, two main techniques are 
usually adopted. The first approach is an automated data auditing and cleaning by adding 
validations to the entry fields in the portal system to prevent users from keying in extreme 
values. The second, is by exploratory data analysis and cleaning conducted manually by the 
person analysing the data (Hellerstein 2008). In this study, three steps of data cleaning were 
adopted; 
1. Checking that all data entries fall within the cut-points of the NACR portal system. 
2. Manually removing any clinically non-meaningful numbers such as height over 2.3 
meters. 
3. Deleting any values outside three standard deviations of the mean (3 SD rule). 
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 Statistical modelling 
A model is a scaled-down version of a real-world phenomenon. A real-world phenomenon 
can be any incident deserving of inquiry and investigation, especially events that are 
particularly unusual or of distinctive importance (Sandywell 2011). Scientists have been 
always attracted to explain and discover real-world phenomenon. Whatever phenomenon 
they desire to explore, they collect sample data from real world to represent this 
phenomenon as they cannot have access to every subject of the population. The collected 
data will then be used to test a hypothesis they previously developed about the phenomenon 
under investigation. Testing a hypothesis involves building statistical models which are a 
smaller representation of the data collected. A statistical model is normally shaped by 
mathematical equations to express the relationships among number of variables and 
therefore statistical model can be looked at as ‘a formal representation of a theory’ (Adèr & 
Mellenbergh 2008). However, any statistical model we construct should enable us to make 
predictions or inferences about the real world that are as accurate as possible based on the 
observed data. The degree to which a statistical model represent the collected data, is known 
as the fit of the model (Field A. 2013). A good fit model, therefore, is an excellent 
representation of the real-world situation and vice versa. Consequently, all statistical models 
can be represented by the following equation: 
𝑂𝑢𝑡𝑐𝑜𝑚𝑒 = (𝑚𝑜𝑑𝑒𝑙) + 𝑒𝑟𝑟𝑜𝑟 
In fact, statistical models are used in daily life without necessarily realising it. When we 
summarise a set of numerical data into a mean or when we represent categorical data in 
proportions then we are using statistical modelling. Any model we chose to represent our 
observed data, will vary depending on our study design, type of collected data and what we 
are trying to measure (Field A. 2013). Respectively, models can also vary in its complexity.   
As discussed above, the choice of a statistical model is guided by number of factors. This is 
because every modelling tool answers specific questions. For example, if we want to 
determine whether there are any statistical significance differences between the means of 
two or more independent groups, we can use a one-way analysis of variance model 
(ANOVA). While if our study purpose is to make predictions about the value of an outcome 
variable based on the value of independent variables then we use linear regression model. 
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The choice of a statistical model can also be informed by the shape of the relationships 
between the dependant and independent variables. Sometimes the shape of the relationship is 
best described by a non-linear relationship e.g. polynomial or curved. This is best explored 
in descriptive statistics by graphical representation between the investigated variables. 
Whatever statistical model we chose to represent our observed data, a critical part of the 
process involves checking to make sure that the data we want to analyse can actually be 
represented using this model. In fact, inferring conclusions about any tested population 
almost always requires some background assumptions. Those assumptions must be 
considered carefully as violating assumptions can risk the model validity which could 
generate incorrect conclusions. For example, all parametric tests assume that the sample data 
are drawn from a normally distributed population. While non-parametric tests make 
assumptions about random and independence of sampling. 
 As previously stated, for any statistical model we construct we have to assess the goodness 
of fit, i.e. how much does it represent the population. A simple way to check the fit of any 
statistical model is to assess the deviance between the observed values and the expected 
values generated by the constructed model. This deviance can be used to assess the total 
error in any model (Davis 2008). A large deviance indicates large error in the model and 
therefore a lack of fit. The process of quantifying the amount of error in any model is known 
as model diagnostics. Model diagnostics is possibly the most important tool in the modelling 
building process (Molenberghs, G 2007). As a result, many statistical tools have been 
developed for model diagnostics. These tools can be primary tools such as graphical residual 
analysis or sophisticated numerical methods such as lack-of-fit tests. The choice of the 
appropriate tool will mainly depend on the type of model constructed as primary tools are 
often difficult to interpret due to constraints on the residuals imposed by the estimation of 
the unknown parameters.  
The central thesis of this work is to investigate the factors that will predict CR engagement, 
uptake and adherence in the PCI population. This will be achieved by conducting a 
retrospective secondary analysis of the UK National Audit of Cardiac Rehabilitation for 
patients who underwent PCI from 2013 to 2016. Three themed studies will be conducted 
each concerned with a different outcome. The first study seeks to investigate the factors that 
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are associated with CR engagement measuring a dichotomous outcome (engaged / not-
engaged). The second study will examine the factors associated with starting CR measuring 
a dichotomous outcome (started / not-started). In the third study the factors that lead patients 
to complete CR programme will be evaluated measuring a binary outcome (completed / not-
completed). Since we are predicting a binary outcome in all three studies, then the statistical 
model of choice will be a binomial logistic regression model. Binomial logistic regression 
model (often referred to as just logistic regression) attempts to predict the likelihood of an 
observation falling into one of two categories of a dichotomous dependent variable 
(outcome) based on one or more independent variables (predictors) that can be either 
continuous or categorical (Field 2013). 
Although other types of logistic regression can deal with ordinal and multinomial outcomes, 
here we will limit our discussion to binomial logistic regression. More about logistic 
regression model, its assumptions and its validation tools it will be discussed briefly in the 
following section. 
3.5.2.1 Logistic regression 
The appropriate statistical model to choose when predicting an outcome that can only take a 
value of two categories (0 or 1) is logistic regression (Davis 2008). Logistic regression in 
health sciences is used when predicting a binary dependant variable such as the probability 
of a patient to have a characteristic or experience the event (code 1) or else (code 0) based on 
observed characteristics of the patient (age, sex, body mass index, results of various blood 
tests, etc.) or other factors (Freedman 2005). Although the dependant variable can only take 
values of 0 and 1, the predicted value generated by the model take the form of probabilities 
based on the values of the independent variables. The higher the predicted value, the more 
chance this patient will have the characteristic or experience the event measured (Newman 
2000). 
Although logistic regression and linear regression are both a special case of the generalised 
linear model, they are based on different assumptions. A key difference between the two 
models can be seen in two different features of logistic regression. First, logistic regression 
is used for modelling categorical dependant variable while linear regression is used for 
modelling continuous variables. Second, in logistic regression the predicted values are 
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restricted to (0, 1) and displayed as the probability of particular outcomes while linear 
regression predicted values of the dependent variable based on different values of the 
independent variables (Freedman 2005).  
Probit regression uses similar techniques as logistic regression with a difference that that 
probit regression uses cumulative normal distribution while logistic regression employs 
cumulative logistic distribution to estimate the probabilities of the outcome. In fact, the 
cumulative logistic and normal distributions have almost similar shape. However, the 
cumulative logistic distribution has heavier tails (higher kurtosis), which often increases the 
robustness of analyses based on it compared with using the cumulative normal distribution 
(Menard 2010). 
3.5.2.2 Model assumptions 
As was pointed out previously, a critical part of constructing a model involves checking for 
assumptions. In fact, logistic regression has seven assumptions that must be met. Meeting 
those assumptions will allow us to ensure the accuracy of our model and test how our model 
fits the observed data (Lund, M., Lund 2015). The first four assumptions relate to the study 
design which includes; binary outcome variable, two or more predictors, independence of 
observations and there should be at least 15 observations per predictor. The rest three 
assumptions relate to the nature of the collected data. First, there must be a linear 
relationship between a continuous predictor and the logit transformation of the outcome. 
Second, the data shouldn’t show multicollinearity. That is, predictor inserted in the models 
are not highly correlated with each other. Finally, there should be no significant outliers, 
high leverage points or highly influential points. These terms refer to observations in the 
data that are in some way unrealistic and may have a very negative impact on the regression 
equation (Lund, M., Lund 2015). 
3.5.2.3 Model diagnostics 
The validity of inferences drawn from a model depends on satisfying the assumptions. Once 
the prediction model is fitted to the data, it is essential to check that this model is actually a 
valid model. A good model is one that ‘fits’ the data well, in the sense that the values 
predicted by the model are in close agreement with those observed. A careful evaluation of 
the extent to which the constructed model provides a good representation of the observed 
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data is vital. A main purpose of model diagnostics is to identify subjects who are 
problematic under the constructed model (David Hosmer, Stanely Lemeshow 2013). 
To test if each predictor is adding to the model goodness of fit we use Wald test. This test 
evaluates the statistical significance of the coefficient of each predictor. If the coefficient of a 
certain predictor is statistically not significant then we assume that removing the variable from 
the model will not substantially harm the fit of that model. Another method to assess the 
goodness of fit for a model is to check the residuals. Residuals in any model are the differences 
between the observed values in the data and the predicted values from the final model. If the 
residuals are randomly distributed that suggests a good fit. On the other hand, if non-random 
structure is evident in the residuals, it is a clear sign that the model fits the data poorly. 
A logistic regression model is preferable over another model if it provides a better fit to the 
data with fewer predictors. This can be achieved by conducting a procedure called the 
likelihood ratio test between two or more models. This test compares the likelihood of the 
data under the full model against the likelihood of the data under another model with less 
predictors. Obviously, the log likelihood of a model (how well it fits the data) will be lower 
if a predictor is removed, however, this test assesses if the observed difference between the 
two models is statistically significant. Pseudo R² in logistic regression model is a good 
representation of the log likelihood ratio where it divides the log likelihood ratio of the fitted 
model over the log likelihood ratio of the null model (without predictors). The Pseudo R² 
measure is expressed in values ranging from 0 to 1, with values closer to zero indicating that 
the model has no predictive power (Menard 2010). 
Another test to determine the data goodness of fit is the Hosmer-Lemeshow test. This test 
shows how close the predicted probabilities are to the observed data. This is done 
segmenting the observed data with similar predicting probabilities into the same groups. A 
Pearson chi-square test is then conducted to evaluate if the difference between predicted 
values and observed values is statistically significant. Not statistically significant p-value of 
the Hosmer-Lemeshow test indicates that the model fits data well. However, it has been 
noted that this rule might be difficult to achieve if working with large datasets (David 
Hosmer, Stanely Lemeshow 2013). 
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The receiving operating characteristics curve (ROC curve), is a measure of how correctly the 
model classifies cases. Using the ratio of positive data points which are correctly classified 
as positive and the ratio of negative data points that are incorrectly classified as positive, a 
graph is produced to show the trade-off between the proportions of values correctly 
predicted compared with the proportion of values incorrectly predicted. Ultimately, the area 
under the ROC curve, or AUROC is the most meaningful measure in this graph. That metric 
ranges from 0.50 to 1.00, and values above 0.80 indicate that the model has a good 
predictive power (Hernández-Orallo 2013). 
3.5.2.4 Model validation 
Any statistical model developed for prediction needs validation (Miller et al. 1991). Model 
validation is conducted to ensure that the predicted values generated by the model are likely 
to predict outcomes on future subjects or subjects not used to develop the model. Model 
validation is an important step to ascertain that predicted values fairly represent the collected 
data and to ensure they are generalisable to other populations. The two main methods of 
model validation are external validation and internal validation (Harrell 2015). 
External validation involves testing the final developed model in subjects external to those 
used for model development (Riley et al. 2016). External validation can explore genuine 
differences in the characteristics of subjects used to develop the model and those used to test 
it in addition to testing how well the model performs (Collins et al. 2014). External 
validation can vary in stringency. Testing the developed model in another population 
extracted from another country is considered the most stringent form of external validation 
while testing the model in same geographic area but from different settings is a less stringent 
form of external validation. The least stringent form of external validation is what is known 
as data-splitting. This is when part of the data is not used to develop the model but as a test 
sample (Harrell 2015). 
Although external validation is a useful tool to validate prediction models, it is commonly 
unused. In 2010, a systematic review of 78 studies used external validation method 
concluded that ‘there is a dearth of well-conducted and clearly reported external validation 
studies’ (Riley et al. 2016). There are two likely causes for that, first, data-splitting 
technique results in lower precision and power of the model due to the reduced sample size. 
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Second, evaluating prediction models on other datasets by different researchers is rare due to 
insufficiencies in the reported methodology of the majority of published validation studies 
(Collins et al. 2014). 
Internal validation involves fitting and validating the model by carefully using one series of 
data (Harrell 2015). Resampling methods can be utilised to compute unbiased estimates of 
the prediction model performance without scarifying the sample size. The most efficient 
internal validation technique is claimed to be bootstrapping technique (Steyerberg et al. 
2001). Bootstrapping is a more sophisticated approach to data-splitting which is achieved by 
computer-intensive resampling techniques. In bootstrapping, repeated random samples are 
drawn from the estimation sample (commonly 1000 iterations) thereby creating artificial 
datasets on which models are estimated. Based on these coefficient estimates, events are 
predicted in the estimation sample (Gutacker et al. 2015). A drawback of this technique is its 
limitation when used with other computerised techniques such as multiple imputation (see 
section 3.5.1).  
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4 Engagement study 
4.1 Abstract 
 Background and Aims 
Despite the proven benefits of cardiac rehabilitation (CR), utilisation rates remain below 
recommendation in the percutaneous coronary intervention (PCI) cohort in most European 
countries. Although extensive research has been carried out on CR uptake, no previous study 
has investigated the factors that lead patients to attend the initial CR baseline assessment 
(CR engagement). This paper attempts to provide new insights into CR engagement in the 
growing PCI population. 
 Methods and Results 
In total, I analysed data on 59,807 patients who underwent PCI during 2013 to 2016 (mean 
age 65 years; 25% female). 20 factors were hypothesized to have a direct impact on CR 
engagement and they were grouped into 4 main categories; namely socio-demographic 
factors, cardiac risk factors, medical status and service-level factors. A binary logistic 
regression model was constructed to examine the association between CR engagement and 
tested factors. All but one of the proposed factors had a statistically significant impact on CR 
engagement. Results showed that CR engagement decreases by 1.2% per year of age (OR 
0.98) and is approximately 7% lower (OR 0.93) in female patients, while patients are 4.4 
times more likely to engage if they receive a confirmed joining date (OR 4.4). The final 
model achieved 86.6% sensitivity and 49.0% specificity with an area under the receiver 
operating characteristic curve of 0.755. 
 Conclusion 
The present results highlight the important factors of the likelihood of CR engagement. This 
implies that future strategies should focus on factors that are associated with CR 
engagement. 
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4.2 Introduction 
Cardiac rehabilitation (CR), which is defined as a structured multidisciplinary intervention 
for cardiovascular risk assessment and management, advice on structured exercise training, 
psychosocial support and the appropriate prescription and adherence to cardio-protective 
drugs, is the most investigated form of secondary prevention interventions (Piepoli et al., 
2016b). CR has been established as one of the most clinically and cost-effective intervention 
in cardiovascular (CVD) disease management (Dalal, Doherty and Taylor, 2015). CR 
improves clinical outcomes by modifying cardiac risk factors and is cost saving through a 
reduction in unplanned re-admissions for cardiac problems (NICE, 2013). Participation in a 
CR programme for patients hospitalized for an acute coronary event or revascularization is 
therefore recommended by European guidelines (class 1 level A) (Piepoli et al., 2016a). 
However, despite the proven benefits of CR it remains underutilised in many healthcare 
systems, with major inequities in access for certain patient groups such as the elderly and 
female patients (Sumner, Grace and Doherty, 2016). Furthermore, it has previously been 
observed that utilisation rates are lower than expected in patients undergoing percutaneous 
coronary interventions (PCI) in most European countries (Humphrey, Guazzi and Niebauer, 
2014). 
Although extensive research has been carried out on CR uptake (e.g. proportion of eligible 
patients starting core CR), researchers have not investigated the factors that are associated 
with patients attending an initial CR baseline assessment (CR engagement), which informs 
the design of the tailored CR programme. Not all patients who attend the initial CR baseline 
assessment take part in the core CR programme, and not all patients that are eligible engage 
with CR at all. European guidelines continue to recommend CR initial assessment as a 
minimum standard and core component of CR (Windecker et al., 2014). 
According to the British Association for Cardiovascular Prevention and Rehabilitation 
(BACPR) this baseline assessment could commence on a ward prior to discharge, or at an 
outpatient clinic or when they first attend the outpatient programme. It is only deemed 
complete when a formal assessment of lifestyle risk factors (smoking, diet, fitness and 
physical activity status), psychosocial health status, medical risk factors (blood pressure, 
lipids and glucose) and use of cardio-protective therapies has taken place (BACPR, 2017).  
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This paper aims to provide new insights into the factors that lead patients in the PCI 
population to attend their initial CR baseline assessment. I hypothesised that CR engagement 
is not a single patient decision but also related to service level initiatives. 
4.3 Methods 
This study investigates factors that will predict patient engagement with CR among PCI 
patients. Logistic regression model will be constructed to identify predictors of CR 
engagement among the selected population. 
 Data source 
The NACR is operated in collaboration with NHS Digital to monitor the quality of and 
outcomes from cardiovascular secondary prevention and rehabilitation services in the UK. 
NACR has approval that is gained on an annual basis (under section 251 of the NHS act 
2006) to collect anonymised patient data for a range of clinical variables without the explicit 
consent from individual patients (NACR, 2016). Data are gathered by clinicians through 
validated questionnaires that are completed via a secure online system hosted by NHS 
Digital. The secure online data include details of patients’ demographic characteristics, 
clinical condition and lifestyle. NACR has shown to be representative of CR provision in the 
UK with 72% of all CR programmes entering data electronically using the NACR online 
system (NACR, 2016). 
To investigate the impact of social deprivation on CR uptake, the Index of Multiple 
Deprivation (IMD) 2010 was linked to NACR data set. The IMD is the official measure of 
relative deprivation for small areas (or neighbourhoods) in England (DCLG, 2015). The 
IMD scores are based on 8 distinct domains of deprivation with respect to income, 
employment, education, skills and training, health and disability, crime, barriers to housing 
and services, and living environment. These are combined, using appropriate weights, to 
generate an approximate overall deprivation score for each individual patient according to 
their small area of residence (Sumner, Grace and Doherty, 2016). 
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  Design and inclusion criteria 
This is a retrospective observational study using data retrieved from the NACR dataset for 
the period 1st April 2013 to 31st March 2016. Although NACR collects data for three 
countries (England, Northern Ireland and Wales), only patients in England were included in 
the study as the IMD is only available for English small areas. In addition, patients were 
included in the analyses if they had any type of PCI treatment during the study period and 
were referred to CR (Figure 4.1). Referral to a CR programme in England is usually 
conducted while the patient is still admitted or shortly after discharge for day case PCI 
patients (Sumner, Grace and Doherty, 2016). 
 
Figure 4.1 Study Flow and sample size. 
  Factors investigated 
Twenty factors from the primary data set were hypothesised to have a direct impact on 
patients’ decision to engage in CR based on the wider literature on CR uptake (Balady et al., 
2011; Clark et al., 2012; van Engen-Verheul et al., 2013; Grace et al., 2008; Gravely-Witte 
et al., 2010; Karmali et al., 2014) (Table 4.1). Predictor variables were either categorical or 
continuous depending on the method of data collection in NACR. The IMD score was 
grouped into 5 equal-sized quintile groups where the first quintile includes the most-
deprived patients and the fifth quintile includes the least-deprived patients.  
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Table 4.1 Hypothesised predictors for CR engagement. 
 Socio-demographic 
factors 
Cardiac risk 
factors 
Patient’s 
medical status 
Service level factors 
1 Age High blood pressure Total number of 
comorbidities 
Referred to CR by 
2 Sex Diabetes Previous 
cardiac event 
Venue of Source of 
referral to CR 
3 Ethnicity High blood 
cholesterol 
Angina Hospital length of stay 
4 Marital status Anxiety  Received confirmed 
joining date 
5 Index of multiple 
deprivation (IMD) 
Depression  PCI type 
6 
 
Family history  Patient received early CR 
 
A detailed explanation of the investigated factors and their subcategories can be found in 
(Appendix 9.4). 
  Data analysis 
Descriptive statistics were calculated to compare differences in baseline characteristics 
between engaged and non-engaged patients. I used t-test for continuous variables and chi-
square tests for categorical variables with p-values < 0.05 considered to be statistically 
significant.  
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A binary logistic regression model was constructed to predict the probability of CR 
engagement and to examine the association among the research variables. I followed a 
backward selection process in which all variables were entered simultaneously in the model 
and variables with p-value > 0.05 were removed. This process was repeated until all 
variables had p<0.05. I also used forward selection techniques, beginning with a simple 
model including patients’ socio-demographic factors only, to which the other three blocks of 
predictors (Table 4.1) were then added in sequence to create three additional, increasingly 
more complex models. The four models were then tested against each other on the basis of 
log likelihood and variance explained (Pseudo-R2). 
Since age and gender were reported in the literature as a major determinant of CR 
accessibility and outcomes (Thomas et al., 2014; NACR, 2016; Al Quait and Doherty, 
2016), age and gender-specific interaction was tested by inserting a 2-way age and gender 
interaction term in the model as a separate variable. To account for other interactions in the 
model between gender and any other tested variable, the analysis was repeated for males and 
females separately (stratified analysis). 
The final model’s goodness-of-fit was evaluated using a Hosmer and Lemeshow test (Field, 
2013). To validate the model predictive power, a receiver operating characteristic (ROC) 
curve  was plotted and model accuracy was measured by the area under the ROC curve 
(AUC) (Hajian-Tilaki, 2013). 
Under the assumption that missing values are missing at random, all variables with > 5% 
missingness were handled by multiple imputation using 20 imputed data sets. The resulting 
estimates were pooled using Rubin’s rule. All analyses were performed using SPSS version 
24. 
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4.4 Results  
The analysis sample included 59,807 patients. The baseline characteristics of both groups 
(engaged and not-engaged) are illustrated in (Table 4.2).  
Table 4.2 Baseline characteristics of both groups. 
Factor Engaged Not-engaged P value 
N  
38,246 (63.9%) 21,561 (36.1%) <0.001 
Mean age (SD) 
64.16 (11.7) 65.36 (12.4) <0.001 
% Female 
24.7% 25.6% 0.012 
Ethnicity (White) 
85% 81% <0.001 
Marital Status (single) 
23.3% 25.9% <0.001 
IMD* score (5)7 25.4% 19.3% <0.001 
% Comorbidities (+3) 
30.1% 23.6% <0.001 
% Elective PCI procedure 
35 % 32.6% <0.001 
% Day case procedure 
15.9% 18.4% <0.001 
 
                                                     
7 Ratio of least deprived patients in the cohort 
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In (Table 4.3) a comparison of the summary statistics for the four models created as 
explained in the methods section.  
Table 4.3 summary statistics for the four models created by forward stepwise 
regression. 
Model -2 Log likelihood 
ratio 
Pseudo R Correctly classified cases 
Model 18 77226.16 0.02 63.9% 
Model 29 73698.13 0.03 64% 
Model 310 72608.09 0.05 64.8% 
Model 411 (final) 63847.12 0.25 73.1% 
 
The final model was statistically significant, χ² (32) = 11928.8, p < 0.0005. The model 
explained 25% (Nagelkerke R²) of the variance in CR engagement and correctly classified 
73.1% of cases. Sensitivity was 86.6%, specificity was 49%, positive predictive value was 
75.1% and negative predictive value was 67.3%. The ROC curve test indicates that the final 
model has a good predictive ability with AUC of 0.755 (SE = 0.002, 95% CI, 0.751 to 
0.759) (Figure 4.2). 
                                                     
8 Socio-demographic factors only. 
9 Model 1 plus risk factors. 
10 Model 2 plus patient’s medical status. 
11 Model 3 plus service level factors. 
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Figure 4.2 ROC curve of the final CR engagement model. 
 To assess the model for influential cases, Cook’s distance test and leverage values were 
computed. There were no unusually high values in both tests (all < 1). Hosmer and 
Lemeshow test in the final model is not statistically significant (p = 0.349) indicating that 
the model is not a poor fit. Of the twenty predictors tested, only hypertension was found to 
be not statistically significant (Table 4.4). Splitting the data into male and female groups to 
account for gender related interaction with other variables did not reveal any significant 
change in the reported results. 
Table 4.4 Pooled estimates of the logistic regression model predicting likelihood of 
CR engagement. 
Factor12 Categories 
P 
value 
Odds 
ratio 
95% CI for OR 
Lower Upper 
Age In years 0.000 0.988 0.987 0.990 
Sex (male) Female 0.002 0.929 0.885 0.974 
Ethnicity (White) Ethnicity Black 0.222 1.239 0.878 1.749 
                                                     
12 Predictor with base category in brackets. 
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Ethnicity South Asian 0.001 0.866 0.792 0.946 
Ethnicity Other 0.000 0.757 0.712 0.804 
Marital status (Single) 
In partnership 0.000 1.223 1.144 1.307 
Previously partnered 0.000 1.250 1.153 1.355 
IMD rank (1 most deprived) 
IMD rank (2) 0.480 1.029 0.951 1.113 
IMD rank (3) 0.000 1.190 1.101 1.288 
IMD rank (4) 0.000 1.240 1.155 1.331 
IMD rank(5) 0.000 1.464 1.363 1.572 
Cardiac risk factors (no) 
Hypertension 0.407 0.977 0.923 1.033 
Diabetes 0.000 0.877 0.822 0.935 
Depression 0.000 1.561 1.374 1.774 
Hypercholesterolemia 0.000 0.787 0.743 0.834 
Family History 0.005 1.093 1.027 1.162 
Angina 0.000 1.225 1.144 1.312 
Anxiety 0.000 1.435 1.257 1.639 
Number of comorbidities (0) 
Comorbidity < 3 0.000 1.589 1.477 1.710 
Comorbidity > 3 0.000 1.802 1.586 2.048 
History of previous  cardiac 
event (no) 
Previous event 0.000 0.749 0.715 0.786 
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Patient refereed by 
(consultant) 
Cardiac nurse 0.000 0.902 0.854 0.953 
GP 0.467 1.791 0.348 9.204 
Primary care nurse 0.056 1.391 0.992 1.953 
Other 0.085 1.097 0.987 1.219 
Venue of source of referral 
(NHS Trust) 
General Practice 0.000 9.302* 7.803 11.091 
BMI/Private Hospital 0.035 0.810 0.667 0.985 
Hospital length of stay 
(overnight stay) 
Day Case 0.000 0.736 0.691 0.784 
Received confirmed joining 
date (no) 
Yes 0.000 4.443 4.239 4.656 
PCI type (primary) 
MI 0.000 1.111 1.060 1.165 
Elective 0.000 1.211 1.146 1.278 
Patient received early CR (no) Yes 0.000 0.533 0.509 0.558 
Constant - 0.000 5.602 3.830 8.194 
*The effect inflated by small sample size. 
4.5 Discussion 
This is the first study to investigate the determinants of CR engagement in patients following 
PCI treatment. In this retrospective secondary analysis, it was found that the probability of 
CR engagement decreases by 1.2% (OR 0.98, 95% CI 0.987 to 0.990) per additional year of 
patient age, and is approximately 7.1% lower (OR 0.929, 95% CI 0.885 to 0.974) for female 
patients compared to male patients. These novel results, obtained from routine clinical data 
support the findings of earlier systematic reviews and meta-analyses which indicate that 
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existing CR programmes are more attractive to middle-aged male patients, thus perhaps 
being less attractive for the elderly or female patients (Windecker et al., 2014; Wenger, 
2008; Anderson et al., 2016; Menezes et al., 2014). 
The recent European guidelines on cardiovascular disease prevention have emphasised that 
minority ethnic groups like South Asians have a higher risk of CVD but are less represented 
in CR programmes (Piepoli et al., 2016a; Karmali et al., 2014). Our results support this and 
suggest that South Asians are less likely to engage in CR compared to the majority ethnic 
white patient population (OR 0.866), thereby identifying a potential mechanism that leads to 
differential uptake of CR programmes. Also, CR engagement was significantly correlated 
with the index of social deprivation as measured by IMD where CR engagement increased 
from the most deprived to the least deprived patients (except for the first two most deprived 
deciles). Current European and international guidelines have called for equal access for all 
MI patients, including those from minority ethnic groups and socially deprived groups, and 
our results question the extent to which this has been achieved. (National Institute for Health 
and Care Excellence, 2013; Graham et al., 2007; Balady et al., 2011). In addition, single 
patients are less likely to be engaged in CR compared to partnered or previously partnered 
patients (22% and 25 % respectively). This may be because couples facilitate attendance by 
providing social support, transportation to CR centres or communication with health 
professionals (Clark et al., 2012). However, note that previously partnered patients are the 
most engaged CR group. 
The current study found that cardiac risk factors play a major role in CR engagement. 
Diabetes (OR 0.88), hypercholesterolemia (OR 0.79) and history of previous cardiac event 
(OR 0.749) are associated with reduced CR engagement while hypertension was not found 
to be a significant predictor of CR engagement (P = 0.404). Other risk factors such as angina 
(OR 1.22), anxiety (OR 1.43), depression (OR 1.56) and family history of cardiac disease 
(OR 1.09) were found to increase the likelihood of patients’ engagement in CR. One 
unanticipated finding was that the number of comorbidities was not found to be in itself a 
barrier to CR engagement. This finding contradicts a retrospective analysis conducted in the 
Netherland (van Engen-Verheul et al., 2013) and another Canadian qualitative study (Grace 
et al., 2009) although these studies were investigating uptake to core CR not CR 
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engagement, i.e. the initial baseline assessment that may take place before or at the very 
beginning of core CR sessions.  
If patients had a life-saving PCI (primary PCI) they were less likely to engage in CR 
compared to MI/PCI and elective PCI (OR = 1.21 and OR = 1.11). Having PCI as a day case 
procedure also reduced the likelihood of CR engagement by 27%. This result may be 
explained by the fact that a day case procedure reduces the time window to identify and 
recruit patients to CR thus requiring programmes to be more innovative in contacting 
patients (Sumner, Grace and Doherty, 2016). Another finding that was contrary to 
expectations is that patients who took part in early phase 1 CR sessions (either inpatient or 
home-based programmes) were less likely to start the core CR programme (OR = 0.533). 
One of the most telling findings to emerge from the analysis is that patients who were given 
a firm date to attend the initial CR assessment were over 4 times more likely to engage in 
CR (OR 4.443). Also, patients who have been referred from a general practice were more 
than 9 times more likely to attend the assessment session compared to patients referred from 
hospital setting (OR 9.30). The primary route of referral in our sample was through a 
hospital cardiac nurse (74.7% of patients), and these patients were significantly less likely to 
engage in CR compared to patients referred by consultant, general practitioner (GP) or 
primary care nurse (OR 0.902). It is difficult to explain this result, however the strength of 
healthcare professional endorsement for CR is known to play a significant role in CR uptake 
(Grace et al., 2008).It has been also reported in several studies that nurses have been shown 
to be more successful coordinators of secondary preventive programmes (Jennings and 
Astin, 2017). 
The analysis of CR engagement undertaken here has extended our understanding of the 
determinants of low CR utilisation rates in England. Although age and gender are significant 
determinants of CR engagement, which is also true for CR uptake, (Table 4.4) illustrates 
how service level factors play a major role in CR engagement. These findings highlight that 
service level initiatives, such as providing a firm date to attend the initial CR baseline 
assessment, play an important part in promoting initial CR engagement. Further research 
should be undertaken to investigate the differences and determinants between those patients 
who start CR and those who drop out. 
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4.6 Study limitations 
The definition of CR engagement is novel and required the use of a combination of NACR 
data fields, which will benefit from repeat studies in other CR datasets to further validate 
this approach. In addition, the NACR dataset is setup to evaluate service quality and 
outcomes so some other relevant factors influencing CR engagement may have been missed. 
Also, while I evaluated the type of PCI as a determinant of engagement, it is likely that these 
correlate with unobserved clinical factors, so that our estimate of the effect of PCI type may 
be subject to confounding.  
4.7 Conclusion  
This is the first study on CR engagement from a nationally representative cohort of patients. 
This paper provides new insights into the factors that lead patients to attend their CR initial 
baseline assessment (CR engagement) in the growing PCI population. The most obvious 
finding to emerge from this study is that CR engagement is not a single patient decision but 
is also related to service level factors, over which healthcare systems have more direct 
control. The findings should make an important contribution to our understanding of the 
relatively low CR utilisation rates in this cohort despite the known benefits of CR. 
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5 Uptake study 
5.1 Abstract 
 Background 
Cardiac rehabilitation (CR) uptake rates are still below recommendations in most European 
countries. Age and female gender have been identified in the literature as barriers against CR 
uptake. This study evaluated the extent by which age and gender determine the likelihood of 
CR uptake among percutaneous coronary intervention (PCI) patients in England. 
 Methods 
I analysed routine clinical data from the UK National Audit of Cardiac Rehabilitation for 
patients who underwent PCI in 2013 to 2016 and had completed a baseline CR assessment. 
A hierarchical logistic regression model, using multiple imputation as appropriate, assessed 
the impact of age and gender on CR uptake while accounting for patients’ characteristics and 
service level factors. 
 Results 
The sample consisted of 38,246 patients (64.2 ±11.7 years, 75.3% male), of which 28,263 
(73.9%) patients started CR (63.6 ±11.4 years, 76% male). The likelihood of starting CR 
decreases with patient age (OR: 0.98, 95% CI: 0.98 to 0.99) and is higher for women than 
men (OR: 1.58, 95% CI: 1.11to 2.25). There was significant interaction revealing that 
younger women (≤ 57 years) are more likely to start CR compared to younger men (OR: 
0.98, 95% CI: 0.98 to 0.99) while older women were found to be less likely to join compared 
to younger/middle age women or older men (> 57 years).  
 Conclusion 
Strategies to increase CR uptake in PCI patients should consider age in the context of gender 
when offering CR and deploy tailored support to enable patients to progress from assessment 
to starting CR.  
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5.2 Introduction 
Since the first PCI procedure was conducted by Andreas Gruentzig in 1977, this 
revascularisation technique has significantly developed and nowadays represents the first 
choice of treatment for CAD. This huge success of PCI procedures is underpinned by 
improved rates of survival and more attention should be made towards improving patients’ 
quality of life and preventing secondary cardiac events. This goal can be achieved by 
offering patients a comprehensive CR programme which has been evidenced to reduce 
mortality, hospital readmissions and improve quality of life (Anderson et al., 2016; Rauch et 
al., 2016; Sumner, Harrison and Doherty, 2017). The proven efficacy of CR has made it 
(Class 1 level A) recommendation by the European Society of Cardiology, the American 
Heart Association, and the American College of Cardiology (Ruano-Ravina et al., 2016). 
However, rates of CR uptake in the PCI population remain low despite guideline 
recommendations. The UK National Audit of Cardiac Rehabilitation (NACR) report in 2016 
has shown low uptake in the English cohort of patients following myocardial infarction (MI) 
(40%) and elective PCI (45%) compared to the world-leading uptake rate in the CABG 
population (58%). This is of major concern since PCIs now constitute the vast majority of 
revascularisation procedures in the UK (96,143 compared to 17,513 CABG procedures in 
2014) (Townsend et al., 2015) and, as a result, around 50,000 eligible patients were not 
accessing vital CR services to improve their chance of recovery and reduce the risk of 
suffering another cardiac event (NACR, 2015). 
A large and growing body of literature analyses health care-seeking behaviours and the 
determinants of health services utilisation to understand how people engage with the 
healthcare systems. Several lines of evidence suggest that health care-seeking behaviour is 
influenced by many patient characteristics such as patient demographics and socio-economic 
status (Thompson et al., 2016). Existing research specifically recognises the critical role 
played by age and gender in health related behaviours (Deeks et al., 2009; Thompson et al., 
2016). Similarly, two recent systematic reviews of determinants of CR uptake identified age 
and gender as important independent factor (Ruano-Ravina et al., 2016; Karmali et al., 
2014). 
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One criticism of the existing literature on CR uptake is that most studies have been limited 
by their small sample size, particularly for minority groups in their population such as 
females and older patients. Also the rapid advances in the technology and applicability of 
PCI in addition to changes in patients’ health behaviours over time require continuous re-
evaluation of CR uptake determinants. This study sought to provide updated estimates of CR 
uptake determinants. It will also investigate the impact of age and gender effects on CR 
uptake using a large routine clinical data for patients who underwent PCI and test whether 
the age gradient in uptake varies by gender, i.e. whether there is an inter-relationship 
(interaction) between age and gender.  
5.3 Methods 
 Design and inclusion criteria 
This is a retrospective observational study where data retrieved from the NACR dataset for 
the period 1st April 2013 to 31st March 2016. Patients were included in the analyses if they 
had any type of PCI treatment in England during the study period, were referred to CR and 
had attended a pre-CR assessment session (Figure 5.1). Although NACR collects data for 
three countries (England, Wales and Northern Ireland), only patients residing in England 
were included to allow for consistent measurement of social deprivation using the English 
Index of Multiple Deprivation (IMD). Referral to a CR programme in England is usually 
conducted while the patient is still admitted or shortly after discharge for day case PCI 
patients while the pre-CR assessment is implemented on a ward prior to discharge, or at an 
outpatient clinic in CR phase 2 or when they first attend a core CR (outpatient ) programme 
(Sumner, Grace and Doherty, 2016; BACPR, 2017).  
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Figure 5.1 Study flow and sample size. 
 Data source 
In collaboration with NHS Digital and British Heart Foundation (BHF), NACR monitors the 
quality and outcomes of cardiac rehabilitation services in the UK. NACR has been approval 
by NHS Digital under section 251 of the NHS Act 2006 to collect anonymised patient data 
for a set of clinical variables via a secure online portal. These data are gathered by clinicians 
through specifically designed and validated questionnaires and include details of patients’ 
demographic characteristics, clinical conditions and lifestyles (NACR, 2016). In 2016, the 
total number of CR programmes delivering core CR in the UK and participating in NACR 
was 318. With nearly 90% survey response rate in 2015, NACR dataset is considered highly 
representative of CR provision in the UK (NACR, 2015). 
To take account of the impact of social deprivation on CR uptake, the Index of Multiple 
Deprivation (IMD) 2010 reported at the Clinical Commissioning Group (CCG) level, was 
linked to NACR data set. The IMD scores are based on 8 distinct domains of deprivation: 
income, employment, education, skills and training, health and disability, crime, barriers to 
housing and services, and living environment. These are combined, using appropriate 
weights, to calculate the IMD for each individual patient (Sumner, Grace and Doherty, 
2016). Patients were assigned to one of five equal-sized groups according to the quintiles of 
the distribution of IMD scores, with the first quintile group representing the most-deprived 
patients. 
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 Measures 
CR uptake in this study was defined as starting the CR exercise-based programme 
(outpatient CR) by attending at least one outpatient CR session (Suaya et al., 2007; Karmali 
et al., 2014). Noting that only patients who had a baseline assessment (engaged) were 
included in the analysis. This study also attempts to explore the impact of age and gender as 
independent and inter-related factors informing CR uptake. Twenty-six other factors were 
included in the analysis to adjust for their potentially confounding influence on uptake 
(Table 5.1).  
Table 5.1 the factors that impact CR uptake classified into 4 main categories. 
 
Patient’s socio-
demographics 
Cardiac risk factors 
Lifestyle & 
Medical status 
Service level factors 
1 Ethnicity High blood pressure Physical fitness Referred to CR by 
2 Marital status Diabetes Being overweight Source of referral to CR 
3 Employment Physical inactivity Social support Hospital length of stay 
4 
Index of multiple 
deprivation (IMD) 
High blood cholesterol Alcohol intake 
Time from event to 
baseline assessment 
5 
Age*gender     
(interaction term) 
Anxiety Smoking 
Received confirmed 
joining date 
6  Depression 
Total number of 
comorbidities 
PCI type 
7  Family history 
Previous cardiac 
event 
Patient received early 
CR 
8   Angina  
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Those factors were selected based on the existing literature and the data fields collected in 
NACR. A number of factors were identified in previous studies as determinants of CR 
uptake but not collected in NACR (e.g. transportation, place of residence, religion, etc.) and 
were therefore not considered in our analysis. The control factors were grouped into four 
main categories (blocks), namely socio-demographic factors, cardiac risk factors, lifestyle & 
medical status and service-level factors. Detailed explanation of the selected factors and 
their subcategories are shown in (Appendix 9.5). 
 Data analysis  
I first calculated descriptive statistics and compared baseline characteristics between starters 
and non-starters using t-tests for continuous variables and chi-square tests for categorical 
variables, with a p-value < 0.05 considered statistically significant.  
Binary logistic regression model was developed to predict the probability of starting CR and 
to examine the association among the research variables. The first set of models were 
created following a backward selection process where all variables entered simultaneously, 
variables with p-value > 0.05 were removed and the process was repeated until no variables 
had p-value > 0.05. I also conducted forward stepwise regression in which variable were 
entered as blocks. A simple model with patient’s age, gender and their interaction term was 
first constructed. Then a second more complex model was created by adding socio-
demographics to the first model. A third, fourth and fifth models were built alternately by 
adding the three remaining sets of variables in (Table 5.1), i.e. cardiac risk factors, lifestyle 
& medical status and service level factors. The five constructed models were then tested 
against each other to find the best model in explaining the highest variance of the outcome.  
The final model goodness-of-fit was tested using a Hosmer and Lemeshow test (Field, 
2013). To validate the model predictive power, a receiver operating characteristic curve 
(ROC curve) was plotted and model accuracy was measured by the area under the curve 
(AUC) (Hajian-Tilaki, 2013).  
I used multiple imputation for variables containing missing data. This was done under the 
assumption that values are missing at random, i.e. the probability of a value to be missing is 
a function of observable patient characteristics and random chance, not the value of the 
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variable itself. 20 imputed data sets were created and the resulting estimates were pooled 
using Rubin’s rule. All analyses were performed using SPSS version 24. 
5.4 Results  
The sample included 38,246 patients. The baseline characteristics of both groups (starters 
and non-starters) are illustrated in (Table 5.2). 
Table 5.2 Baseline characteristics of both groups. 
Patient characteristic 
Starters  
(N=28,263, 73.9%) 
Non-starters 
(N=9,983, 26.1%) 
P-value 
Mean age (SD) 
63.59 (11.4) 65.79 (12.3) <0.001 
% Female 
24% 26.6% <0.001 
Ethnicity (White) 
84.5% 86.5% <0.001 
Employment (Retired) 
35.3% 29% <0.001 
% Smokers 
8.7% 13.8% <0.001 
% Comorbidities (+3) 
44.1% 55.9% 0.242 
% Elective PCI procedure 
34.2% 37.3% <0.001 
% Moderate physical 
activity13 
27.9% 18.2% <0.001 
% Day case PCI 
14.6% 13.7% 0.006 
                                                     
13 Ratio of patients taking moderate physical activity for 150 minutes per week. 
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A binomial logistic regression was performed to ascertain the impact of the 28 predefined 
patient and clinical factors on the likelihood of patients joining a CR programme. The final 
model was statistically significant, χ² (10) = 7145.26, p < 0.0005. The model explained 25% 
(Nagelkerke R²) of the variance in CR uptake and correctly classified 78.9% of cases. With a 
cut-value set at 0.5 the Sensitivity was 94.4%, specificity was 35.2%, positive predictive 
value was 80.5% and negative predictive value was 68.8%. Table 5.3 presents the summary 
statistics of these five models constructed by means of forward selection. 
Table 5.3 summary statistics for the five models created by forward stepwise 
regression. 
Model -2 Log likelihood 
ratio 
Pseudo R Correctly classified cases 
Model 114 43518.53 0.011 73.9% 
Model 215 43079.71 0.028 73.9% 
Model 316 42750.83 0.040 73.9% 
Model 417 41981.18 0.068 74.1% 
Model 518  (final) 36663.74 0.250 78.9% 
In the final model, out of the twenty-eight predictor variables only five were not statistically 
significant: BMI, depression, social support, alcohol input and physical fitness (p > 0.05). 
                                                     
14 Age, gender and interaction term only. 
15 Model 1 plus Socio-demographic factors 
16 Model 2 plus risk factors. 
17 Model 3 plus patient’s medical status. 
18 Model 4 plus service level factors. 
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The remaining twenty-three variables were all statistically significant in the final model (p < 
0.05). Table 5.4 displays the results of all investigated determinants in the model. 
Table 5.4 Results of all investigated determinants in the model. 
Factor Categories P value Odds ratio 95% CI for OR 
Lower Upper 
Age In years 0.003 0.989 0.981 0.996 
Sex (Male) Female 0.007 1.625 1.139 2.320 
Interaction term Age*Sex 0.004 0.992 0.987 0.998 
Ethnicity (White) Black 0.597 1.129 0.719 1.772 
South Asian 0.017 0.862 0.763 0.974 
Other 0.279 1.051 0.960 1.151 
Patient received 
early CR 
Yes 0.000 0.809 0.761 0.860 
IMD rank (1 most 
deprived) 
IMD rank (2) 0.000 1.305 1.180 1.444 
IMD rank (3) 0.000 1.436 1.300 1.585 
IMD rank (4) 0.000 1.487 1.341 1.649 
IMD rank(5) 0.000 1.819 1.644 2.013 
Comorbidities Hypertension 0.000 1.141 1.068 1.220 
Diabetes 0.000 0.860 0.796 0.929 
Physical activity 0.001 1.151 1.065 1.245 
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Hypercholesterolemia 0.012 1.098 1.021 1.180 
Family History 0.000 1.217 1.133 1.306 
Angina 0.000 0.772 0.713 0.836 
Anxiety 0.001 1.311 1.122 1.531 
Depression 0.097 0.887 0.771 1.022 
BMI Assessment 1 > 30 0.574 1.021 0.948 1.100 
History of previous 
cardiac event 
Yes 0.000 0.769 0.722 0.820 
Employment 
(employed) 
Unemployed 0.275 1.072 0.945 1.215 
Retired 0.020 1.142 1.022 1.277 
Marital Status 
(Single) 
In partnership 0.004 1.146 1.044 1.257 
Previous partnership 0.289 1.063 0.950 1.190 
Social support Yes 0.758 1.018 0.910 1.138 
Alcohol intake ≤14 units/week 0.102 0.921 0.834 1.017 
Smoking status Smoker 0.000 0.599 0.549 0.653 
Physical fitness Yes 0.196 1.047 0.977 1.122 
Number of 
comorbidities (0) 
Comorbidity < 3 0.131 0.944 0.876 1.017 
Comorbidity > 3 0.009 0.862 0.770 0.964 
Cardiac nurse 0.000 1.300 1.214 1.392 
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Patient refereed by 
(consultant) 
GP 0.041 2.312 1.037 5.155 
Primary care nurse 0.000 5.093 2.878 9.010 
Other 0.000 1.287 1.120 1.478 
Hospital length of 
stay (overnight stay) 
Day Case 0.000 1.202 1.106 1.306 
Source of referral 
(NHS Trust) 
General Practice 0.000 0.290 0.249 0.338 
Source of Referral 
(BMI/Private Hospital) 
0.295 0.819 0.559 1.199 
Received confirmed 
joining date 
Yes 0.000 2.137 1.965 2.324 
PCI type (primary) PCI Type  (MI) 0.001 0.892 0.835 0.954 
PCI Type (Elective) 0.000 0.779 0.724 0.838 
Waiting time from 
cardiac event to pre-
CR assessment (2 
Weeks) 
4 Weeks 0.000 1.832 1.705 1.968 
6 Weeks 0.000 2.265 2.094 2.451 
8 Weeks 0.000 2.471 2.212 2.760 
> 8 Weeks 0.000 2.495 2.279 2.733 
Constant 0.000 5.413 3.004 9.756 
In addition, a significant interaction term was found between age and sex (OR = 0.993, 95% 
CI 0.987 to 0.998) (Figure 5.2). 
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Figure 5.2 Age by sex interaction term. 
In order to account for potential outliers and influential cases in the final model, Cook’s 
distance test and standardised residuals were assessed (Field, 2013). There were no 
unusually high values of Cook’s distance (all < 1) and the standardised residuals with < 5% 
of the values > ±3. The final model also proved to be a good predictor of the outcome 
variable (Hosmer and Lemeshow test: p = 0.231) indicating that the model is not a poor fit 
(Tabachnick and Linda Fidell, 2007). The ROC curve test indicates that the model has a 
good predictive ability with AUC of 0.76 (SE = 0.003, 95% CI: 0.75 to 0.77). 
 
Figure 5.3 ROC curve for the final CR uptake model. 
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5.5 Discussion 
Prior to discussing the findings of the results, a note on emphasis is important as unlike most 
of the literature, which has focused on uptake from all eligible patients, I have focused on 
what determines uptake for those patients who had completed a baseline CR assessment (Al 
Quait et al., 2017). In this secondary analysis of the NACR dataset, the likelihood of starting 
CR decreased statistically significantly with age (OR 0.98, 95% CI 0.98 to 0.995) and 
women were 63% more likely to start CR compared to men (OR 1.63, 95% CI 1.14 to 2.32). 
Also there is a significant interaction term between age and gender. In statistics, we say there 
is an interaction term when the value of an independent variable in the tested model differs 
significantly depending on the level of another independent variable (Field 2013).  This age-
gender interaction term is showing that younger women (< 57 years) are more likely to start 
CR than younger men (OR 1.6, 95% CI 1.1 to 2.2) while older women were found to be less 
likely to join compared to younger/middle age women or older men (> 57 years old) (Figure 
5.2). These results seem to be consistent with other research conducted in health seeking 
behaviour which found that men aged 45-65 are less likely to utilise medical services (Cook 
et al., 1990). However, other researchers in the same field have shown no significant 
difference in health seeking behaviour between genders (Galdas, Cheater and Marshall, 
2005). This discrepancy in the literature could be attributed to the widespread differences in 
study design and samples investigated. These findings builds on those observed in earlier 
CR systematic reviews and meta-analyses which collectively support the idea that existing 
CR programme designs are possibly informed by randomised trial studies where the 
dominant population was middle-aged patients hence it is not attractive for the elderly 
especially old female patients (Windecker et al., 2014; Wenger, 2008; Anderson et al., 2016; 
Menezes et al., 2014). 
A number of other factors besides age and gender were statistically significant determinants 
of CR uptake. One important factors is the source of referral to CR. Multiple healthcare 
professionals, with a broad range of expertise, are usually involved in patient treatment after 
a cardiac event. Each profession should, in its own way, encourage patients to participate in 
CR after hospital discharge (Arena et al., 2012). Particularly, the strength of physician 
endorsement to CR plays a significant role in CR endorsement (Grace et al., 2008). This 
analysis has shown that patients who were referred from a primary care setting (GP or 
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primary care nurse) were more likely to start CR compared to patients referred from a 
hospital settings (consultant or cardiac nurse). These differences may be explained in part by 
the stronger relationship between patients and their GP’s due to continual nature of primary 
care. Another important finding was that patients who were given a firm date to start CR by 
a phone call, letter or email were twice as likely to start CR (OR 2.1, 95% CI: 1.9 to 2.3).  
A Cochrane systematic review has shown that minority ethnic groups were under-
represented in CR programmes (Karmali et al., 2014). This is in agreement with the findings 
presented here as South Asians were found less likely to start CR compared to British White 
(OR 0.87, 95% CI:). Also, CR uptake decreased with increasing relative socio-economic 
deprivation. These findings points to inequalities in access to care and potential 
discrimination. Partnered patients tend to be more likely to join CR than single and 
previously partnered patients (p = 0.028, OR 1.1). This finding align with other qualitative 
research which indicated that couples are facilitating attendance by providing social support, 
transportation to CR centres or communication with health professionals (Clark et al., 2012). 
In the literature, there is a debate whether social support is a predictor of CR enrolment. For 
example, the presidential advisory of the American Heart Association (AHA) has identified 
the lack of social support as a barrier against CR attendance (Balady et al., 2011) but it did 
not prove to be a predictive factor in a prospective multisite qualitative study conducted by 
Grace et al (Grace et al., 2008). The current study confirms the lack of association between 
social support and CR uptake in PCI patients. 
CR programmes in the UK and elsewhere are predominantly exercised based. Therefore it is 
anticipated that patients with higher physical fitness are more likely to join. NHS guidelines 
for adults aged from 19-64 recommends at least 150 minutes of moderate physical activity 
per week (NHS, 2015). Those patients who follow the guidelines and answered ‘Yes’ to the 
question ‘Do you take regular physical activity of at least 30 minutes duration on average 5 
times a week?’ in the NACR questionnaire were found to start CR more frequently (OR 1.2). 
Also hypertensive, patients with hyperlipidaemia and family history of heart disease were 
found to be more likely to start CR than the others (OR = 1.1, OR = 1.1, OR = 1.2) 
respectively. However this analysis further supports the idea that CR programmes are still 
not attractive to certain patient groups like smokers and diabetic patients, or that the health 
service fails to engage with these patient groups sufficiently. This study found that smokers 
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are less likely to start CR by 40% (OR 0.6). This result may help to reveal part of the 
uncertainty reported by Murray et al (Murray et al., 2012) in their systematic narrative 
review of quantitative observational studies which found that smoking produced conflicting 
results with regards to CR uptake. Finally the number of comorbidities was identified as a 
barrier in CR uptake in this analysis. This finding is consistent with a retrospective analysis 
conducted in the Netherlands (van Engen-Verheul et al., 2013) and another Canadian 
qualitative study (Grace et al., 2009). 
For improved CR outcomes, the UK National Institute for Health and Care Excellence 
(NICE) in line with national guidelines suggests that pre-CR assessment should start within 
24 days of cardiac event (NICE commissioning guides, 2013). However, the findings of the 
current study suggests that early assessment may impact negatively on CR uptake. For 
example, patients being assessed 8 weeks after the event were 2.5 times (95% CI) more 
likely to start CR compared to those assessed in the first 2 weeks of the event.  
Although uptake rates in PCI patients in the UK far exceed those seen in other European 
countries (47% compared to an average rate of 30% across Europe) they are still below the 
target rate of 65% across all treatment groups specified in the national clinical guideline (DH 
Cardiovascular Disease Team, 2013). However, CR uptake in the UK continues to rise and 
the percentage of MI+PCI patients attending CR has increased in 2014 and now stands at 
58% (NACR, 2016). Being the largest national CR database in Europe, NACR is an 
essential part of the international quality assurance network which monitor the extent to 
which CR programmes perform against key service indicators and achieve expected patient 
outcomes. 
5.6 Study limitations 
The generalisability of these results is subject to certain limitations. For instance, patients 
were considered to start CR if they had a baseline assessment (engaged) and attended at least 
one outpatient CR session. Also the primary dataset is setup to evaluate final outcomes but 
not CR uptake, therefore it is likely that some other factors previously reported in the 
literature influencing CR uptake and not collected in NACR dataset have been missed (e.g. 
travel distance and patient’s level of education). Also while I evaluated the type of PCI as a 
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determinant of uptake, it is likely that these correlate with unobserved clinical factors, so 
that our estimate of the effect of PCI type may be subject to confounding. 
5.7 Conclusion 
Improving CR uptake in PCI patients remains a significant challenge for healthcare 
professionals. Future strategies to increase CR uptake in PCI cohort should not consider age 
and gender as entirely independently determinants but should also consider age in the 
context of gender. Approaches to increase uptake may therefore be differentiated by age and 
gender profile of the target population. These findings enhance our understanding of 
determinants of CR uptake and suggests that some of the theoretical expectations about CR 
uptake are not substantiated by analyses of large, routine clinical datasets. 
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6 Adherence study 
6.1 Abstract 
 Background 
Cardiac rehabilitation (CR) adherence rates in clinical practice are far from optimal in most 
European countries particular in the Percutaneous Coronary Intervention (PCI) cohort. 
Previous research proposed variations in the mode of CR delivery as a potential solution to 
high dropout rates. 
 Purpose 
This study has two main objectives, first to investigate the determinants of cardiac 
rehabilitation (CR) adherence in the percutaneous coronary intervention (PCI) cohort. 
Second, to assess variations in the mode of CR delivery in the UK and its impact on 
adherence rates. 
 Methods 
I adopted a mixed prospective retrospective research methodology to answer the study 
objectives. First, I analysed routine clinical data from the UK National Audit of Cardiac 
Rehabilitation (NACR) for patients who underwent PCI in 2013 to 2016 and had started CR. 
Second, an online survey was administered to 296 CR programmes across the UK to assess 
characteristics in the mode of CR delivery. Finally, I merged the data to assess different 
factors on CR adherence rates by constructing a hierarchical logistic regression model, using 
multiple imputation as appropriate and cluster-robust sandwich estimator. 
 Results 
The sample consisted of 28,263 patients nested in 141 CR programmes across the UK (63.6 
±11.4 years, 76% men and 84.5% Whites) of which 22,173 (78.5%) patients completed the 
CR programme. The final analytical model had 13 significant predictors of CR dropout. 
Among which, the likelihood of completing CR decreases if the patient was younger, 
smoking at baseline, socially deprived and unemployed. I also concluded that there was no 
significant differences in adherence rates between home-based and group-based programmes 
either on patients’ level or centre level. 
 Conclusion 
It is evidently clear from the findings that different modes of CR delivery have the similar 
adherence rates. These data support further clinical development of CR programmes to be 
more attractive to all patient groups.  
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6.2 Introduction 
Accounting for 45% of all deaths, cardiovascular disease (CVD) causes 3.9 million deaths in 
Europe alone. Gender-adjusted mortality rates show 1.8 million deaths in men (40% of all 
deaths) and 2.1 million deaths in women (49% of all deaths). In addition, approximately 
11.3 million new cases of CVD have been registered in 2015 making the total number of 
Europeans living with this disease at ~85 million patients. This high prevalence of CVD has 
an estimated cost to the European economy of €210 billion annually. The economic burden 
of CVD is not limited to production losses of those of working age, but also extend to the 
amount of money that carers sacrifice to provide unpaid care for their partners, parents or 
relatives suffering from CVD (Wilkins et al., 2017). Moreover, European age-adjusted 
mortality rates have decreased indicating that people are living longer with cardiovascular 
conditions and the challenge now is to optimise their quality of life (Bjarnason-Wehrens et 
al., 2010). 
On the other hand, Cardiac Rehabilitation (CR) has been proven to be one of the most 
clinically and cost-effective intervention in the management of CVD (BACPR, 2017). It is 
now well established that, from a variety of high quality research, CR reduces mortality, 
hospital readmission and improves quality of life (Anderson et al., 2016; Rauch et al., 2016; 
Sumner, Harrison and Doherty, 2017). As a result, participation in a CR programme 
following a cardiovascular event is class 1 level A recommendation by the European Society 
of Cardiology (ESC) and several other national and international regulating bodies 
worldwide (Ruano-Ravina et al., 2016). Despite the proven benefits, delivery of routine 
practice CR still has considerable challenges with referral, uptake and adherence remaining 
unresolved and implicated in the underutilisation of CR in most European countries 
(Humphrey, Guazzi and Niebauer, 2014).   
The next challenge after facilitating patients’ attendance to the outpatient CR, is to maintain 
adherence to the programme. This is particularly important since CR national registries and 
audit data have shown wide range of dropout rates (24% to 77%) of patients who start the 
outpatient CR programme (Turk-Adawi et al., 2013; NACR, 2016). Causal factors leading to 
these high dropout rates remain speculative since they mainly come from trials via 
systematic reviews while dropout rates are measured in routine clinical data. Considering the 
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intrinsic differences in population between trials and registry data, higher quality research 
based on routine clinical data should be directed towards investigating this persistent 
problem. A recently published systematic review on CR participation and adherence 
reported that the information on which factors impede CR adherence is scarce despite the 
high dropout rates (Ruano-Ravina et al., 2016). 
This study therefore set out to assess the determinants of CR adherence in the growing 
percutaneous coronary intervention (PCI) cohort. PCI population has been specifically 
selected since it represents the first choice of treatment for coronary artery disease (CAD) in 
the last decade (Diletti et al., 2014). The second objective of this study is to assess variations 
in the mode of CR delivery in the UK and its impact on adherence rates. The latter objective 
was set since there is some evidence that supporting patient preference in the mode of CR 
delivery  proposed as a potential solution to high dropout rates (Dalal, Doherty and Taylor, 
2015). This is of interest particularly after the updated Cochrane systematic review which 
concluded that home- and centre-based CR programmes seem to be similarly effective in 
improving clinical and health-related quality of life for cardiac patients (Anderson et al., 
2017a; Ruano-Ravina et al., 2016). 
6.3 Methods 
The methodological approach taken in this study is primarily retrospective research design 
with an additional prospective approach to address the two main objectives of the study. 
This paper uses routinely collected data retrieved from the UK National Audit of Cardiac 
Rehabilitation (NACR) dataset to investigate the determinants of CR adherence. The study 
also employed a prospective survey in order to gain insights into the mode of CR delivered 
within the UK. 
 Retrospective approach 
The study used a routine clinical data retrieved from the NACR dataset for the period 1st 
April 2013 to 31st March 2016. The decision to use an observational design was based on its 
ability to allow the researcher to observe ‘in natural settings’ the differences in how 
interventions are delivered (Anglemyer, Horvath and Bero, 2014). Moreover, observational 
designs are vital in building clinical evidence, exploring how an intervention is practiced on 
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the ground and understanding disparities in access to and delivery of healthcare services 
(Carlson and Morrison, 2009). In addition, the population captured in a comprehensive 
routine audit is more representative than volunteer participants within RCTs particularly 
with regards to mean age and female representation. The data source, inclusion criteria and 
ethical approval have been described elsewhere (Al Quait et al., 2017). 
6.3.1.1 Measures 
The primary dependent variable in this study is CR adherence. It is a binary variable with 
two categories: completers and dropouts. A patient is considered a completer if he or she 
satisfies two conditions: first, performing a CR assessment at the end of the outpatient 
programme (assessment 2). Second, marked as a completer by a CR programme staff 
member. Otherwise, they are considered as a dropout (Figure 6.1). 
 
Figure 6.1 Study flow and sample size. 
With regards to the independent variables, 28 factors were hypothesised to have a potential 
direct impact towards CR adherence. This is based on the searched literature and according 
to its availability in the primary analysed dataset (Table 6.1). These factors were either 
continuous or categorical depending on the method of data collection in NACR. 
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Table 6.1 Hypothesised factors for CR adherence. 
 Socio-
demographic 
factors 
Cardiac risk 
factors 
Life style & 
Health status 
Service level factors 
1 Age Hypertension Alcohol intake CR centre prescribed 
dose 
2 Gender Hyperlipidaemia Smoking Group/alone core CR 
3 Ethnicity Diabetes Physical fitness Supervised/self-
delivered 
4 IMD Score Physical 
inactivity 
Comorbidities MDT centre 
5 Marital status Being 
overweight 
Previous cardiac 
event 
BACPR certified centre 
6 Social support Anxiety Family history PCI type 
7 Employment Depression Angina Waiting time 
 
To investigate the impact of social deprivation on CR uptake, the Index of Multiple 
Deprivation (IMD) 2010 was linked to NACR data set. The IMD is the official measure of 
relative deprivation for small areas (or neighbourhoods) in England (DCLG, 2015). The 
IMD scores are based on 8 distinct domains of deprivation with respect to income, 
employment, education, skills and training, health and disability, crime, barriers to housing 
and services, and living environment. These are combined, using appropriate weights, to 
generate an approximate overall deprivation score for each individual patient according to 
their small area of residence (Sumner, Grace and Doherty, 2016).  A detailed explanation of 
the investigated factors and their subcategories can be found in (Appendix 9.6). 
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6.3.1.2 Statistical analysis 
To begin this process, descriptive statistics were generated for a set of variables to compare 
differences in baseline characteristics between completers and dropouts. Independent sample 
t-tests were computed for continuous variables and chi-square tests for categorical variables. 
A p value <0.05 was considered statistically significant. Under the assumption that missing 
values are missing at random, all variables with > 5% missingness were handled by multiple 
imputation using 20 imputed data sets. The resulting estimates were pooled using Rubin’s 
rule. 
As the primary dependent variable is binary (completed/dropout), a binary logistic 
regression model was developed to predict the probability of CR adherence and to examine 
the association among the research variables. A backward selection technique was followed 
in which all variables were entered simultaneously in the model and variables with p-value > 
0.05 were removed. This process was repeated until all variables had p0.05. Since age and 
gender were reported in the literature as  major determinants of CR accessibility and 
outcomes, (Thomas et al., 2014; Al Quait and Doherty, 2016) age and gender-specific 
interaction was tested by inserting a 2-way age and gender interaction term in the model as a 
separate variable.  
Due to the nested nature of the primary dataset, patients are clustered within CR centres. 
This meant that it was not possible to assume the independency of observations within 
groups i.e. residuals might be correlated within but not across groups. To account for this 
issue, the cluster-robust sandwich estimator was used (Rogers, 1993; Williams, 2000). To 
validate the model’s predictive power, a receiver operating characteristic (ROC) curve was 
plotted and model accuracy was measured by the area under the ROC curve (AUC) (Hajian-
Tilaki, 2013). Data management, descriptive statistics and multiple imputation was 
performed using SPSS software (version 24) while the logistic regression model and 
diagnostics were conducted using STATA SE (version 15). 
 Prospective approach 
Our survey sought to clarify variation in the mode of delivery as part of routine outpatient 
clinical practice, at a programme level, and use this to complement the main study (Berkwits 
and Inui, 1998; Morgan, 1998). This was the first time NACR survey questions designed to 
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capture the diversity of the mode of delivery in routine CR were developed in partnership 
with the NACR team and clinical lead. This was sent out to all 296 CR users currently on the 
CR registry as of August, 2017. Although all survey responses were used to help the NACR 
build programme level data when evaluating the impact of variations in the mode of CR 
delivery on adherence rates, only survey responses being linked with the NACR patient level 
data will be analysed. A Pearson correlation analysis was conducted in order to assess the 
association between mode of CR delivery and adherence rate. The example of the survey is 
shown in (Appendix 9.7). 
6.3.2.1 Population  
The survey was sent to primary contacts at CR programmes that consisted of 296 recipients. 
The primary contacts were assigned as each programme registered with the NACR and were 
entered onto the online registry. In the cases where the CR team enter NACR data these have 
also been approved by the Caldicott guardian at the local trust. 
6.3.2.2 Questionnaire 
The survey was completed as an online questionnaire through Survey Monkey 
(https://www.surveymonkey.co.uk/). The survey asked programmes whether their mode of 
CR delivery consisted of group-based or mixture of group and home-based, once the 
programme stated their mode of delivery a series of questions specific to their response was 
asked. These included type of home-based, supervision level with a final question, where 
relevant, on the reasons for not offering a particular mode such as home-based. 
6.4 Results 
The first set of analyses examined the determinants of CR adherence. Table 6.2 compares 
the baseline characteristics of completers and dropouts. A total of 28,263 patients clustered 
in 141 CR programmes across England (63.6 ±11.4 years, 76% men and 84.5% Whites) 
were analysed. 
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Table 6.2 Baseline characteristics of both groups. 
Factor Completed Dropouts 
Sample size 22,173 (78.5%) 6,090 (21.5%) 
Mean age (SD) 64.03 (11.1) 61.99 (12.4) 
% Female 23.4% 26.3% 
Ethnicity (White) 85.3% 81.5% 
Employed 25.5% 23.2% 
IMD score (5)19 25.5% 16.7% 
Comorbidities (+3) 29.0% 33.3% 
Physical inactivity20 29.3% 22.7% 
Smokers 7.1% 14.6% 
Waiting time21 42.3 41.9 
 
 Adherence determinants 
Out of the 28 determinants tested in the first logistic regression model, 15 turned out to be 
not statistically significant including the age by sex interaction term (p > 0.05) (Table 6.3). 
This first model was statistically significant with χ² (27.44) = 3829876.4, p < 0.001. 
  
                                                     
19 Ratio of least deprived patients in the cohort. 
20 Ratio of patients taking moderate physical activity for 150 minutes per week at baseline assessment. 
21 Mean waiting time from index event to starting CR in days. 
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Table 6.3 First model with all independent variables inserted. 
Variable Odds Ratio [95% CI] P value 
Age (years) 1.011 1.005 1.017 0.000 
Sex (male) 1.279 0.853 1.916 0.233 
Age by Sex interaction 0.995 0.989 1.001 0.132 
Ethnicity (White) 
    
Black 0.909 0.581 1.422 0.676 
South Asian 0.840 0.685 1.030 0.094 
Other 0.803 0.698 0.924 0.002 
IMD (1 most deprived) 
    
2 1.316 1.143 1.516 0.000 
3 1.407 1.181 1.676 0.000 
4 1.526 1.278 1.823 0.000 
5 1.917 1.594 2.304 0.000 
Marital (single) 
    
Partnered 1.093 0.949 1.260 0.217 
Previous partnership 0.891 0.758 1.047 0.162 
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Social support (y/n) 1.153 1.038 1.281 0.008 
Employment (employed) 
    
Unemployed 0.823 0.724 0.937 0.003 
Retired 0.955 0.864 1.057 0.373 
BMI 0.842 0.781 0.907 0.000 
Physical inactivity (150 min/week) 
(y/n) 
1.210 1.100 1.331 0.000 
Physical fitness (self-reported) 
(y/n) 
1.114 1.008 1.231 0.035 
Smoking (y/n) 0.496 0.446 0.552 0.000 
Alcohol intake (y/n) 1.037 0.929 1.158 0.514 
Angina (y/n) 0.973 0.841 1.126 0.717 
Diabetes (y/n) 0.892 0.808 0.984 0.022 
Hypertension (y/n) 1.072 0.972 1.183 0.165 
Anxiety (y/n) 1.074 0.919 1.255 0.368 
Depression (y/n) 0.711 0.607 0.834 0.000 
Family History (y/n) 0.952 0.834 1.087 0.467 
Hyperlipidaemia (y/n) 1.003 0.880 1.145 0.959 
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Comorbidities number 
    
 ≤ 2 1.110 0.847 1.454 0.451 
 > 3 0.973 0.729 1.299 0.852 
Previous cardiac Event (y/n) 0.866 0.761 0.987 0.031 
PCI Type 
    
MI PCI 0.920 0.832 1.018 0.105 
Elective PCI 0.961 0.853 1.083 0.517 
CR dose (sessions/weeks) 1.552 1.255 1.919 0.000 
Group CR delivery (alone) 1.167 0.979 1.390 0.084 
Supervised CR delivery 
(unsupervised) 
0.868 0.644 1.171 0.355 
Time from event to Core CR 
(days) 
0.999 0.995 1.003 0.652 
BACPR Certified Centre (y/n) 0.946 0.701 1.276 0.716 
Multidisciplinary team centre 
(y/n) 
1.180 0.840 1.659 0.340 
After removing the 15 variables with p > 0.05 the test was run again and only 1 variable 
turned out to be not statistically significant, previous cardiac event (p = 0.071) (Table 6.4). 
This second model was also statistically significant with χ² (33.38) = 1913544.8, p < 0.001.  
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Table 6.4 Second model with all significant variables in the first model. 
Variable Odds Ratio [95% CI] P value 
Age (years) 1.009 1.003 1.014 0.002 
Ethnicity (White) 
    
Black 0.946 0.606 1.476 0.805 
South Asian 0.866 0.698 1.074 0.189 
Other 0.826 0.722 0.945 0.005 
IMD (1 most deprived) 
    
2 1.329 1.139 1.551 0.000 
3 1.428 1.176 1.734 0.000 
4 1.552 1.271 1.895 0.000 
5 1.962 1.582 2.432 0.000 
Social support 1.187 1.073 1.312 0.001 
Employment (employed) 
    
Unemployed 0.818 0.718 0.933 0.003 
Retired 0.943 0.853 1.044 0.259 
BMI (y/n) 0.841 0.780 0.906 0.000 
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Physical inactivity (150 
min/week) 
1.218 1.108 1.339 0.000 
Physical fitness (self-reported) 
(y/n) 
1.124 1.014 1.246 0.026 
Smoking (y/n) 0.486 0.437 0.540 0.000 
Diabetes (y/n) 0.888 0.800 0.986 0.026 
Depression (y/n) 0.699 0.586 0.832 0.000 
Previous cardiac event (y/n) 0.867 0.743 1.012 0.071 
CR dose (Sessions/weeks) 1.561 1.261 1.933 0.000 
After removing the previous cardiac event variable the test was run again and all remaining 
12 variables were significant (Table 6.5). This final model was statistically significant, χ² 
(34.23) = 1811961.6, p < 0.001. 
Table 6.5 Significant determinants in the final CR adherence model. 
Variable Odds Ratio [95% CI] P value 
Age (years) 1.008 1.003 1.014 0.004 
Ethnicity (White) 
    
Black 0.939 0.606 1.454 0.777 
South Asian 0.857 0.694 1.059 0.154 
Other 0.825 0.722 0.943 0.005 
IMD (1 most deprived) 
    
152 
2 1.330 1.140 1.551 0.000 
3 1.433 1.182 1.738 0.000 
4 1.555 1.275 1.896 0.000 
5 1.968 1.590 2.436 0.000 
Social support 1.191 1.076 1.317 0.001 
Employment (employed) 
    
Unemployed 0.818 0.717 0.934 0.003 
Retired 0.940 0.849 1.040 0.230 
BMI > 30 (y/n) 0.839 0.779 0.903 0.000 
Physical inactivity (150 
min/week) (y/n) 
1.217 1.107 1.338 0.000 
Physical fitness (self-
reported) (y/n) 
1.126 1.016 1.248 0.024 
Smoking (y/n) 0.487 0.438 0.541 0.000 
Diabetes (y/n) 0.870 0.775 0.976 0.017 
Depression (y/n) 0.687 0.573 0.824 0.000 
CR dose (Sessions/weeks) 1.566 1.265 1.938 0.000 
 
The model had a pseudo R2 over imputed data equal to 0.046. The ROC curve test indicates 
that the model has a good predictive ability with AUC of 0.65 (Figure 6.2). 
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Figure 6.2 ROC for the third model.  
 Survey results 
The total number of CR programmes delivering core CR in the UK is 301 while the total 
number of programmes entering data electronically in the NACR portal is 224 (74%) 
(NACR 2017). The questionnaire was sent to 296 programmes and a total of 167 
programmes (56.4%) responded, 118 programmes (70.7%) are NACR users and 49 
programmes (29.3%) are not. Figure 6.2 provides a flow diagram of the response rate for CR 
teams, these are split into NACR users and non NACR users. This is due to the survey 
responses being linked with routine patient level data to provide an extra level of analysis for 
adherence to CR. 
 
Figure 6.3 Survey respondents flow chart. 
154 
Out of the 167 respondent programmes, 104 (62.3%) programmes were  delivering CR in 
both settings and 61 (36.5%) programmes delivered CR in group-based setting only while 1 
(0.6%) programme were delivering CR as home-based only and 1 (0.6%) programme 
delivering acute hospital ward CR only. The responses to the other survey questions is 
displayed in (Table 6.6). Finally, the Pearson Chi-square test revealed no significant 
association between mode of CR delivery and adherence rate (p = 0.53, OR: 0.93, 95% CI: 
0.87 to 1.01). 
Table 6.6 Responses to survey questions. 
Mode of 
Delivery 
Mode specific questions 
Responses 
 
Count % 
Programmes 
delivering 
CR as home- 
& group-
based 
(104 
responses) 
Home Question 1, do you deliver Heart 
Manual? 
No 67 64.4% 
Yes 37 35.6% 
Home Question 1, do you deliver Angina Plan? 
No 96 92.3% 
Yes 8 7.7% 
Home Question 1, delivered as Individual 
Patient Programme Supervised? 
No 52 50% 
Yes 52 50% 
Home Question 1, do you deliver Individual 
Patient Programme Not Supervised? 
No 43 41.3% 
Yes 61 58.7% 
Home Question 1, do you deliver Individual 
Other (such as home visits, face to face)? 
No 104 100% 
Yes 0 0% 
Programmes 
delivering 
CR as group 
based only 
(61 
responses) 
Group Question 1, why don't you deliver Home 
based no Funding? 
No 14 22.9% 
Yes 47 77.1% 
Group Question 1, why don't you deliver Home 
based provided elsewhere? 
No 56 91.8% 
Yes 5 8.2% 
Group Question 1, why don't you deliver Home 
based no staff? 
No 41 67.2% 
Yes 20 32.8% 
Group Question 1, why don't you deliver Home 
based no demand? 
No 57 93.4% 
Yes 4 6.6% 
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6.5 Discussion 
The present study was designed to investigate the factors influencing CR adherence, 
including mode of CR delivery, in the PCI cohort. A mixed prospective retrospective 
methodological approach was adopted to better serve the goals of the study. The 
retrospective cohort consisted of 28,263 patients with a mean age of 63.6 years (±11.4). 
Within the cohort, 24% were women and 15.5% from minor ethnic groups. The investigated 
cohort were nested in 141 CR centres across the UK and 78.5% managed to complete the 
core CR programme. 
With respect to the first objective of the study, our routine clinical data have shown that 
younger age is associated with higher dropout rates (odds ratio (OR) 1.008, 95% CI 1.003 to 
1.014) confirming similar findings in previous cohort studies (Casey et al., 2008; Yohannes 
AM, Yalfani A, Doherty P, 2007; Sarrafzadegan et al., 2007; Harrison and Wardle, 2005; 
Turk-Adawi et al., 2013). This study has been unable to demonstrate that gender is a 
predictor of CR completion. This outcome is contrary to a previous UK study which 
conducted a multivariate analysis in a smaller cohort (n = 203) recruited from a university 
teaching hospital (Yohannes AM, Yalfani A, Doherty P, 2007). Also another middle-eastern 
study found that the odds of female participants to dropout early is 1.82 compared to male 
participants (Sarrafzadegan et al., 2007). However, in a logistic regression analysis 
controlling for age, BMI, employment status and depression (Casey et al. 2008) concluded 
that gender is not a predictor of CR completion (OR: 1.34, 95% CI: 0.86 to 2.06). The 
possible interference of interaction between age and gender was also tested in this study and 
found to be not significant. 
In contrast to earlier finding by a previous UK study (Banerjee, Gupta and Singh, 2007) 
which revealed that South Asians are less likely than Whites to adhere to CR, this study 
found that South Asians and Black patients are not statistically different than Whites in CR 
adherence rates. However, participants from other ethnic minorities were found to be 17% 
less likely to adhere to CR compared with Whites (OR: 0.825, 95% CI: 0.722 to 0.943). This 
result seems to be in part consistent with an American study which found that Non-whites 
were less likely to adhere to CR than Whites (OR: 0.60, 95% CI: 0.41 to 0.88)(Turk-Adawi 
et al., 2013). 
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The most obvious finding to emerge from patient’s demographic determinants is the 
significant correlation between the index of social deprivation as measured by IMD and CR 
adherence. The current results show that low CR adherence is associated with the most 
deprived and increases in the least deprived patients. These results builds on those of a 
Candian retrospective study (N = 18,980) which also found that CR completion rates in a 
mixed CABG/PCI population are significantly higher in high-income neighbourhoods 
compared with low-income neighbourhoods (Lemstra et al., 2013). Participant’s marital 
status in this study had no significant influence on adherence rates which is in accordance 
with Sarrafzadegan et al. (2007) study (Sarrafzadegan et al., 2007). Nevertheless, those 
patients who reported having ‘enough social support if they needed and wanted it’ were 
found to be more likely to adhere to CR than their counterparts (OR: 1.191, 95% CI: 1.076 
to 1.317). 
Our results display lower adherence rates in unemployed participants compared to those 
employed or retired (OR: 0.818, 95% CI: 0.717 to 0.934). This finding is partially in line 
with an older prospective smaller size Australian study (N = 652) which found that retired 
and unemployed MI patients are more likely to drop out early than employed participants 
(OR: 1.83 and 4.69) respectively (Worcester et al., 2004). This is in contrast of the findings 
of a prospective Iranian study which reported that the number of CR sessions in which the 
subjects attended did not differ according to job category (Sarrafzadegan et al., 2007). 
Among studies investigating CR adherence, diabetes mellitus as an adherence determinant is 
also one of the most reported cardiac risk factor. Our findings show that diabetic patients are 
13% less likely to complete the CR programme compared to non-diabetic patients (OR: 
0.870, 95% CI: 0.775 to 0.976). Two previous multivariate studies reporting diabetes were 
controversial. While an American retrospective secondary analysis study observed higher 
adherence rates in patients with diabetes than non-diabetics (OR: 1.3, 95% CI: 1.13 to 1.49) 
(Turk-Adawi et al., 2013), a primary prospective Australian study reported that male 
diabetic patients have higher dropout rates (OR: 3.38, 95% CI: 1.43 to 7.97) (Worcester et 
al., 2004). In the same vein but with a less robust method, Armstrong et al. (2014) reported 
that 84.9% of non-diabetic patients versus 79.6% of diabetic patients completed the 12-
weekk CR programme (p < 0.001). 
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The impact of obesity, either reported as a BMI or waist size measurement, on CR adherence 
has been reported in previous studies. Our results show that patients with BMI > 30 are less 
likely to complete CR compared to those < 30 (OR: 0.839, 95% CI: 0.779 to 0.903). This 
builds on the findings of Sarrafzadegan et al. (2007) who reported that patients with BMI > 
30 were significantly more likely to dropout (OR: 0.95, 95% CI: 0.92 to 0.98) 
(Sarrafzadegan et al., 2007). This result differs from an American retrospective secondary 
analysis study that found no significant association between BMI or body weight and CR 
completion(Casey et al., 2008). Two other studies that investigated BMI in women and older 
patients (> 65 years) reached the same conclusion. 
The impact of physical inactivity as a cardiac risk factor on CR adherence has been 
investigated in this study and found to be significant. Those patients performing ≥150 
minutes of moderate exercise per week were found to be 22% more likely to complete the 
core CR programme (OR: 1.217, 95% CI: 1.107 to 1.338). This finding is similar to that 
reported in a previous prospective Australian study which found that women who exercise < 
6 hours/week are 2.29 more likely to drop out than women exercising ≥ 6 hours/week (OR: 
2.29, 95% CI: 0.58 to 9.03) and women who never exercise are 7.32 more likely to drop out 
(OR: 7.32, 95% CI: 1.32 to 41.21) (Worcester et al., 2004). The last significant factor in the 
cardiac risk factor group is depression. I found that patients with the comorbidity of 
depression are less likely to complete CR (OR: 0.687, 95% CI: 0.573 to 0.824). This finding 
is supported by Casey et al. (2008) who reported that participants who had higher levels of 
depressive symptoms were less likely to complete CR (OR: 0.96, 95% CI: 0.93 to 0.99) 
(Casey et al., 2008). 
Another important finding was that smokers were less likely to adhere to CR than non-
smokers (OR: 0.487, 95% CI: 0.438 to 0.541). This result reflects those of Worcester et al. 
(2004) and Sarrafzadegan et al. (2007) who also found that former smokers and current 
smokers are more likely to drop out from CR than those who never smoked (Worcester et 
al., 2004; Sarrafzadegan et al., 2007). Also Doll et al. (2015) who investigated CR adherence 
among older patients (> 65) reported that current and recent smokers are attending less 
number of CR sessions than non-smokers (Doll et al., 2015). However, three other studies 
revealed no significant association between CR adherence and smoking status (Beckie et al., 
2015; Yohannes AM, Yalfani A, Doherty P, 2007; Turk-Adawi et al., 2013). 
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One of our most telling findings is that CR adherence rate increases as the number of 
sessions per week increases (CR dose). I found that patients who were attending more CR 
sessions per week are more likely to stay in the programme. The adherence rate increases 
57% for each extra session attended per week (OR: 1.566, 95% CI: 1.265 to 1.938). Our 
analysis also revealed that those patients who were able to perform at least 2 minutes of 
moderate to very heavy physical activity are 13% more likely to complete a CR programme 
than their counterparts (OR: 1.126, 95% CI: 1.107 to 1.338). 
An important concept that emerged from our multivariate analysis was that there is no 
significant association between adherence rate and how CR was delivered. This study is the 
first to have created two binary patient level variable that measures if CR was delivered in 
group-based or individual-based and a second binary variable measuring if CR was 
delivered under supervision of CR team or it was self-delivered. Although both variables 
were significant (p < 0.05) at the univariate level, this association failed to hold at the final 
multivariate analysis. This finding is contrary to the limited evidence found by a recent 
Cochrane systematic review of a small increase in the level of completion with home-based 
compared with centre-based programmes (Anderson et al., 2017b). This discrepancy in 
findings could be attributed to differences in population characteristics between routine 
clinical studies and randomised control trials. For example, the population mean age in this 
study is 63.6 years with 24% women while the Cochrane review had a younger mean age of 
56 years with only 19% women. 
With regard to survey results, the overall response to the survey was good (56.4%). This 
high response rate, 169 programme out of 301, enables us to confidently describe how CR is 
delivered across the UK. From this data, 62.3% of programmes are capable of delivering CR 
in both settings (group-based and home based) while 36.5% deliver CR as group-based only. 
Lack of funding and appropriate staff were the main two reasons for not being able to offer 
home-based CR as reported by the surveyed programmes. While half of the programmes 
delivering CR as home based deliver it without any form of supervision (Table 4). What 
stands out when merging survey results with patients’ data is that adherence rates are not 
influenced by the mode of CR delivery. These results draw our attention to the importance 
of considering expanding the utilisation of home-based CR. 
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6.6 Study limitations 
Since the primary investigated dataset is setup to evaluate final outcomes but not CR 
adherence, there is uncertainty whether some other factors influencing CR adherence have 
been missed. For instance, other factors that has been reported to influence CR adherence 
rates such as rural residency and education level were not included in the analysis. 
Furthermore, it has been previously reported that adherence rates in programme delivered by 
a multidisciplinary team are higher than other programmes (Turk-Adawi et al., 2013), 
however, the amount of time contributed from each discipline in the programme was not 
included in this analysis. Also the sample size in the adherence study was the smallest of all 
three retrospective NACR based studies, which means that the population that complete may 
not be representative of all CR patients. For example, baseline analysis found that the 
percentage of single patients in the adherence group is only 8.2% of the total marital status 
cohort compared to 23.3% in the engagement group and 8.9% in the uptake group (Table 
7.2). 
6.7 Conclusion 
This is the first comprehensive study to investigate CR adherence rates in the growing PCI 
population. The key strengths of this study are the mixed prospective retrospective 
methodology approach adopted and the relatively large sample size obtained from a routine 
clinical dataset. The findings from this study make several contributions to the current 
literature. First, our multivariate analyses revealed that current CR programmes are not 
attractive to smokers, unemployed and socially deprived patients. The second major finding 
was that adherence rates between group-based and home-based programmes are similar 
despite the recent evidence from a Cochrane systematic review. This was confirmed by our 
survey results which found no significant adherence rate differences between programmes 
delivering CR as group-based only and those delivering CR in both settings. 
  
160 
7 Synthesis study  
7.1 Introduction 
A patient journey through modern comprehensive CR programme is a multifaceted highly 
variable process. However, CR pathway is made up of key stages that need to occur to 
enable patients to achieve meaningful clinical outcomes and long-term behavioural change. 
These key stages begins with patient presentation following a cardiac event and ends up with 
discharge and transition to long-term management (Figure 1.4) (BACPR, 2017). Such 
planned and structured pathway of care ensures continuity in treatment of heart disease and 
the ability to tailor CR to the individual needs of patients. CR also provide safe and 
predictable methods of disease management which enables a multi-disciplinary team of 
healthcare professionals to provide a unified evidence-based treatment to all patients 
(Giuliano et al., 2017).  
The CR pathway commonly consists of three main phases (inpatient, outpatient and long-
term maintenance) (Piepoli et al., 2016). The outpatient CR, also known as core CR, is a 
cornerstone phase in the delivery of CR to patients whether delivered as hospital based, 
community based or home based. Patients’ participation in outpatient CR is globally 
considered the main determinant of optimal CR utilisation. Extensive research, both 
qualitative and quantitative, have been utilised to understand factors associated with poor 
patients utilisation of outpatient CR (Murray et al., 2012; Clark et al., 2012; Karmali et al., 
2014; Ruano-Ravina et al., 2016). However, as this thesis has shown, research varies in 
terms of design, targeted population and era which might be a significant source of 
heterogeneity when conducting a synthesis of literature. 
Although the previous four chapters in this thesis independently explored the determinants 
of CR engagement, uptake and adherence in the literature and in a routine clinical dataset, 
there is an added benefit to be gained from pulling together data and findings from each of 
those four chapters. This study therefore set out to combine a number of different pieces into 
a whole which should allow for a higher level of evaluation and understanding of the 
findings. It will concisely summarise and link different sources of data in order to enhance 
our understanding of CR low participation rates in the PCI cohort. This study will also 
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challenge our previous theoretical expectations and conventional evidence about barriers in 
CR utilisation and substantiate this approach using routine clinical data. Moreover, it will 
provide a framework that will map an intervention with respect to identified barriers to 
promote CR along the patient journey in the PCI population. 
7.2 Methods 
All studies in this thesis are retrospective observational studies using data retrieved from the 
NACR dataset for the period 1st April 2013 to 31st March 2016. Although NACR collects 
data for three countries (England, Northern Ireland and Wales), only patients in England 
were included in the studies as the IMD is only available for small areas in England. In all 
three themed studies in the thesis plus the systematic review, the researcher attempted to 
keep the investigated factors as consistent as possible to facilitate data synthesis among 
studies (Table 7.1). Nevertheless, evaluating all these variables in all studies was subject to 
their availability in the primary NACR dataset or in the investigated studies included in the 
systematic review. Also service level factors varied among the three studies, particularly in 
the adherence study, to better serve the research outcome in each case. 
This chapter will start by evaluating the number of patients interacting with each key stage 
of CR pathway from the initiation of the cardiac event to completing the outpatient CR 
programme during the study period. This approach will allow us to identify; (1) number of 
eligible patients missing out on this effective treatment at each stage (2) identify which key 
stage has the highest dropout rate. This chapter will also compare differences in baseline 
characteristics across all three groups (engagement, uptake and completion). Since the 
analysis will involve three different groups, analysis of variance test for continuous variables 
and chi-square tests for categorical variables will be used. A p-values < 0.05 will be 
considered statistically significant. 
 
162 
Table 7.1 Unified tested variables in all studies (service level factors from adherence study). 
 Socio-demographic 
factors 
Cardiac risk 
factors 
Life style & 
Health status 
Service level 
factors 
1 Age Hypertension Alcohol intake CR dose 
2 Sex Hyperlipidaemia Smoking Group/alone core 
CR 
3 Ethnicity Diabetes Physical fitness Supervised/self-
delivered 
4 IMD Score Physical activity Comorbidities MDT centre 
5 Marital status Being 
overweight 
Previous cardiac 
event 
BACPR certified 
programme 
6 Social support Anxiety Family history PCI type 
7 Employment Depression Angina Time from event to 
starting CR 
 
Furthermore, this chapter will attempt to analyse individual patterns of change in cohort 
characteristics among those engaged, started and completed CR in a routine clinical dataset. 
These changes will then be compared to the existing scientific evidence derived from 
various study designs (systematic review in chapter 2). 
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7.3 Results  
 Patient flow 
During the study period, a total of 149,597 cardiac events were recorded in the NACR 
dataset (Figure 7.1). Out of this cohort 70,303 (47%) patients underwent a PCI procedure. 
Due to the adoption of automatic referral strategy for all patients groups eligible to CR in 
England, all patients who are likely to benefit from CR were referred (85.1%).  
 
Figure 7.1 Patient flow chart during study period. 
As can be noted, all described stages in this journey -so far- are less influenced by the 
patient’s decision to participate in CR. However, post CR referral stages are strongly 
impacted by informed patient’s decision. For patients agreeing to engage, a baseline CR 
assessment is conducted (assessment 1) (Figure 7.1). Approximately 64% of eligible CR 
patients engaged with CR at this stage. In other words, 21,561 eligible CR patients decided 
not to utilise this treatment at this early stage. Of those engaged in CR, 73.9% started the 
outpatient CR programme while 78.5% of starters completed the programme. 
Based on the data presented in (Figure 7.1), a total of 59,807 PCI patients were eligible to 
receive CR in the specified study period. Despite this, only 22,173 (37.1%) completed the 
programme while 37,634 (62.9%) patients decided not to join CR at different stages. 
Approximately half of those patients (57%) were denied CR participation at the first point of 
contact with outpatient CR (CR engagement).  
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 Baseline characteristics 
In this section, a comparison of differences in baseline characteristics among patients in the 
three studies will be presented. Table 7.2 presents temporal changes in baseline 
characteristics while (Figure 7.2) displays changes of trends in the same context. 
 Table 7.2 Baseline characteristics of all groups. 
Factor Engaged Started Completed p - value 
N 
38,246 (63.9%) 28,263 (73.9%) 22,173 (78.5%) 0.001 
Mean age (SD) 
64.16 (11.7) 63.59 (11.4) 64.03 (11.1) 0.001 
% Female 
24.7% 24% 23.4% 0.001 
% Ethnicity (White) 
85% 84.5% 85.3% 0.001 
% Marital Status 
(single) 
23.3% 8.9% 8.2% 0.001 
% IMD* score (5)22 
25.4% 27% 28.9% 0.001 
% Comorbidities (+3) 
30.1% 44.1% 29.0% 0.001 
% Elective PCI 
procedure 
35 % 34.2% 34.3% 0.001 
 
                                                     
22 Ratio of least deprived patients in the cohort 
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Figure 7.2 Trend changes in baseline characteristics among groups. 
 Determinants synthesis 
The three themed studies in this thesis investigated CR engagement, uptake and completion 
by testing a predefined set of determinants as shown in (Table 7.1). In this section, all 
investigated determinants will be displayed in one table to map the role of each determinant 
in every interaction stage of outpatient CR. In (Table 7.3) there are four columns where the 
first one displays the name of the determinant and the remaining three columns represent 
each interaction stage of outpatient CR. Every cell in this table has two types of data; (1) a 
ratio to show the effect size of that determinant on each stage (2) a small coloured arrow. 
The arrow reflects the role of that determinant in outpatient CR where red colour means it is 
a barrier, green colour indicates it is a facilitator and yellow colour indicates that this 
determinant is not statistically significant at this stage. 
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Table 7.3 Pooled investigated determinants as reported in all three studies. 
Variable Engagement Uptake Adherence 
Older age (years) 1.2% 1.2% 1.1% 
Female gender 7% 58% 
 
Age by gender interaction  1% 
 
Ethnicity (White)   
 
Black     
South Asian  13% 15% 
 
Other  24%  20% 
IMD (1 most deprived)   
 
IMD 2  31% 32% 
IMD 3 19% 44% 41% 
IMD 4 24% 50% 53% 
IMD 5 46% 84% 92% 
Marital (single)   
 
Partnered 22% 15% 
 
Previous partnership 25%   
Social support (yes) -  15% 
Employment (employed)   
 
Unemployed -  18% 
Retired - 13% 
 
BMI > 30 -  16% 
Physical inactivity (150 min/week) 
(yes) 
- 16% 21% 
Physical fitness (self-reported) (yes) -  11% 
Current smoker - 40% 50% 
Increased alcohol intake -   
Angina (yes) 23% 23% 
 
Diabetes (yes) 22% 24% 11% 
Hypertension (yes)  15%  
Anxiety (yes) 44% 24%  
Depression (yes) 56%  29% 
Family History (yes) 9% 22%  
Hyperlipidaemia (yes) 21% 10%  
Comorbidities number   
 
Comorbidities ≤ 2 59%  
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Comorbidities > 3 80% 15% 
 
Variable Engagement Uptake Adherence 
Previous cardiac Event (yes) 25% 23% 
 
PCI Type (Primary)   
 
MI PCI 11% 10%  
Elective PCI 21% 22%  
CR dose (sessions/weeks) - - 55% 
Group CR delivery (alone) - -  
Supervised CR delivery (unsupervised) - -  
Waiting Times between stages - 26%  
BACPR Certified Centre (yes) - -  
Multidisciplinary team centre (yes) - -  
Received confirmed joining date (yes) 444% 214% - 
Patient received early CR (yes) 47% 19% - 
Day Case 26% 21% - 
Venue of source of referral (NHS Trust)    
General Practice 930% 71% - 
BMI/Private Hospital 19%  - 
 
Patient refereed by (consultant) 
   
Cardiac nurse 10% 30% - 
GP  230% - 
Primary care nurse  509% - 
Other  29% - 
Key: (     = barrier,        = facilitator,           = no effect) 
 Pooled determinants merged with evidence 
What follows is an attempt to compare findings derived from clinical data with more 
conventional evidence. This will be achieved by merging (Table 7.3) with (Table 2.7). This 
approach will allow the reader to quickly identify agreements and disagreements between 
the literature and routine clinical data. A note of caution is due here since the table does not 
display the quality nor the strength of the systematic review evidence. For the systematic 
review rows, each cell denotes two types of data; (1) a figure to show the total number of 
studies investigated that determinant (2) a small coloured doughnut chart. The chart reflects 
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the proportion of studies that reported the determinant as a barrier (red colour), facilitator 
(green colour) or not statistically significant (yellow colour). The same colour coding and 
legends described previously are adopted in (Table 7.4). Only variables reported in both 
sources are displayed. 
Table 7.4 Investigated determinants merged with systematic review evidence. 
Variable Source23 Engagement Uptake Adherence 
Older age Audit 1.2% 1.2% 1.1% 
SR 3 29 7 
Female gender Audit 7% 58%  
 
SR 1 14 5 
Ethnic minority Audit 19% 15% 20% 
SR 1 8 3 
Least deprived Audit 46% 84% 92% 
SR - 5 1 
Partnered Audit 22% 15% 
 
SR 3 13 1 
Social support (y/n) Audit -  15% 
SR - 10 - 
Employed Audit - 13% 18% 
SR 1 11 3 
BMI > 30 Audit -  16% 
SR 1 12 1 
Physical inactivity (yes) Audit - 16% 21% 
                                                     
23 Audit = NACR data / SR = systematic review data 
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SR 2 4 1 
Smoking (yes) Audit - 40% 50% 
SR 3 9 6 
Variable Source  Engagement Uptake Adherence 
Angina (yes) Audit 23% 23%  
SR - 4 - 
Diabetes (yes) Audit 22% 24% 11% 
SR 2 13 6 
Hypertension (yes) Audit  15%  
SR - 8 3 
Anxiety (yes) Audit 44% 24%  
SR - 4 2 
Depression (yes) Audit 56%  29% 
SR 1 2 2 
Family history of cardiac 
disease (yes) 
Audit 9% 22%  
SR 1 - 3 
Hyperlipidaemia (yes) Audit 21% 10%  
SR 1 9 3 
Increased number of 
comorbidities 
Audit 80% 15%  
SR 1 3 1 
Previous cardiac Event (yes) Audit 25% 23%  
SR - 13 1 
Elective PCI (yes) Audit 21% 22%  
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SR - 1 - 
Multidisciplinary team 
centre (yes) 
Audit - -  
SR - - 1 
Variable Source  Engagement Uptake Adherence 
Received confirmed joining 
date (yes) 
Audit 444% 214% - 
SR - 2 - 
Patient received early CR 
(yes) 
Audit 47% 19% - 
SR - 1 - 
Day case PCI (yes) Audit 26% 21% - 
SR - 3 - 
BMI/Private Hospital Audit 19%  - 
SR - 1 - 
Key:     = barrier,       = facilitator,           = no effect,   
Systematic review (SR) findings:        = proportion of studies in each category 
7.4 Discussion 
This is the first study to investigate the three key interaction stages (engagement, uptake and 
completion) in outpatient CR for the PCI population. It is also the first study to synthesise 
evidence from routine clinical data to what is known in the literature. 
 Patient Flow  
This study utilised a patient flow perspective summarised in Figure 7.1 which clearly 
indicates that the majority of patients decided not initiate CR in an earlier stage 
(engagement). Our analysis, of the earlier parts of the patient journey, differs substantially 
from previous studies, which have largely investigated in CR uptake (Karmali et al., 2014; 
Ruano-Ravina et al., 2016). This finding reflects the importance of the CR engagement 
study conducted in this thesis as being the first from a nationally representative cohort of 
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PCI patients providing new insights into the factors that lead patients to attend their CR 
initial baseline assessment. 
 Baseline characteristics 
The second result presented in this study is changes in baseline characteristics among key 
stages in outpatient CR (Table 7.2) and (Figure 7.2). With regards to ratios of those who 
interact with each stage we can see an upward trend as the ratio of engagers (63.9%) is lower 
than starters (73.9%) and completers (78.5%). A possible explanation for this phenomena is 
that those who overcome the barriers in engagement are more likely to continue until the end 
of the outpatient programme especially as some of those barriers are common among all 
stages. With regards to age, we see that the mean age of starters is significantly less than the 
mean age of engagers and completers (p < 0.001) while there is no significant statistical 
difference between engagers and completers (p = 0.179). A downward trend in the ratio of 
females progressing through the three stages can be easily spotted (24.7% to 24% to 23.4%) 
(p < 0.001). 
As far as ethnicity is concerned, Whites are less likely to start CR compared with those 
engaging or completing CR. Although this difference is statistically significant (p < 0.001), 
it might be related to the large sample size (large degrees of freedom). The ratio of single 
patients engaging in CR (23.3%) is relatively higher than singles starting or completing the 
programme (8.9% and 8.2%) respectively. This may be because couples facilitate attendance 
by providing social support, transportation to CR centres or communication with health 
professionals (Clark et al., 2012; Al Quait et al., 2017).  
In general, CR utilisation seems to be significantly correlated with the index of social 
deprivation. An upward trend can be drawn as the proportion of least deprived patients 
steadily increases with each stage of outpatient CR (25.4%, 27% and 28.9%) respectively. 
The proportion of patients with 3 or more comorbidities is higher in the starting group 
(44.1%) compared with those engaged (30.1%) and those completing the programme (29%) 
(p < 0.001). The final reported factor in this analysis is the proportion of elective PCI 
procedures. The analysis shows that the proportion of patients entering each three elements 
of the patient journey were very similar at 35%, 34.2% and 34.3% for engagement uptake 
and completing CR respectively. Although this factor is statistically significant in favour of 
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more elective PCI patients engaging in CR, than the other stages, this level of difference 
(<1%) is not of clinical importance due to the small generated effect size. 
 Determinants synthesis 
This topic is best discussed in groups according to the classification reported in Table 7.1 - 
Socio-demographic, cardiac risk factors, Life style & Health status and Service level factors. 
In addition, it is appropriate, for the sake of clarity, that (Table 7.3) and (Table 7.4) are 
discussed together in this section. 
7.4.3.1 Socio-demographic factors 
The study findings shows that older age is associated with decreased CR engagement and 
uptake. However, this is not the case in CR adherence as older patients are more likely to 
complete the programme than younger patients. Although our results are in line with the 
investigated studies in the systematic review this is the first time this has been established in 
the PCI population using routine clinical data.  
The role of participants’ gender on the three stages of CR utilisation was found to be 
inconsistent. With respect to engagement, women are 7% less likely to engage in CR than 
men. This finding is supported by the only study reporting on this factor which was also a 
secondary retrospective analysis study (Smith, Harkness and Arthur, 2006). As far as uptake 
is concerned, the data shows an unexpected finding by stating that women are 57% more 
likely to start CR than men which is contrary to most of the previous studies in the literature 
investigating determinants of uptake. This rather contradictory finding may be explained by 
the fact that this is the first study to test for the impact of age-gender interaction on uptake in 
the PCI population. With regards to CR adherence, the analysis revealed that gender is not a 
significant determinant. This finding is in contrast to four studies in the systematic review 
and in line with one retrospective secondary analysis study (Casey et al., 2008). The 
discrepancies between routine clinical data and systematic review data with regards to 
gender might be attributed to the smaller number of females in studies used in systematic 
reviews of CR. This is because data provides a large enough sample of patients (including 
minorities) to be investigated and followed for longer periods which is a major limitation in 
most of the literature. 
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Patients from ethnic minorities are less likely to utilise CR as per the data. This finding is 
partially supported by the systematic review results (Banerjee, Gupta and Singh, 2007; 
Parashar et al., 2012; Reges et al., 2013a; Turk-Adawi et al., 2013). The same can also be 
said about social deprivation where the least deprived patients are more likely to utilise CR 
in both data sources. Being in relationship also promotes CR engagement and uptake as 
reported from the data. However this determinant was found to be not significant with 
regards to CR adherence. Social support can enhance CR adherence but not CR uptake as 
found in the audit data while being employed in full or part time will enhance uptake but 
decrease adherence rates by 18%. Nevertheless, most studies in the systematic review report 
social support and employment as not significant determinants (Missik, 1999; Parashar et al., 
2012). 
7.4.3.2 Cardiac risk factors 
The analysis found that obesity (measured by BMI > 30) is a barrier against CR adherence. 
However this association is not significant in CR uptake. With regards to engagement, this 
measure is not reported in the audit data at this early stage as patients have not carried out an 
assessment. The only study investigating this at this stage was in a systematic review and it 
found risk factors not to be significant determinants of engagement. Subjects reporting they 
are physically active are more likely to uptake and complete CR as per the audit data. This 
finding is supported by three studies in the systematic review. Again this determinant is not 
reported in the clinical data with regards to engagement and the only study investigating it in 
a systematic review was not significant. 
The data further supports the idea that current CR programmes are not attractive to smokers 
and diabetic patients, or that the health service fails to capture these patient groups 
sufficiently. Hypertensive patients were more likely to uptake CR by 15% although this 
association was found not significant in the other two stages. This finding is not supported 
by the systematic review data as four studies found hypertension a barrier against CR uptake 
and another four found it not significant. Hyperlipidaemia was a barrier against CR 
engagement (21%) a facilitator in CR uptake (10%) and not significant in CR adherence.  
Subjects with a family history of cardiac disease were slightly more likely to engage in CR 
by 9% and more likely to uptake CR by 22%. This association was not significant in CR 
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adherence which are in agreement with three studies from the systematic review. Anxious 
patients engage and take up CR more than non-anxious patients as revealed by the data 
analysis. With regards to CR adherence, this association was not significant despite anxiety 
being reported as a barrier against CR adherence in two studies in the systematic review. 
The association between depression and CR utilisation stages was not consistent as 
depressed patients are more likely to engage (56%), less likely to complete (29%) and not 
significantly associated with uptake. The latter result contradicts with the two studies from 
the systematic review which classified depression as a barrier against CR uptake. 
7.4.3.3  Life style & Health status factors 
Patients suffering from angina pectoris are 23% more likely to engage in CR but also 23% 
less likely to start it as the data display. With respect to adherence, the association was found 
to be not significant. However, the feeling of cardiac symptoms like angina or chest pain 
was not associated with CR uptake as reported in three studies included in the systematic 
review. While one Danish retrospective study (N = 206) found that chest pain is a positive 
predictor of CR uptake. Patients with an experience of a previous cardiac event were less 
likely to utilise CR in engagement and uptake but not adherence. This finding is partially 
consistent with other research investigating CR uptake. 
Another important indicator of patient’s wellbeing is the increased number of comorbidities 
(≥ 3). This determinant was not found to be in itself a barrier to CR engagement. This 
finding is supported by the only study (N = 1268) reporting on this determinant in the 
systematic review which found it also not significant. With regards to uptake, increased 
number of comorbidities was reported as a barrier in the clinical practice data. This is in line 
with an Australian retrospective analysis study which found that patients with two or more 
comorbidities are less likely to start CR. Nevertheless, there was no significant association 
between CR adherence and increased number of comorbidities in clinical and systematic 
review data. 
7.4.3.4  Service level factors 
Patients who underwent an elective PCI procedure were more likely to engage in CR by 
21% and less likely to take up CR by 22%. Only one large secondary retrospective analysis 
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study (N = 35,752) reported on this determinant and supported the clinical data results with 
regard to CR uptake. Surprisingly, patients who took part in early phase 1 CR sessions 
(either inpatient or home-based programmes) were less likely to engage in CR (47%) and 
also less likely to start it (19%). The systematic review data on this determinant comes only 
from one small (N = 179) primary prospective study which concluded that early CR is a 
barrier against CR uptake. In the same context, patients who underwent a day case procedure 
were 26% less likely to engage in CR but 21% more likely to uptake it. Three studies from 
the systematic review found this association not significant in CR uptake while only one 
American secondary retrospective analysis study was in agreement with the audit finding. 
One of the most telling findings to emerge from (Table 7.4) is that patients who were given a 
firm date to engage or start CR were much more likely to utilise CR (444% and 214%) 
respectively. Only two studies from the systematic review investigated the impact of this 
determinant on CR uptake. A UK secondary retrospective study (N = 508) concluded that 
patients not receiving a confirmed joining CR appointment were found to be less likely to 
start CR than those who were given an appointment (OR: 0.31) (Melville et al., 1999). Also 
an Israeli primary prospective study (N = 420) reported that patients who received a letter to 
start CR were more likely to join than those who didn’t (OR: 2.79) (Reges et al., 2013b). 
Type of hospital where the patient was referred from has been labelled as a significant 
determinant in CR engagement. Clinical audit data results show that patients who were 
referred from a private/BMI hospital are 19% less likely to engage in CR compared to 
patients referred from a NHS trust. However, this determinant was found not significant in 
CR uptake although an Australian retrospective secondary analysis reported that patients 
admitted to private hospitals are 32% more likely to start CR than those admitted to teaching 
hospitals (Sundararajan et al., 2004). The routine clinical audit data has been unable to 
demonstrate that delivering CR by a multidisciplinary team can improve CR adherence. This 
finding is contrary to an American secondary retrospective analysis (N =4,412) which 
concluded programmes delivering CR by a multidisciplinary team have higher rates of 
adherence (Turk-Adawi et al., 2013). It is difficult to explain this discrepancy in findings 
between the two studies especially both has similar study design (secondary retrospective 
analysis) and statistical techniques (clustered regression). However, the American study 
used forward stepwise regression while the thesis study used backward stepwise regression. 
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Forward stepwise regression is normally used when multicollinearity is a problem which 
was not the case in the thesis study (Jennvich, 1977). Another possible explanation for this 
inconsistency in findings is the way CR adherence is defined between the two studies. While 
the outcome variable in the American study is defined as attending at least 21 exercise 
sessions, a patient is considered a completer in the NACR data if he or she satisfies two 
conditions: first, performed a CR assessment at the end of the outpatient programme. 
Second, marked as a completer by a CR programme staff member. Noting that the median 
national number of CR sessions attended in 2016 in the UK was 18 sessions (NACR, 2016). 
7.5 Limitations 
Due to the fact that CR and the way it is developed vary a lot between countries and between 
centres, there are some discrepancies between factors reported in the audit data and what is 
concluded from the systematic review. Also there is a considerable heterogeneity between 
similar factors reported in both data sources. It could be argued that the external validity of 
studies based on national audits might be limited to that country. 
7.6 Conclusion from the synthesis study 
This is the first synthesis study to investigate CR utilisation at the three key interaction 
stages in outpatient CR from a nationally representative cohort of PCI patients. This 
synthesis has also the added benefit of comparing this synthesised evidence to a systematic 
review results. The findings from this study make several contributions to the current 
literature. First, this chapter has demonstrated that decisions about determinants of CR 
utilisation should take account of all relevant study designs (e.g. trial and retrospective 
observational studies) that capture the complexity of the cardiology patient journey. Another 
telling finding to emerge from this study is that CR engagement is the stage where most 
patients fail to achieve. Also this study reveals that current CR programmes are not attractive 
to those from most deprived areas, diabetics and smokers. The research has also shown that 
CR utilisation is not a single patient decision but is also related to service level factors, over 
which healthcare systems have more direct control.  
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8 Conclusion of the thesis 
8.1 Summary 
Despite its well established evidence, CR remains underutilised in many healthcare systems. 
Also previous research has shown major inequities in CR access for certain patient groups 
such as the elderly and socially deprived patients. Furthermore, it has previously been 
observed that CR utilisation rates are lower than expected in patients undergoing PCI 
procedures in most European countries. These findings question the extent of 
implementation of national, European and world guidelines which suggest that CR should be 
equally accessible and relevant to all patient groups after an MI event (Graham et al., 2007; 
Balady et al., 2011; NICE, 2015). 
There were two primary aims of this PhD thesis: first, to systematically review the available 
literature around the determinants of optimal CR utilisation in the eligible PCI population. 
Second, this thesis aimed to assess the extent to which those determinants identified in the 
literature are applicable to the CR population in England by conducting a retrospective 
secondary analysis of the NACR dataset. In general, the objective of this thesis was to 
contribute to the growing area of CR research by exploring those determinants in the PCI 
population and validating them against routinely collected clinical data. 
8.2 Key findings 
This is the first detailed research to investigate CR utilisation at the three key interaction 
stages in outpatient CR from a nationally representative cohort of PCI patients. The findings 
from this research make several contributions to the current literature. These findings also 
enhance our understanding of the determinants of CR utilisation and suggests that some of 
the theoretical expectations about CR uptake are not substantiated by analyses of large, 
routine clinical datasets. The main findings of this thesis can be listed as follows: 
 A systematic review of the literature around CR utilisation revealed few studies 
investigating CR engagement although the majority of patients decide not to initiate CR 
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at this early stage. Most of the current research has been directed to investigate CR 
uptake and adherence which have relatively higher utilisation rates than CR engagement. 
 The analysis of CR engagement undertaken in this thesis has extended our 
understanding of the determinants of low CR utilisation rates in England. Although age 
and gender are significant determinants of CR engagement, which is also true for CR 
uptake, service level factors play a major role in CR engagement. 
 With regards to CR uptake, there was significant interaction revealing that younger 
women (≤ 57 years) are more likely to start CR compared to younger men while older 
women were found to be less likely to join compared to younger/middle age women or 
older men (> 57 years). 
 In terms of CR adherence, the results suggest that there was no significant differences in 
adherence rates between home-based and group-based programmes either on patients’ 
level or centre level. 
 Taken together, the findings propose that current CR programmes in England are not 
attractive to those who are socially deprived, diabetic and smokers. 
8.3 Limitations 
Despite the implementation of robust statistical techniques and conducting the analysis in 
large high quality database that contains all of the characteristics and variables, 
observational studies remain susceptible to selection bias. Selection bias, as explained in 
chapter 3, can lead to large unobserved differences between treatment and control groups 
which may result in false estimates of treatment effects (confounding) and therefore 
manipulate the outcomes being measured. In addition, the analysed dataset was designed to 
monitor how CR is delivered in the UK but not CR utilisation. Therefore, some other 
relevant determinants influencing CR utilisation that were reported in previous studies and 
not collected in the primary dataset have been missed. It is unfortunate that the analyses did 
not include determinants like patient’s education level, transportation time and English 
language proficiency. 
One of the greatest challenges when using large datasets is how to deal with missing data 
and outliers in an appropriate way as the researcher has no means to access the original 
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dataset. Due to the nature of how NACR collects its data, there is a considerable number of 
missingness in the data. Although multiple imputation as a validated robust method of 
handling missingness in the data was adopted, it remains a computational approximation 
processes of replacing the missing value with a range of values that the true value could 
have taken. As a result, it is important to bear in mind the possible increased uncertainty and 
errors in any conclusions drawn. In addition, NACR data collection involves human 
operators keying in data which may occasionally introduce entry errors that can impact the 
quality of data and may affect the outcome result. However, the automated data auditing and 
cleaning techniques implemented in the NACR portal plus the manual data cleaning 
conducted by the researcher should help overcome this issue. 
Another source of weakness in this thesis which could have affected the analyses was that 
the population investigated was a mix bag of all PCI types in which some intrinsic patient 
related clinical factors are different. However, PCI type was used as a predictor in the related 
analyses to minimise the effect of this issue. 
8.4 Implications 
The findings of this thesis have significant implications for the understanding of how to 
improve CR utilisation in the growing PCI cohort. The most obvious finding to emerge from 
this research: 
 More emphasis should be placed on strategies to improve early CR engagement. Such 
strategies have the potential to benefit many more patients as they progress to their 
cardiology/rehab journey.  
 CR utilisation is not a single patient decision but is also related to service level factors, 
over which healthcare systems have more direct control. Taken together, some of the 
determinants like age and gender are not modifiable and the only way to counter their 
influence is to understand how CR is offered and seek solutions around how to optimise 
throughput so that services tackle such inequalities. For example, future strategies to 
increase CR uptake in the PCI cohort should not consider age and gender as entirely 
independently determinants but should also consider age in the context of gender. 
180 
Approaches to increase CR uptake may therefore be differentiated by age and gender 
profile of the target population.  
 Current CR programmes in England are not taking up by those who are socially 
deprived, diabetic, smokers and had previous cardiac event. These findings support the 
idea that CR programmes in England should be tailored to suite different patient groups 
and that one size CR programme doesn’t fit all patients. In addition, CR commissioners 
should deploy tailored support to enable different patient groups to progress from the 
baseline assessment to completing the programme. Particularly, the results from this 
research suggest that there were no significant differences in adherence rates between 
home-based and group-based programmes either on patients’ level or centre level. 
8.5 Recommendations 
The findings of this thesis suggest several courses of action for local CR programmes and 
CR stakeholders these include: 
 First, early engagement with CR is a priority as it enables each local CR programme to 
maximise patient’s throughput. This research has identified barriers and facilitators that 
programmes can learn from to aid engagement, uptake and adherence. 
 Second, it was evident from this research that service level factors play a major role in 
CR utilisation. There is, therefore, a definite need for people who assure and regulate 
CR in the UK to intervene (Figure 1.3). NACR and BACPR have been working together 
to develop a certification system that ensures that CR programmes in the UK are 
meeting a pre-specified minimum standards. These minimum standards are designed to 
enable the assessment of any variation in the quality of service delivered to patients. 
Using the national audit data and the research generated through it, like the thesis, can 
inform how programmes meet the minimum standards in an objective and fair way. 
Based on this thesis new minimum standards such as the confirmed join date could be 
added to the national certification criteria. 
 Third, continued efforts are needed to maintain and improve the quality of the NACR 
data. With the current ratio of missingness in the NACR dataset the quality and validity 
of research generated through it is compromised. Although some statistical techniques, 
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such as multiple imputation, have the potential to strengthen the validity of research 
outcomes, it comes with the expense of time and scarifying hybrid sophisticated 
statistical techniques like bootstrapping and multilevel modelling. Another aspect of 
improving the quality of the NACR data is through limiting data entry errors. Although 
NACR has tightened up on data quality procedures to align with NICE guidance and the 
emerging NHS commissioning and accountability frameworks, more work can be done 
by adding validations to the entry fields in the NACR portal system to prevent users 
from keying in extreme values accidentally. 
8.6 Future research 
This research has thrown up many questions in need of further investigation of CR 
utilisation determinants. These investigations might be conducted using different research 
methods and may include the following: 
 There is a tendency in the CR literature to include mixed population when investigating 
CR utilisation. This is of a concern particularly with the presence of some intrinsic 
patient related clinical factors in each population. For example, the PCI cohort are 
different in terms of age, number of comorbidities and hospital length of stay than other 
patient groups such as CABG and heart failure. Future research should therefore 
concentrate on stratifying each group separately when conducting the analysis. 
 The analysis of CR engagement undertaken in this thesis has revealed that service level 
factors play a major role at this critical stage of CR utilisation. This would be a fruitful 
area for further which will enhance our understanding of low CR utilisation rates. 
 In the CR engagement study, the analysis revealed that patients who were given a firm 
date to attend the initial CR assessment were over 4 times more likely to engage in CR. 
A sub-analysis of patient groups who are most likely to benefit from this technique can 
be conducted. 
 In the uptake study, it was found out that younger men and older women are less likely 
to start CR. Further qualitative research might explore why younger men and older 
women are less likely to uptake CR. 
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 With regards to CR adherence, the thesis analysis confirmed previously reported 
findings in the literature that there is no significant differences in adherence rates 
between home-based and group-based programmes either on patients’ level or centre 
level. Further studies need to be done to investigate home-based CR in terms of 
availability, outcomes and possible methods of delivery such as web-based applications, 
home visits or telephone calls. 
 This research has established a framework that can be utilised to develop an intervention 
with respect to identified barriers to promote CR utilisation in the PCI population.  
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Appendices 
Appendix A.1 The five main search terms used to identify relevant 
literature. 
1 CR Indication terms 
Arteriosclerosis/ or Myocardial Infarction/ or Coronary Thrombosis/ or Acute 
Coronary Syndrome/ or Angina, Unstable/ or Angina Pectoris/ or Coronary Disease/ 
or Coronary Artery Disease/ or Coronary Artery Bypass/ or Arterial Occlusive 
Diseases/ or Angioplasty, Balloon/ or Angioplasty, Balloon, Coronary/ or Stents/ or 
Angioplasty/ or Postoperative Complications/ or Angioplasty, Balloon, Coronary/ or 
Coronary Angiography/ or Acute Coronary Syndrome/ or Percutaneous Coronary 
Intervention/ or Myocardial Reperfusion Injury/ or Coronary Disease/ or 
Myocardial Infarction/ or Coronary Circulation/ or Coronary Disease/ or Coronary 
Artery Bypass/rh [Rehabilitation]/ or Coronary Artery Disease/ or Coronary 
Disease/ or Myocardial Infarction/ or Coronary Angiography/ or Acute Coronary 
Syndrome/ 
2 CR terms 
Rehabilitation Research/ or Rehabilitation/ or Cardiac Rehabilitation/ or Psychiatric 
Rehabilitation/ or Rehabilitation Nursing/ or "Physical and Rehabilitation 
Medicine"/ or Rehabilitation Centers/ 
3 Utilisation terms 
(compliance or complie$ or comply$).ti,ab./ Or (take up or promot$ or utilisation or 
utilisation).ti,ab./ or (uptake or attend$ or accept or particip$).ti,ab./ or exp Patient 
Compliance/ or (non?compli$ or non?attend$).ti,ab./ or (nonparticipat$ or non-
participat$).ti,ab./ or (nonattend$ or non-attend$).ti,ab./ or (non-utiliz$ or non-
utilis$).ti,ab./ or (adher$ or non-adhere$).ti,ab./ or (compl$ or non-compl$).ti,ab. 
4 Determinants terms 
exp Ethnic Groups/ or exp Refugees/ or exp Cultural characteristics/ or 
((underserve$ or disadvantage$) adj6 (group$ or population$)).tw./ or ethnic$.tw./ or 
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(migrant$ or immigrant$).tw./ or ((hard to reach or depriv$ or disadvantage$ or 
Under?represented or under-represented or under?served or underserved or low 
income or poor or low$ socio?economic? or low socio economic or low$ socio 
demographic$ or low socio?demographic or inequal$ or inequit$) adj3 (status or 
group? or population? or position or disparity or area or region or place?)).ti,ab./ or 
((Gender adj difference) or (female adj patient?) or wom?n).ti,ab./ or ((Old or elder$ 
or homeless or traveler) adj patient?).tw./ or exp Aged/ or Sex factors/ or Age 
factors/ or Poverty/ or Minority Groups/ or Income/ or Social Class/ or (cormorbid$ 
or co-morbid$).ti,ab./ or exp Homeless Persons/ 
5 Study design terms 
randomized controlled trial.mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique identifier, 
synonyms]/ or controlled clinical trial.mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier, synonyms]/ or randomized.mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier, synonyms]/ or Cohort Studies/ or Follow-Up Studies/ or Longitudinal 
Studies/or Prospective Studies/ or Cohort Studies/ or Retrospective Studies/ 
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Appendix A.2 Medline (incl. PubMed): Search interface: PubMed – 
Date of search: Aug 16 2017. 
# Searches 
1 Arteriosclerosis/ or Myocardial Infarction/ or Coronary Thrombosis/ or Acute 
Coronary Syndrome/ or Angina, Unstable/ or Angina Pectoris/ or Coronary 
Disease/ or Coronary Artery Disease/ 
2 Coronary Artery Bypass/ 
3 Arterial Occlusive Diseases/ or Angioplasty, Balloon/ or Angioplasty, Balloon, 
Coronary/ or Stents/ or Angioplasty/  
4 Postoperative Complications/ or Angioplasty, Balloon, Coronary/ or Coronary 
Angiography/ or Acute Coronary Syndrome/ or Percutaneous Coronary 
Intervention/ 
5 Myocardial Reperfusion Injury/ or Coronary Disease/ or Myocardial Infarction/  
6 Coronary Circulation/ or Coronary Disease/  
7 Coronary Artery Bypass/rh [Rehabilitation]  
8 Coronary Artery Disease/ or Coronary Disease/ or Myocardial Infarction/ or 
Coronary Angiography/ or Acute Coronary Syndrome/ 
9 Rehabilitation Research/ or Rehabilitation/ or Cardiac Rehabilitation/ or Psychiatric 
Rehabilitation/ or Rehabilitation Nursing/ or "Physical and Rehabilitation 
Medicine"/ or Rehabilitation Centers/  
10 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
11 randomized controlled trial.mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique identifier, 
synonyms] 
12 controlled clinical trial.mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary 
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concept word, rare disease supplementary concept word, unique identifier, 
synonyms]  
13 randomized.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms] 
14 Cohort Studies/  
15 Follow-Up Studies/  
16 Longitudinal Studies/ 
17 Prospective Studies/ 
18 Cohort Studies/  
19 Retrospective Studies/  
20 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 
21 exp Ethnic Groups/  
22 exp Refugees/  
23 exp Cultural characteristics/ 
24 ((underserve$ or disadvantage$) adj6 (group$ or population$)).tw. 
25 ethnic$.tw. 
26 (migrant$ or immigrant$).tw. 
27 refugees.tw. 
28 ((hard to reach or depriv$ or disadvantage$ or Under?represented or under-
represented or under?served or underserved or low income or poor or low$ 
socio?economic? or low socio economic or low$ socio demographic$ or low 
socio?demographic or inequal$ or inequit$) adj3 (status or group? or population? or 
position or disparity or area or region or place?)).ti,ab. 
29 ((Gender adj difference) or (female adj patient?) or wom?n).ti,ab. 
30 ((Old or elder$ or homeless or traveler) adj patient?).tw.  
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31 exp Aged/ 
32 Sex factors/ 
33 Age factors/ 
34 Poverty/ 
35 Minority Groups/ 
36 Income/ 
37 Social Class/ 
38 (cormorbid$ or co-morbid$).ti,ab. 
39 exp Homeless Persons/  
40 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 
or 36 or 37 or 38 or 39  
41 (compliance or complie$ or comply$).ti,ab.  
42 (take up or promot$ or utilisation or utilisation).ti,ab.  
43 (uptake or attend$ or accept or particip$).ti,ab.  
44 exp Patient Compliance/ 
45 (non?compli$ or non?attend$).ti,ab. 
46 (nonparticipat$ or non-participat$).ti,ab. 
47 (nonattend$ or non-attend$).ti,ab. 
48 (non-utiliz$ or non-utilis$).ti,ab.  
49 (adher$ or non-adhere$).ti,ab. 
50 (compl$ or non-compl$).ti,ab.  
51 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50  
52 limit 51 to (english language and humans) 
53 9 and 10 and 20 and 40 and 51 and 52 
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Appendix A.3 Extraction sheet for selected studies. 
Study 1st author 
Country of 
origin 
Study 
design 
Population 
diagnosis 
Population 
treatment 
Measured 
outcome 
Sample size 
Sample 
mean age 
Female 
ratio 
Gallagher 2003 Australia 
Primary 
prospective 
MI CABG uptake 196 67.1 100 
Harlan 1995 US 
Primary 
prospective 
CAD CABG uptake 393 63 19 
Shanmugasegaram 2013 Canada 
Primary 
prospective 
ACS Mixed uptake 1809 65.2 27 
Brual 2010 Canada 
Primary 
prospective 
CAD Mixed uptake 1268 66.3 28.2 
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Mochari 2006 US 
Primary 
prospective 
CHD Mixed uptake 304 62.3 100 
Dunlay2009 US 
Primary 
prospective 
MI Mixed uptake 179 64.8 34.1 
Yohannes 2007 UK 
Primary 
prospective 
MI Mixed adherence 189 60 31.7 
King 2001 Canada 
Primary 
prospective 
MI mixed uptake 304 N/A 24 
Sanderson 2010 US 
Primary 
prospective 
mixed Mixed uptake 131 61 100 
Reges 2013 Israel 
Primary 
prospective 
ACS N/A uptake 420 59.6 15.5 
190 
Molloy 2008 UK 
Primary 
prospective 
ACS N/A uptake 193 60.6 23 
Missik 1999 US 
Primary 
prospective 
CHD N/A uptake 370 66.2 100 
French 2005 UK 
Primary 
prospective 
MI N/A uptake 194 63.3 26.8 
Cupples 2010 
Northern 
Ireland 
Primary 
prospective 
MI N/A uptake 432 N/A N/A 
SooHoo 2016 Australia 
Primary 
prospective 
ACS PCI uptake 246 63.6 21 
Gracea 2008 Canada 
Primary 
prospective 
CAD Mixed Engagement 1268 66 28 
191 
Hoffmanna 2013 Switzerland 
Primary 
prospective 
CAD PCI/CABG uptake 309 69.2 33.7 
Lane 2001 UK 
Primary 
prospective 
MI PCI/CABG uptake 263 61.6 24 
Grace 2010 Canada 
Primary 
prospective 
ACS Mixed Engagement 661 61.2 23.8 
Allen 2004 US 
Primary 
prospective 
MI PCI/CABG uptake 253 66 100 
Beckie2015 US 
Primary 
prospective 
mixed Mixed adherence 252 N/A 100 
Grace 2011 Canada 
Primary 
prospective 
ACS PCI/CABG Engagement 2635 65 26.8 
192 
Sarrafzadegan 2007 Iran 
Primary 
prospective 
MI PCI/CABG adherence 1115 55 24 
Worcester 2004 Australia 
Primary 
prospective 
MI PCI/CABG 
uptake/adher
ence 
652 64.9 30 
Harrison 2005 UK 
Primary 
prospective 
Mixed PCI/CABG 
uptake/adher
ence 
313 67.3 31.4 
Grace 2016 Canada * mixed mixed adherence 169 63.6 100 
Beckie 2010 US * Mixed Mixed adherence 252 63.6 100 
Banerjee 2007 Canada 
Secondary 
retrospective 
CAD CABG adherence 1200 57.5 78.5 
193 
Smith 2006 Canada 
Secondary 
retrospective 
CAD CABG 
Engagement/
uptake 
3536 64 20.9 
Doll 2015 US 
Secondary 
retrospective 
MI Mixed adherence 11862 73.5 37 
Armstrong 2014 Canada 
Secondary 
retrospective 
MIxed Mixed adherence 8582 59.5 28 
Turk-Adawi 2013 US 
Secondary 
retrospective 
mixed MIxed adherence 4412 65 30.4 
Casey 2008 US 
Secondary 
retrospective 
mixed Mixed adherence 600 66.5 30.4 
Suaya 2007 US 
Secondary 
retrospective 
MI CABG uptake 267427 N/A 44.1 
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McKee 2014 Ireland 
Secondary 
retrospective 
ACS Mixed uptake 1172 62.5 24.6 
Lemstra 2013 Canada 
Secondary 
retrospective 
CHD PCI/CABG 
uptake/adher
ence 
18980 N/A N/A 
Parashar 2012 US 
Secondary 
retrospective 
MI mixed uptake 2096 60.4 29 
Dunlay 2014 US 
Secondary 
retrospective 
MI Mixed uptake 2991 67.3 40.6 
Chamosa 2015 Spain 
Secondary 
retrospective 
mixed Mixed uptake 756 58.02 16.4 
Turk-Adawi 2014 US 
Secondary 
retrospective 
mixed Mixed uptake 6874 N/A 30.7 
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Engen-Verheul 2012 Netherlands 
Secondary 
retrospective 
mixed Mixed uptake 35752 N/A 40.1 
Evenson 1998 US 
Secondary 
retrospective 
MIxed Mixed uptake 3841 N/A 42 
Melville 1999 UK 
Secondary 
retrospective 
MI N/A uptake 508 N/A N/A 
Nielsen K 2008 Denmark 
Secondary 
retrospective 
MI PCI/CABG uptake 206 59.8 24.5 
Beauchamp 2013 Australia 
Secondary 
retrospective 
MI PCI/CABG uptake 281 62 48 
Sundararajan 2004 Australia 
Secondary 
retrospective 
MI PCI/CABG uptake 12821 N/A N/A 
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Appendix B.1 Predictor variables description for CR engagement. 
Predictor variable Description  
Age Patient’s age  calculated from date of birth to hospital 
admission in years 
Sex Male, female 
Ethnicity Patient’s ethnic group as reported in primary data (White, 
Black, south Asian and other ethnicity) 
Marital status Patient’s marital status during event (single, in partnership 
or previously partnered) 
IMD rank Index of Multiple Deprivation score grouped into 5 equal-
sized groups according to score. Quintile 1 represents 
most-deprived patients and quintile 5 represents least-
deprived patients. 
High blood pressure, 
Diabetes, High blood 
cholesterol, Anxiety, 
Depression, Family history 
Coded ‘yes’ if documented during hospital admission 
otherwise no 
Total number of 
comorbidities 
The sum of patient’s total comorbidities reported in 
NACR dataset which includes (Angina, Arthritis, Cancer, 
Diabetes, Rheumatism, Stroke, Osteoporosis, 
Hypertension, Chronic bronchitis, Emphysema, Asthma, 
Claudication, Chronic Back Problems, Anxiety, 
Depression, Erectile Dysfunction, Dyslipidaemia and 
Other Comorbid Complaint).   
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Previous cardiac event Coded ‘yes’ if patient has history of previous cardiac event 
such as MI, cardiac arrest, pacemaker, bypass surgery, 
congenital heart disease, PCI, heart failure…etc.  
Referred to CR by The healthcare professional who referred the patient to CR 
(consultant, cardiac nurse, general practitioner, primary 
care nurse or other). 
Venue of source of referral 
to CR 
The healthcare institution where referral was issued 
(national health service (NHS) trust, general practice (GB) 
or BMI/Private hospital. 
Hospital stay length A binary categorical variable that is coded into 1 if the PCI 
procedure was performed as ‘day case’ and 0 for overnight 
stay.  
Received confirmed joining 
date 
Coded ‘yes’ if patient’s has received a firm start date for 
the core rehab phase. 
PCI type Type of PCI treatment delivered to patient during the 
cardiac event (primary, MI or elective). 
Patient received early CR Coded ‘yes if the patient received early phase 1 CR 
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Appendix B.2 Explanation of the independent factors of CR uptake 
included in the analysis and their subcategories. 
Predictor variable Description  
Age Patient’s age calculated from date of birth to hospital 
admission in two subcategories; young < 65 years and 
elderly > 65 years  
Gender Binary variable (Male, female) 
Ethnicity Patient’s ethnic group (White, Black, south Asian or other) 
High blood pressure, 
Diabetes, High blood 
cholesterol, Anxiety, 
Depression, Family 
history 
Binary variable coded ‘yes’ if documented during baseline 
assessment otherwise no 
Physical activity Binary variable coded ‘yes’ if patients take regular physical 
activity of at least 150 minutes over 7 days 
Being overweight Binary variable coded ‘yes’ if patients body max index 
(BMI) > 30 
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Employment Patients employment status during event (employed, 
unemployed or retired) 
Marital status Patient’s marital status during event (single, partnered, or 
previous partnership) 
Social support Binary (yes/no) variable based on patient’s own answer to 
the question ‘During the past week was someone available 
to help you if you needed and wanted help? 
Alcohol intake Binary variable coded ‘1’ if patient’s alcohol intake > 21 
units/week for men and > 14 units/week for women 
otherwise ‘0’ 
Smoking Binary variable coded ‘yes’ if the patient was smoking 
during the event, no or unknown if otherwise 
Physical fitness Binary variable coded ‘yes if the patient answered moderate, 
heavy or very heavy to the question ‘during the past week 
what was the hardest physical activity you could do for at 
least 2 minutes?’ 
Comorbidities Total number of comorbidities during the event 
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Referred to CR by Who referred the patient to CR (hospital setting or primary 
setting) 
Hospital stay length Binary variable coded ‘1’ if PCI  done as a day case 
procedure and ‘0’ if patient stayed overnight in hospital 
Venue of source of 
referral 
Where referral comes from (NHS trust, general practice or 
private hospital)  
Time from event to 
Assessment 
Waiting time from cardiac event to pre-CR assessment in 
weeks 
Received confirmed 
joining date 
Binary variable coded ‘1’ if patient received a confirmed 
date to start CR from CR centre otherwise ‘0’ 
PCI type Type of PCI treatment received (primary PCI, MI PCI or 
elective PCI) 
Previous cardiac event Binary variable coded ‘yes’ if patient has a history of 
previous cardiac event such as PCI, MI, Angina… etc. 
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Received early CR Binary variable coded ‘yes’ if patient received phase 1 CR 
during hospitalisation   
Index of multiple 
deprivation (IMD) 
IMD score was grouped into 5 equal-sized groups according 
to score where quintile 1 represents most-deprived patients 
and quintile 5 represents least-deprived patients. 
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Appendix B.3 Explanation of the independent factors for CR 
adherence included in the analysis and their subcategories. 
Predictor variable Description  
Age Patient’s age calculated from date of birth to hospital 
admission in two subcategories; young < 65 years and 
elderly > 65 years  
Sex Binary variable (Male, female) 
Ethnicity Patient’s ethnic group (White, Black, south Asian or other) 
Index of multiple 
deprivation (IMD) 
IMD score was grouped into 5 equal-sized groups 
according to score where quintile 1 represents most-
deprived patients and quintile 5 represents least-deprived 
patients. 
Marital status Patient’s marital status during event (single, partnered, or 
previous partnership) 
Social support Binary (yes/no) variable based on patient’s own answer to 
the question ‘During the past week was someone available 
to help you if you needed and wanted help? 
Employment Patients employment status during event (employed either 
full time or part time, unemployed or retired) 
High blood pressure, 
Diabetes, High blood 
cholesterol, Anxiety, 
Depression 
Binary variable coded ‘yes’ if documented during baseline 
assessment otherwise no 
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Physical activity Binary variable coded ‘yes’ if patients take regular physical 
activity of at least 150 minutes per week 
Being overweight Binary variable coded ‘yes’ if patients body max index 
(BMI) > 30 
Alcohol intake Binary variable coded ‘1’ if patient’s alcohol intake > 21 
units/week for men and > 14 units/week for women 
otherwise ‘0’ 
Smoking Binary variable coded ‘yes’ if the patient was smoking 
during the event, no or unknown if otherwise 
Physical fitness Binary variable coded ‘yes if the patient answered 
moderate, heavy or very heavy to the question ‘during the 
past week what was the hardest physical activity you could 
do for at least 2 minutes?’ 
Comorbidities Total number of comorbidities during the event coded into 
3 subcategories (0 comorbidity, ≤ 2 comorbidities and ≥ 3 
comorbidities) 
Previous cardiac event Binary variable coded ‘yes’ if patient has a history of 
previous cardiac event such as PCI, MI, Angina… etc. 
Family history Binary variable coded ‘yes’ if patient has a family history 
of cardiac disease 
Angina Binary variable coded ‘yes’ if angina pectoris is 
documented during baseline assessment otherwise no 
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CR dose Total number of sessions attended divided by programme 
duration in weeks (session/week) 
Group/alone CR Binary variable coded ‘1’ if the patient attended CR in a 
group based settings 
Supervised/self-
delivered 
Binary variable coded ‘1’ if the programme was delivered 
under the supervision of the CR team either in group based 
or individually through home visits, telephone calls… etc. 
MDT centre The programme is delivered by a multidisciplinary team 
BACPR certified 
programme 
Binary variable coded ‘1’ if the programme is certified by 
the British Association for Cardiovascular Prevention and 
Rehabilitation 
PCI type Type of PCI treatment received (primary PCI, MI PCI or 
elective PCI) 
Time from event to 
starting CR 
Waiting time from the index cardiac event to the first 
session of the outpatient CR programme in days 
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Appendix C.1 CR mode of delivery survey. 
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Appendix C.2 NACR self-reporting questionnaire. 
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Appendix D.1 Engagement study publication. 
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Appendix D.2 Cardiac rehabilitation history publication. 
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Appendix D.3 Impact of age and gender on CR uptake publication. 
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Appendix E.1 SPSS syntax used to create analyses variables  
* Encoding: UTF-8. 
 *    type of treatment variable 
DATASET ACTIVATE DataSet1. 
RECODE survey_cat (2=1) (3=1) (6=1) (5=2) (15=2) (1=3) (4=3) (8=3) (ELSE=SYSMIS) 
INTO  
    Treatment_Type. 
EXECUTE. 
 
 *    Select MI and Young Age 
USE ALL. 
COMPUTE filter_$=(NVALID(MIonly) & NVALID(Age18to65)). 
VARIABLE LABELS filter_$ 'NVALID(MIonly) & NVALID(Age18to65) (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
 * MT only variable  
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RECODE MT_Group (0=1) (ELSE=SYSMIS) INTO MT_Only. 
EXECUTE. 
 
 * Referred by split into cardiac source and primary source 
RECODE ReferredBy (1=0) (2=0) (3=1) (4=1) (ELSE=SYSMIS) INTO ReferredBy2. 
VARIABLE LABELS  ReferredBy2 'Cardiac Referral Vs Primary '. 
EXECUTE. 
 * Grouping By date Variable (for jan 2010 to dec 2015) 
DATASET ACTIVATE DataSet1. 
IF  (IEDate >= DATE.DMY(1,1,2010) & IEDate <= DATE.DMY(31,12,2010)) 
GroupingByDate=1. 
EXECUTE. 
IF  (IEDate >= DATE.DMY(1,1,2011) & IEDate <= DATE.DMY(31,12,2011)) 
GroupingByDate=2. 
EXECUTE. 
IF  (IEDate >= DATE.DMY(1,1,2012) & IEDate <= DATE.DMY(31,12,2012)) 
GroupingByDate=3. 
EXECUTE. 
IF  (IEDate >= DATE.DMY(1,1,2013) & IEDate <= DATE.DMY(31,12,2013)) 
GroupingByDate=4. 
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EXECUTE. 
IF  (IEDate >= DATE.DMY(1,1,2014) & IEDate <= DATE.DMY(31,12,2014)) 
GroupingByDate=5. 
EXECUTE. 
 
IF  (IEDate >= DATE.DMY(1,1,2015) & IEDate <= DATE.DMY(31,12,2015)) 
GroupingByDate=6. 
EXECUTE. 
 *  Grouping By date Variable (for july 2010 to june 2015) 
DATASET ACTIVATE DataSet1. 
IF  (IEDate >= DATE.DMY(1,7,2010) & IEDate <= DATE.DMY(30,6,2011)) 
GroupingByDate2015=1. 
EXECUTE. 
IF  (IEDate >= DATE.DMY(1,7,2011) & IEDate <= DATE.DMY(30,6,2012)) 
GroupingByDate2015=2. 
EXECUTE. 
IF  (IEDate >= DATE.DMY(1,7,2012) & IEDate <= DATE.DMY(30,6,2013)) 
GroupingByDate2015=3. 
EXECUTE. 
IF  (IEDate >= DATE.DMY(1,7,2013) & IEDate <= DATE.DMY(30,6,2014)) 
GroupingByDate2015=4. 
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EXECUTE. 
IF  (IEDate >= DATE.DMY(1,7,2014) & IEDate <= DATE.DMY(30,6,2015)) 
GroupingByDate2015=5. 
EXECUTE. 
 
 
 
 * Age Group Variable from 18 to 65 & >65 
DATASET ACTIVATE DataSet1. 
IF  (AgeAtInitiatingEvent  >= 66 & AgeAtInitiatingEvent <= 120) AgeGroup2=1. 
EXECUTE. 
IF  (AgeAtInitiatingEvent  >= 18 & AgeAtInitiatingEvent <= 65) AgeGroup2=0. 
EXECUTE. 
 
 * Reason for not joining core rehab splittied to medical and non medical reasons 
RECODE ReasonForNotTakingPart.Core (3=1) (13=1) (14=1) (12=1) (10=1) (8=1) (20=1) 
(21=1) (16=1)  
    (1=2) (2=2) (4=2) (5=2) (6=2) (7=2) (9=2) (11=2) (15=2) (17=2) (18=2) (19=2) (22=3) 
(99=3)  
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    (SYSMIS=SYSMIS) INTO ReasonsForNotStarting. 
VARIABLE LABELS  ReasonsForNotStarting 'Medical Vs Non Medical Reasons'. 
EXECUTE. 
 
* Coding above variable into dichotomus (medical or non medical reasons) 
RECODE ReasonsForNotStarting (1=0) (2=1) (ELSE=SYSMIS) INTO 
Medical.NonMedical.Reasons. 
EXECUTE. 
 * Reasons for not completing core rehab into dichtomous variable 
 
RECODE ReasonForNotCompleting.Core (5=0) (6=0) (7=0) (9=0) (1=1) (2=1) (3=1) (4=1) 
(ELSE=SYSMIS)  
    INTO Reasons.Not.Completing. 
EXECUTE. 
 
 * MAD for BMI.1 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
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  /BMI.1_median=MEDIAN(BMI.1). 
Compute BMI_MED = -999. 
if nvalid(BMI.1) = 1 BMI_MED = BMI.1 - BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
 
 
IF  (BMI.1 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and BMI.1 > 
BMI.1_median - (3*(BMI_MED_median*1.4826))) BMI1.NEW=BMI.1. 
EXECUTE. 
 
 * MAD for BMI.2 
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AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
  /BMI.1_median=MEDIAN(BMI.2). 
Compute BMI_MED = -999. 
if nvalid(BMI.2) = 1 BMI_MED = BMI.2 - BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
IF  (BMI.2 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and BMI.2 > 
BMI.1_median - (3*(BMI_MED_median*1.4826))) BMI2.NEW=BMI.2. 
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EXECUTE. 
 * BMI. Change variable 
IF  (BMI1.NEW > 30 & BMI2.NEW > 30) BMI.Change=0. 
EXECUTE. 
IF  (BMI1.NEW > 30 & BMI2.NEW  < 30) BMI.Change=1. 
EXECUTE. 
 * Waist.1 MAD 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
  /BMI.1_median=MEDIAN(waist.1). 
Compute BMI_MED = -999. 
if nvalid(waist.1) = 1 BMI_MED = waist.1 - BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
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AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
IF  (waist.1 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and waist.1 > 
BMI.1_median - (3*(BMI_MED_median*1.4826))) waist.1.NEW=waist.1. 
EXECUTE. 
 * Waist.2 MAD 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
  /BMI.1_median=MEDIAN(waist.2). 
Compute BMI_MED = -999. 
if nvalid(waist.2) = 1 BMI_MED = waist.2 - BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
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AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
IF  (waist.2 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and waist.2 > 
BMI.1_median - (3*(BMI_MED_median*1.4826))) waist.2.NEW=waist.2. 
EXECUTE. 
* waist.1 for male 
IF  (Sex=1 & NVALID(waist.1.NEW)) waist.1.male=waist.1.NEW. 
EXECUTE. 
 * waist.1 female 
IF  (Sex=2 & NVALID(waist.1.NEW)) waist.1.Female=waist.1.NEW. 
EXECUTE. 
  * waist.2 for male 
IF  (Sex=1 & NVALID(waist.2.NEW)) waist.2.male=waist.2.NEW. 
EXECUTE. 
 * waist.2 female 
IF  (Sex=2 & NVALID(waist.2.NEW)) waist.2.Female=waist.2.NEW. 
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EXECUTE. 
* WAIST Change variable 
IF  (waist.1.male > 102 & waist.2.male > 102) Waist.Change.Male=0. 
EXECUTE. 
IF  (waist.1.male > 102 & waist.2.male  < 102) Waist.Change.Male=1. 
EXECUTE. 
 * Waist Change Female 
IF  (waist.1.female > 88 & waist.2.female < 88) Waist.Change.Female=1. 
EXECUTE. 
IF  (waist.1.female > 88 & waist.2.female > 88) Waist.Change.Female=0. 
EXECUTE. 
 * Cholesterol Change Variable 
DATASET ACTIVATE DataSet4. 
IF  (CholesterolTotal.1 > 5 & CholesterolTotal.2 > 5) Cholesterol.Change=0. 
EXECUTE. 
IF  (CholesterolTotal.1 > 5 & CholesterolTotal.2  <= 5) Cholesterol.Change=1. 
EXECUTE. 
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* MAD for BloodPressureSystolic.1 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
  /BMI.1_median=MEDIAN(BloodPressureSystolic.1). 
Compute BMI_MED = -999. 
if nvalid(BloodPressureSystolic.1) = 1 BMI_MED = BloodPressureSystolic.1 - 
BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
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IF  (BloodPressureSystolic.1 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and 
BloodPressureSystolic.1 > BMI.1_median - (3*(BMI_MED_median*1.4826))) 
BloodPressureSystolic.1.NEW=BloodPressureSystolic.1. 
EXECUTE. 
* MAD for BloodPressureSystolic.2 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
  /BMI.1_median=MEDIAN(BloodPressureSystolic.2). 
Compute BMI_MED = -999. 
if nvalid(BloodPressureSystolic.2) = 1 BMI_MED = BloodPressureSystolic.2 - 
BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
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  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
IF  (BloodPressureSystolic.2 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and 
BloodPressureSystolic.2 > BMI.1_median - (3*(BMI_MED_median*1.4826))) 
BloodPressureSystolic.2.NEW=BloodPressureSystolic.2. 
EXECUTE. 
 * BP Change variable 
DATASET ACTIVATE DataSet4. 
IF  (BloodPressureSystolic.1 > 140 & BloodPressureSystolic.2 > 140) 
BloodPressureSystolic.Change=0. 
EXECUTE. 
IF  (BloodPressureSystolic.1 > 140 & BloodPressureSystolic.2  <= 140) 
BloodPressureSystolic.Change=1. 
EXECUTE. 
 * Smoke Diff Variable 
DATASET ACTIVATE DataSet6. 
COMPUTE Smoke_Diff=Smoke1 - Smoke2. 
EXECUTE. 
 * Smoke Change Variable 
RECODE Smoke_Diff (-1=0) (0=0) (1=1) (ELSE=SYSMIS) INTO Smoke.Change. 
EXECUTE. 
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* MAD for ShuttleWalkTestMetres.1 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
  /BMI.1_median=MEDIAN(ShuttleWalkTestMetres.1). 
Compute BMI_MED = -999. 
if nvalid(ShuttleWalkTestMetres.1) = 1 BMI_MED = ShuttleWalkTestMetres.1 - 
BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
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IF  (ShuttleWalkTestMetres.1 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and 
ShuttleWalkTestMetres.1 > BMI.1_median - (3*(BMI_MED_median*1.4826))) 
ShuttleWalkTestMetres.1.NEW=ShuttleWalkTestMetres.1. 
EXECUTE. 
* MAD for ShuttleWalkTestMetres.2 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
  /BMI.1_median=MEDIAN(ShuttleWalkTestMetres.2). 
Compute BMI_MED = -999. 
if nvalid(ShuttleWalkTestMetres.2) = 1 BMI_MED = ShuttleWalkTestMetres.2 - 
BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
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  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
 
 
IF  (ShuttleWalkTestMetres.2 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and 
ShuttleWalkTestMetres.2 > BMI.1_median - (3*(BMI_MED_median*1.4826))) 
ShuttleWalkTestMetres.2.NEW=ShuttleWalkTestMetres.2. 
EXECUTE. 
 * ISWT_Diff Variable 
IF  (NVALID(ShuttleWalkTestMetres.1.NEW) & 
NVALID(ShuttleWalkTestMetres.2.NEW))  
    ISWT_Diff=ShuttleWalkTestMetres.1.NEW - ShuttleWalkTestMetres.2.NEW. 
EXECUTE. 
 * ISWT. Change Variable 
RECODE ISWT_Diff (SYSMIS=SYSMIS) (-900 thru -75=1) (-74 thru 1200=0) INTO 
ISWT.Change. 
EXECUTE. 
* MAD for TAM2.1 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
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  /BMI.1_median=MEDIAN(TAM2.1). 
Compute BMI_MED = -999. 
if nvalid(TAM2.1) = 1 BMI_MED = TAM2.1 - BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
IF  (TAM2.1 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and TAM2.1 > 
BMI.1_median - (3*(BMI_MED_median*1.4826))) TAM2.1.NEW=TAM2.1. 
EXECUTE. 
* MAD for TAM2.2 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
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  /BMI.1_median=MEDIAN(TAM2.2). 
Compute BMI_MED = -999. 
if nvalid(TAM2.2) = 1 BMI_MED = TAM2.2 - BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
 
 * TAM2 Diff Variable 
IF  (NVALID(TAM2.1.NEW) & NVALID(TAM2.2.NEW)) TAM2_Diff=TAM2.1.NEW - 
TAM2.2.NEW. 
EXECUTE. 
 * TAM2 Change Variable 
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RECODE TAM2_Diff (SYSMIS=SYSMIS) (-10000 thru -1=1) (0 thru 20000=0) INTO 
TAM2.Change. 
EXECUTE. 
 * HAD Anxiety difference variable 
DATASET ACTIVATE DataSet1. 
IF  (NVALID(HAD_Anx_1) & NVALID(HAD_Anx_2)) HAD_Anx_Dif=HAD_Anx_1 - 
HAD_Anx_2. 
EXECUTE. 
 * HAD Anx change Variable 
RECODE HAD_Anx_Dif (SYSMIS=SYSMIS) (-4 thru 0=0) (1 thru 4=1) INTO 
HAD_Anx_Change. 
EXECUTE. 
* HAD Depression difference variable 
DATASET ACTIVATE DataSet1. 
IF  (NVALID(HAD_Dep_1) & NVALID(HAD_Dep_2)) HAD_Dep_Dif=HAD_Dep_1 - 
HAD_Dep_2. 
EXECUTE. 
 * HAD Depression change Variable 
RECODE HAD_Dep_Dif (SYSMIS=SYSMIS) (-4 thru 0=0) (1 thru 4=1) INTO 
HAD_Dep_Change. 
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EXECUTE. 
* MAD for SixMinuteWalkMetres.1 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
  /BMI.1_median=MEDIAN(SixMinuteWalkMetres.1). 
 
Compute BMI_MED = -999. 
if nvalid(SixMinuteWalkMetres.1) = 1 BMI_MED = SixMinuteWalkMetres.1 - 
BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
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IF  (SixMinuteWalkMetres.1 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and 
SixMinuteWalkMetres.1 > BMI.1_median - (3*(BMI_MED_median*1.4826))) 
SixMinuteWalkMetres.1.NEW=SixMinuteWalkMetres.1. 
EXECUTE. 
* MAD for SixMinuteWalkMetres.2 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES OVERWRITEVARS=YES 
  /BREAK= 
  /BMI.1_median=MEDIAN(SixMinuteWalkMetres.2). 
Compute BMI_MED = -999. 
if nvalid(SixMinuteWalkMetres.2) = 1 BMI_MED = SixMinuteWalkMetres.2 - 
BMI.1_median. 
RECODE BMI_MED (-999=SYSMIS). 
EXECUTE. 
COMPUTE BMI_MEDABS=ABS(BMI_MED). 
EXECUTE. 
AGGREGATE 
  /OUTFILE=* MODE=ADDVARIABLES 
  /BREAK= 
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  /BMI_MED_median=MEDIAN(BMI_MEDABS). 
IF  (SixMinuteWalkMetres.2 < BMI.1_median + (3*(BMI_MED_median*1.4826)) and 
SixMinuteWalkMetres.2 > BMI.1_median - (3*(BMI_MED_median*1.4826))) 
SixMinuteWalkMetres.2.NEW=SixMinuteWalkMetres.2. 
EXECUTE. 
 * SixMinuteWalkMetres difference variable 
DATASET ACTIVATE DataSet1. 
IF  (NVALID(SixMinuteWalkMetres.1.NEW) & NVALID(SixMinuteWalkMetres.2.NEW))  
    SixMinuteWalkMetres_Diff=SixMinuteWalkMetres.1.NEW - 
SixMinuteWalkMetres.2.NEW. 
EXECUTE. 
 * SixMinuteWalkMetres change variable 
RECODE SixMinuteWalkMetres_Diff (SYSMIS=SYSMIS) (-600 thru -1=1) (0 thru 
1000=0) INTO  
    SixMinuteWalkMetres_Change. 
EXECUTE. 
 * SixMinuteWalkMetres difference variable 
DATASET ACTIVATE DataSet1. 
IF  (NVALID(ThirtyMins5TimesAWeek.1.NEW) & 
NVALID(ThirtyMins5TimesAWeek.2.NEW))  
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    ThirtyMins5TimesAWeek_Diff=ThirtyMins5TimesAWeek.1.NEW - 
ThirtyMins5TimesAWeek.2.NEW. 
EXECUTE. 
 * SixMinuteWalkMetres change variable 
RECODE ThirtyMins5TimesAWeek_Diff (SYSMIS=SYSMIS) (-600 thru -1=1) (0 thru 
1000=0) INTO  
    ThirtyMins5TimesAWeek_Change. 
EXECUTE. 
 * Exercise_50_A Diff Variable 
DATASET ACTIVATE DataSet1. 
COMPUTE Exercise_50_A_Diff=Exercise_50_A1 - Exercise_50_A2. 
EXECUTE. 
 * Exercise_50_A Change Variable 
RECODE Exercise_50_A_Diff (-3 thru -1=1) (0 thru 3=0) (ELSE=SYSMIS) INTO 
Exercise_50_A.Change. 
EXECUTE. 
 * 75 Vigrous Test Recoding to Dichtomous 
DATASET ACTIVATE DataSet1. 
RECODE SeventyFiveMinsOfVigorousExercise.1 SeventyFiveMinsOfVigorousExercise.2 
('N'=0) ('Y'=1)  
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    (MISSING=SYSMIS) INTO SeventyFive.1 SeventyFive.2. 
EXECUTE. 
 * 75 Diff Variable 
 
IF  (NVALID(SeventyFive.1) & NVALID(SeventyFive.2)) 
SeventyFive_Diff=SeventyFive.1 - SeventyFive.2. 
EXECUTE. 
 * 75 Change Varible 
RECODE SeventyFive_Diff (-3 thru -1=1) (0 thru 3=0) (ELSE=SYSMIS) INTO 
SeventyFive.Change. 
EXECUTE. 
 * IE Valid and not Referred Variable 
DATASET ACTIVATE DataSet1. 
IF  (AllCoreReferred = 0) IEventnotReferred=IEValid. 
EXECUTE. 
 * Referred but not Started Group 
IF  (StartValid = 0 & AllCoreReferred = 1) ReferredNotStarted=StartValid. 
EXECUTE. 
 * Comorbidit total variable 
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COMPUTE 
Comorbidity_Sum=SUM(Angina1,Arthritis2,Cancer3,Diabetes4,Rheumatism5,Stroke6,Oste
oporosis7, 
   
Hypertension8,Chronic9,Emphysema10,Asthma11,Claudication12,Chronic13,Anxiety14,De
pression15, 
    Family16,Erectile17,Hyper18,Other99). 
EXECUTE. 
 * Comorbidity by 2 variabel 
IF  (Comorbidity_Sum > 2) ComorbidBy2=1. 
EXECUTE. 
IF  (Comorbidity_Sum  <= 2) ComorbidBy2=0. 
EXECUTE. 
 * New Ethnic Groups Variable 
RECODE EthnicGroup ('A'=1) ('B'=2) ('C'=3) ('H'=4) ('J'=4) ('K'=4) ('D'=5) ('E'=5) ('F'=5) 
('G'=5)  
    ('L'=5) ('M'=5) ('N'=5) ('P'=5) ('R'=5) ('S'=5) (ELSE=SYSMIS) INTO 
New_Ethnic_Groups. 
EXECUTE. 
 * New employment Variable 
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RECODE CurrentEmploymentStatus.1 (1=1) (3=1) (2=2) (4=2) (8=3) (6=4) (11=4) (5=4) 
(7=4) (9=4)  
    (10=4) (12=4) (ELSE=SYSMIS) INTO New_Employment. 
EXECUTE. 
 * New marital status variable 
DATASET ACTIVATE DataSet1. 
RECODE MaritalStatus (1=1) (2=2) (3=2) (4=3) (5=3) (6=3) (ELSE=SYSMIS) INTO 
New_Marital. 
EXECUTE. 
 
 * currently smoking variabel 
DATASET ACTIVATE DataSet1. 
RECODE Smoked.1 Smoked.2 (4=1) (1=0) (2=0) (3=0) (SYSMIS=SYSMIS) 
(ELSE=SYSMIS) INTO  
    CurrentlySmoking.1 CurrentlySmoking.2. 
EXECUTE. 
 * Baseline for males waist above 102cm 
DATASET ACTIVATE DataSet1. 
RECODE waist.1.male (SYSMIS=SYSMIS) (102 thru 1000=1) (1 thru 101=0) INTO 
WaistBaselineRatioMale. 
251 
EXECUTE. 
 * BAseline female waist 88c 
DATASET ACTIVATE DataSet1. 
RECODE waist.1.female (SYSMIS=SYSMIS) (88 thru 1000=1) (1 thru 87=0) INTO 
WaistBaselineRatioFemale. 
EXECUTE. 
 * BMI above 30 at baseline 
RECODE BMI1.NEW (SYSMIS=SYSMIS) (0 thru 30=0) (31 thru 1000=1) INTO 
BMIabove30atBaseline. 
EXECUTE. 
 * BMI above 25 at baeline 
 
RECODE BMI1.NEW (SYSMIS=SYSMIS) (0 thru 25=0) (26 thru 1000=1) INTO 
BMIabove25atBaseline. 
EXECUTE. 
 * Grouping By date Variable (for April 2011 to March 2016) 
DATASET ACTIVATE DataSet1. 
IF  (IEDate >= DATE.DMY(1,4,2011) & IEDate <= DATE.DMY(31,3,2012)) 
GroupingByDate=1. 
EXECUTE. 
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IF  (IEDate >= DATE.DMY(1,4,2012) & IEDate <= DATE.DMY(31,3,2013)) 
GroupingByDate=2. 
EXECUTE. 
IF  (IEDate >= DATE.DMY(1,4,2013) & IEDate <= DATE.DMY(31,3,2014)) 
GroupingByDate=3. 
EXECUTE. 
IF  (IEDate >= DATE.DMY(1,4,2014) & IEDate <= DATE.DMY(31,3,2015)) 
GroupingByDate=4. 
EXECUTE. 
IF  (IEDate >= DATE.DMY(1,4,2015) & IEDate <= DATE.DMY(31,3,2016)) 
GroupingByDate=5. 
EXECUTE. 
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Abbreviations 
AACVPR Association of Cardiovascular Pulmonary Rehabilitation 
ACCF American College of Cardiology Foundation 
ACE Angiotensin-Converting Enzyme 
ACS Acute Coronary Syndrome 
AHA American Heart Association 
BACPR British Association for Cardiovascular Prevention and Rehabilitation 
BCIS British Cardiovascular Intervention Society 
BHF British Heart Foundation 
BMI Body Mass Index 
CABG Coronary Artery Bypass Grafts 
CAD Coronary Artery Disease 
CEBR Centre for Economics and Business Research 
CHD Coronary Heart Disease 
CI Confidence Interval 
CPRP Cardiovascular Prevention And Rehabilitation Programme 
CR Cardiac Rehabilitation 
CVD Cardiovascular Diseases 
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ECG Electrocardiogram 
ESC European Society of Cardiology 
HF Heart Failure 
HRQL Health Related Quality of Life 
IMD Index of Multiple Deprivation 
MI Myocardial Infarction 
MLHFQ Minnesota Living with Heart Failure Questionnaire 
NACR National Audit of Cardiac Rehabilitation 
NHS National Health Service 
NICE National Institute For Health and Care Excellence 
PCI Percutaneous Coronary Intervention 
RCT Randomised Control Trial 
STEMI ST Elevation Myocardial Infarction 
WHF World Health Federation 
WHO World Health Organisation 
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